KOL | Rikard HolmdahlNational and Local Joint Engineering Research Center of Biodiagnosis and Biotherapy, The Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China | Medical ... |
Kol currículo para Rikard Holmdahl
| Year | |
|---|---|
| 2022 | National and Local Joint Engineering Research Center of Biodiagnosis and Biotherapy, The Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China Medical Inflammation Research, MediCity Research Laboratory, University of Turku, Turku, Finland |
| 2021 | The Second Affiliated Hospital of Xi’an Jiaotong University (Xibei Hospital), Xi’an, China Department Medical Biochemistry and Biophysics, Division Medical Inflammation Research, Karolinska Institute, 171 77 Stockholm, Sweden;, (M.A.);, (X.C.);, (B.X.);, (G.F.L.);, (M.Y.B.);, (Y.H.);, (L.B.) Division of Medical Inflammation Research, Dept. of Medical Biochemistry and Biophysics, Karolinska Institute, Stockholm, Sweden |
| 2020 | Dept. of Medical Inflammation Research, Section of Medical Biochemistry and Biophysics, Karolinska Institute, Stockholm Section for Medical Inflammation Research, BMCI11, Lund University, Lund, Sweden National & Local Joint Engineering Research Center of Biodiagnosis and Biotherapy, The Second Affiliated Hospital, Xi'an Jiaotong University, 710004 Xi’an, China Karolinska Institutet |
| 2019 | Section for Medical Inflammation Research, Department of Medical Biochemistry and Biophysics, Karolinska Institute, Solnavägen 9, 171 65, Solna, Sweden Center for Medical Inflammation Research, Southern Medical University, Guangzhou, China R. Holmdahl and C.I. Svensson contributed equally to this paper. |
| 2018 | School of Pharmaceutical Science, Southern Medical University, Guangzhou, China Medical Inflammation Research, Department of Medical Biochemistry and Biophysics, Karolinska Institutet, Stockholm 17177, Sweden. Electronic address: Karolinska University Hospital, Karolinska Institutet, Stockholm, Sweden Medicity Research Laboratory, University of Turku, Turku, Finland |
| 2017 | Karolinska Institutet Division of Medical Inflammation Research Stockholm Sweden Center for Medical Immunopharmacology Research, Southern Medical University, 510515 Guangzhou, China. Medicity Research Laboratory, University of Turku, Turku, Finland, . |
Rikard Holmdahl: Influência estatística
Relatório de execução
| Concept | World rank |
|---|---|
| heterologous cii cells | #1 |
| mcii707 | #1 |
| m1s1a | #1 |
| mouse cii | #1 |
| chronic arthritis rats | #1 |
| cia animal models | #1 |
| protective role cia | #1 |
| arthritis incidence | #1 |
| illness terpenes | #1 |
| cia ul1 | #1 |
| cii lewis rats | #1 |
| u1 epitope | #1 |
| rt1ba | #1 |
| cia2 cia9 | #1 |
| type epitopes | #1 |
| disease monitoring rats | #1 |
| nox2 complex ncf4 | #1 |
| susceptible collagen | #1 |
| cia chromosome | #1 |
| caia cii | #1 |
| igg2a vivo | #1 |
| 1 ncf1 | #1 |
| fecq4 locus | #1 |
| toxin‐1‐producing staphylococci | #1 |
| induced arthritis | #1 |
| nss1 | #1 |
| manifestations lupus disease | #1 |
| maintained pregnancy levels | #1 |
| treatment cii immunization | #1 |
| aq glycopeptide | #1 |
| m2139 ciic1 | #1 |
| cia22 | #1 |
| caia lps | #1 |
| cia eae39 | #1 |
| 6 cii | #1 |
| arthritogenicity cells | #1 |
| tnfα tlr3 expression | #1 |
| collagen epitopes | #1 |
| reactivity cb268 | #1 |
| caia experimental arthritis | #1 |
| disease cd8 deficiency | #1 |
| ros immunohistochemistry implants | #1 |
| pia disease | #1 |
| arthritis tlr3 upregulation | #1 |
| mem lglutamine | #1 |
| ctbcii | #1 |
| arthritis animal | #1 |
| greater osteoclasts | #1 |
| hladrbound peptides | #1 |
| cia oestrogen | #1 |
| ciic1 mab ciif4 | #1 |
| ncf4 mice | #1 |
| genetic control pia | #1 |
| mmc transgene | #1 |
| antibodies pc4 | #1 |
| dth mice trait | #1 |
| emulsions induction | #1 |
| functional nox2 complex | #1 |
| induction phase cia | #1 |
| cartilaginous joints | #1 |
| caia effects | #1 |
| cartilage explants mabs | #1 |
| mice anticd4 treatment | #1 |
| mediate pulmonary inflammation | #1 |
| synovium pia rats | #1 |
| arthritis darkness | #1 |
| pia rheumatoid arthritis | #1 |
| ciiderived | #1 |
| estrogeninduced suppression | #1 |
| antibodies citrullinated peptide | #1 |
| ciispecific cell responses | #1 |
| phemagelatin | #1 |
| ros rns inflammation | #1 |
| cia oia | #1 |
| functional selective fpr1 | #1 |
| complex cia | #1 |
| antigen presentation cii | #1 |
| controlling collagen | #1 |
| snat proteins | #1 |
| cia comp | #1 |
| methods | #1 |
| epitopes cb10 fragment | #1 |
| estrogenmediated suppression | #1 |
| confers arthritis susceptibility | #1 |
| mab ecm | #1 |
| elisagenetyping | #1 |
| rfig lambda | #1 |
| congenic cia40 | #1 |
| clonal expansion arthritis | #1 |
| disease lew | #1 |
| genetic regions | #1 |
| cartilagespecific protein | #1 |
| compdeficient mice | #1 |
| experimental arthritis autoimmune | #1 |
| incidence arthritis | #1 |
| cii immunodominant | #1 |
| ox8 monoclonal | #1 |
| native comp | #1 |
| targeted deletion ncf1 | #1 |
| pc117 | #1 |
| arthritis immunization | #1 |
| effector phase arthritis | #1 |
| position ciilysdnp | #1 |
| ifnbeta experimental arthritis | #1 |
| role major epitopes | #1 |
| b10dr4ncf1 mice cii | #1 |
| development aureus arthritis | #1 |
| congenic fragments | #1 |
| cii antibody | #1 |
| periodontitis rats pia | #1 |
| collagen chains antibody | #1 |
| il10 mmc | #1 |
| skg mutation | #1 |
| mouse chromosome eae39 | #1 |
| ncf1 copy variation | #1 |
| cii 256270 peptide | #1 |
| immunization type | #1 |
| cii pia | #1 |
| role eosinophilia | #1 |
| new arthritis | #1 |
| 4 histone deacetylases | #1 |
| cxb10qf2 | #1 |
| cia swr mouse | #1 |
| frequency chronic arthritis | #1 |
| ncf1m1j mice | #1 |
| cii comp | #1 |
| collagen arthritis iii | #1 |
| increased salt exposure | #1 |
| epitopes cii | #1 |
| sialadenitis incidence | #1 |
| established pia disease | #1 |
| cii anticd4 treatment | #1 |
| tumor models ncf1 | #1 |
| pia4 | #1 |
| lnchc cholesterol metabolism | #1 |
| susceptibility cia | #1 |
| lewis oia | #1 |
| cartilage‐specific | #1 |
| rs201802880 | #1 |
| flss tlr3 expression | #1 |
| animal immunosuppressive agents | #1 |
| cia locus | #1 |
| maintenance arthritis | #1 |
| antibody ciic1 | #1 |
| rats chronic disease | #1 |
| single bout hiit | #1 |
| collagen citrullination | #1 |
| ncf4 | #1 |
| mice th1 cytokines | #1 |
| humans animals arthritis | #1 |
| anticcp2negative patients | #1 |
| arthritis monoclonal | #1 |
| comp arthritis models | #1 |
| collagen langerhans cells | #1 |
| peritonitis sod3 | #1 |
| f1 males influence | #1 |
| dth dba 1 | #1 |
| cia rat cii | #1 |
| h‐2q mice | #1 |
| ll37 rcramp | #1 |
| ncf1 ncf1 mice | #1 |
| spontaneous tissue inflammation | #1 |
| cell determinants cii | #1 |
| lower capacity ros | #1 |
| rats ncf1 gene | #1 |
| chromosome arthritis severity | #1 |
| exacerbation arthritis | #1 |
| ccp positive patients | #1 |
| immunospecific reactions | #1 |
| potent disease accelerator | #1 |
| function ncf1 gene | #1 |
| arthritis adjuvants | #1 |
| disease affinity | #1 |
| homologous type collagen | #1 |
| rat comp | #1 |
| disease development effects | #1 |
| active arthritis complex | #1 |
| daf2cross | #1 |
| antiidiotypic antibodies cd4 | #1 |
| tlr2 tlr2 regulation | #1 |
| m2139 arthritogenic mab | #1 |
| collagen induced | #1 |
| arthritis susceptibility rats | #1 |
| ciif4 mab | #1 |
| mannaninduced | #1 |
| position mouse cii | #1 |
| cii cartilage explants | #1 |
| autoantibody responses cii | #1 |
| nodq×b10q | #1 |
| mannan mice | #1 |
| chronic relapsing arthritis | #1 |
| c4bp alternative pathway | #1 |
| mhc class injections | #1 |
| congenic polymorphism illness | #1 |
| spe acute phase | #1 |
| nox2 functionality | #1 |
| cii major epitope | #1 |
| autoantibodies cii | #1 |
| wild type ncf1 | #1 |
| established arthritis | #1 |
| lewis rats pepsin | #1 |
| regulates severity | #1 |
| ncf1 mice wt | #1 |
| flss polyi | #1 |
| superovulation rate | #1 |
| tolerance cia | #1 |
| experimental autoantigens | #1 |
| mice ncf1m1j mutation | #1 |
| ciispecific antibodies | #1 |
| anticii antibodies | #1 |
| rat recombinants | #1 |
| cells arthritogenicity | #1 |
| tolerance arthritis susceptibility | #1 |
| ros glucose transporter | #1 |
| collageninduced arthritis | #1 |
| estrogen immune responses | #1 |
| autoimmunity mineral oils | #1 |
| csfspecific | #1 |
| reduced oxidative burst | #1 |
| complex aq molecules | #1 |
| mice salt intake | #1 |
| cii vaccination | #1 |
| cryogel column antibodies | #1 |
| b10qnss1 | #1 |
| downregulating oestradiol | #1 |
| cd68‐expressing cells | #1 |
| rats antibody cartilage | #1 |
| cii260 | #1 |
| mice mutated cii | #1 |
| nzw parental strain | #1 |
| arthritis traits | #1 |
| cartilage‐specific antibodiesis | #1 |
| human immunopeptidome lung | #1 |
| homologous type | #1 |
| arthritis multiple | #1 |
| synovial cells macrophages | #1 |
| rt1f haplotype | #1 |
| chronic arthritis development | #1 |
| igg response cii | #1 |
| ncf4 gene | #1 |
| mrl mice estrogen | #1 |
| caia model | #1 |
| b10qnfr | #1 |
| cii lewis | #1 |
| induce arthritis | #1 |
| genetic encephalomyelitis autoimmune | #1 |
| citc1iiip | #1 |
| rheumatoid disease models | #1 |
| therapeutic cleavage | #1 |
| chromosome f1 males | #1 |
| ncf1 polymorphisms | #1 |
| dth response mrl | #1 |
| dba 1jpfp | #1 |
| cia molecular basis | #1 |
| protein expression genes | #1 |
| heterologous cii | #1 |
| epitopes cb11 fragment | #1 |
| rt1u lew1w | #1 |
| mice c3h background | #1 |
| plcpip | #1 |
| ciipeptide | #1 |
| eae b10riii mice | #1 |
| expression ncf1 | #1 |
| nasal treatment ctbcii | #1 |
| glycosylated determinant peptides | #1 |
| arthritis synovial tlr3 | #1 |
| mbq mouse macrophages | #1 |
| pia cii | #1 |
| cii mouse | #1 |
| nox2 function | #1 |
| autoimmune arthritis activation | #1 |
| congenic arthritis | #1 |
| ccp2 negative | #1 |
| rabeximod treatment | #1 |
| β1helix | #1 |
| cia olive oil | #1 |
| inflammatory tissue attack | #1 |
| cii epitopes | #1 |
| animal histocompatibility | #1 |
| autoimmune arthritis apcs | #1 |
| caia riiis segment | #1 |
| treatment physiological doses | #1 |
| ifn signature mice | #1 |
| cia cii | #1 |
| arthritis rat | #1 |
| pia3 chromosome | #1 |
| cii caia | #1 |
| mice interferon gamma | #1 |
| disease arthritis | #1 |
| collagen immunization | #1 |
| mab ciif4 ciic1 | #1 |
| ciif4 ciic1 | #1 |
| siliac | #1 |
| cii triple | #1 |
| development chronic arthritis | #1 |
| bqncf1m1j | #1 |
| cia tsc transgenic | #1 |
| rat congenic data | #1 |
| clec4b | #1 |
| cia vivo priming | #1 |
| periodontitis pristaneinduced arthritis | #1 |
| citrullinated collagen | #1 |
| sensitive wkymvm | #1 |
| spleen cluster | #1 |
| emerging glyco‐based strategies | #1 |
| increased incidence cia | #1 |
| minor cartilage proteins | #1 |
| hg6pi325 | #1 |
| nucleotide reactive | #1 |
| cii response | #1 |
| autoimmune priming | #1 |
| mbp c5a | #1 |
| polymorphism autoimmune diseases | #1 |
| tracheolaryngeal cartilage | #1 |
| mip ncf4 | #1 |
| ncf1 genes | #1 |
| cii256−270 | #1 |
| m1j mice | #1 |
| arthritogenic mabs cii | #1 |
| rat cii cii | #1 |
| arthritis aim | #1 |
| 22 variant r620w | #1 |
| functional nox2 | #1 |
| comp disease monitoring | #1 |
| h2w17 | #1 |
| cii cross reactivity | #1 |
| rat cii | #1 |
| human α‐enolase | #1 |
| mice mutated type | #1 |
| cia opportunities | #1 |
| effects cia | #1 |
| visual signs arthritis | #1 |
| w33t | #1 |
| cia ifa | #1 |
| ciiinduced arthritis | #1 |
| mice darkness | #1 |
| ncf1 mice | #1 |
| oestradiol exacerbation | #1 |
| acpas specificity | #1 |
| cxiia | #1 |
| lys264 | #1 |
| ethylene isostere | #1 |
| arthritis locus | #1 |
| autoantibodies cartilage | #1 |
| collagen arthritis hyaluronanreceptor | #1 |
| dth antibody response | #1 |
| beta haplotype | #1 |
| h2q haplotype | #1 |
| 17βestradiolregulation | #1 |
| signaling characterization | #1 |
| type disease | #1 |
| mumt mice oestrogen | #1 |
| ciif4 cartilage damage | #1 |
| restricted role fcγr | #1 |
| pia eae | #1 |
| presentation arthritis | #1 |
| arthritogenic mabs | #1 |
| oxa backcrosses | #1 |
| collagen ii‐induced | #1 |
| collagen‐induced arthritis | #1 |
| representative swedish | #1 |
| cii epitope | #1 |
| tumors immunosuppressive leukocytes | #1 |
| ym1 alternative activation | #1 |
| cia congenic arthritis | #1 |
| cii human | #1 |
| 237 females | #1 |
| comp lack | #1 |
| cells heterologous cii | #1 |
| encephalomyelitis arthritis | #1 |
| extraarticular cartilage | #1 |
| humanized models disease | #1 |
| c1iii | #1 |
| lymphocytes cartilage | #1 |
| disease suggestive locus | #1 |
| chronic stage arthritis | #1 |
| liver contributes hfdmets | #1 |
| cxi chronic arthritis | #1 |
| ros adaptive immunity | #1 |
| hladrβ10402 | #1 |
| polychondritis mice | #1 |
| cartilage collagen type | #1 |
| drb10401positive | #1 |
| topoisomerase antagonist | #1 |
| cia pia | #1 |
| arthritis chronic | #1 |
| ifa cii ifa | #1 |
| injection adjuvant oils | #1 |
| tolerance induction cii | #1 |
| region ncf1 | #1 |
| ciilysdnp | #1 |
| publication animals arthritis | #1 |
| model rheumatoid arthritis | #1 |
| development pristaneinduced arthritis | #1 |
| pia cix | #1 |
| naive experimental chromosomes | #1 |
| major role rp | #1 |
| blocking arthritis | #1 |
| multiple sclerosis rabeximod | #1 |
| new loci controlling | #1 |
| rabeximod arthritis | #1 |
| rat placenta uterus | #1 |
| presentation cii | #1 |
| h2w3 | #1 |
| eae chromosomes | #1 |
| denidritic cells | #1 |
| idiotype‐specific binding | #1 |
| severe polyarthritis | #1 |
| b10q strain | #1 |
| cii mabs | #1 |
| cii matrix protein | #1 |
| anticii response | #1 |
| scarce clinical samples | #1 |
| substrains ztmrhd | #1 |
| acpa discriminate | #1 |
| b10dr4ncf1 | #1 |
| authors hgpi325339 peptide | #1 |
| cia lysine | #1 |
| modified glycopeptides | #1 |
| h2p mice cia | #1 |
| ul1 ciif4 | #1 |
| cells mouse cii | #1 |
| rats phytol | #1 |
| tlr3 expression flss | #1 |
| il10 cia | #1 |
| development oia | #1 |
| lew ztm ncf1 | #1 |
| major cii | #1 |
| mbq mouse | #1 |
| cii rats | #1 |
| type cii | #1 |
| c3hq | #1 |
| lps caia | #1 |
| dependent autoimmune | #1 |
| arthritis rabeximod | #1 |
| rats synthetic peptide | #1 |
| cells dba mouse | #1 |
| molecule aq | #1 |
| autologous type collagen | #1 |
| tlr3 synovium | #1 |
| cia antibody response | #1 |
| cia development | #1 |
| mcaia | #1 |
| formation arthritis | #1 |
| polymorphism ncf1 | #1 |
| rats pristaneinduced arthritis | #1 |
| eae mtx | #1 |
| daiu | #1 |
| cells cii | #1 |
| sialadenitis cell phenotypes | #1 |
| anti comp | #1 |
| citrullinated collagen arthritis | #1 |
| type collagen cii256−270 | #1 |
| mhc aq | #1 |
| anticii abs | #1 |
| dba 1j | #1 |
| findings new therapy | #1 |
| hfdmets | #1 |
| genetic association ncf1 | #1 |
| g6pi acute arthritis | #1 |
| tolerance arthritis protection | #1 |
| cii immunization treatment | #1 |
| cii induced arthritis | #1 |
| rats antibody response | #1 |
| cells rat cii | #1 |
| injection lewis rat | #1 |
| mabs monoclonal arthritis | #1 |
| arthritis ncf1 allele | #1 |
| ox8 antibodies | #1 |
| arthritis male | #1 |
| tlr3 expression fls | #1 |
| cartilage damage vivo | #1 |
| tumor colonization | #1 |
| rats established pia | #1 |
| serum interferon activity | #1 |
| arthritis males | #1 |
| pristaneprimed cells | #1 |
| cii cell | #1 |
| cia dominant epitope | #1 |
| cia induced arthritis | #1 |
| immune response mbp | #1 |
| ncf1 allele | #1 |
| inflammation caia | #1 |
| ncf1 gene | #1 |
| suppression collagen arthritis | #1 |
| animal genetic predisposition | #1 |
| dominant traits | #1 |
| therapeutic c4bp | #1 |
| rats hfdmets | #1 |
| cii peptide molecules | #1 |
| development cia | #1 |
| mcaia ncf1 | #1 |
| b10q | #1 |
| strains nodq | #1 |
| mucosal tolerance cii | #1 |
| pc4 pc117 | #1 |
| cb268 cii | #1 |
| pristane primed | #1 |
| cix disease | #1 |
| glycosylated epitope structures | #1 |
| mhv runting neonates | #1 |
| ros rheumatoid humans | #1 |
| spread psoriasis | #1 |
| vivo monoclonal mouse | #1 |
| b10riii riiis | #1 |
| pia rats tlr3 | #1 |
| ncf1 spread | #1 |
| phase cia | #1 |
| susceptibility collagen | #1 |
| adjuvant oils | #1 |
| cia13 pia7 | #1 |
| mutated ncf1 | #1 |
| recombinant vaccine inflammation | #1 |
| cia rheumatoid arthritis | #1 |
| cd4 treatment | #1 |
| defined polymeric adjuvant | #1 |
| antibody cartilage blymphocyte | #1 |
| vivo imaging l012 | #1 |
| genes arthritis | #1 |
| single monoclonal | #1 |
| chronic development | #1 |
| cii259 273 | #1 |
| suppressive development | #1 |
| cii immunisation | #1 |
| cell recognition carbohydrates | #1 |
| cia model strains | #1 |
| respiratory burst severity | #1 |
| cii acpa | #1 |
| rats ncf1 | #1 |
| sle‐prone mrl | #1 |
| strains polychondritis | #1 |
| ifnbeta deficiency | #1 |
| polymorphism mitochondrial genome | #1 |
| mice salt concentrations | #1 |
| breeding capacity | #1 |
| ncf1 p47phox | #1 |
| clec4b activation | #1 |
| eae strains severity | #1 |
| arthritis cia | #1 |
| fls ppt medium | #1 |
| 2 nox2 | #1 |
| cia rheumatoid autoantibodies | #1 |
| region eae3 | #1 |
| headache paradigm | #1 |
| glycopeptide stimulation | #1 |
| reactivity cii | #1 |
| ifa rats | #1 |
| tlr3 rna interference | #1 |
| arthritis humans | #1 |
| mgpi325 | #1 |
| arthritis antibody | #1 |
| cd43expressing cells | #1 |
| cia11 | #1 |
| suggestive locus chromosome | #1 |
| injection mannan | #1 |
| genetically segregating crosses | #1 |
| mice functional ncf1 | #1 |
| increase ncf1 | #1 |
| identification genetic regions | #1 |
| ros ncf1 | #1 |
| inconsistent susceptibility | #1 |
| tolerance collagen | #1 |
| carcinoma tumors ros | #1 |
| models rheumatoid | #1 |
| models rheumatoid arthritis | #1 |
| ciispecific | #1 |
| arthritis independent | #1 |
| cii rat cii | #1 |
| arthritis tlr3 | #1 |
| δ228 | #1 |
| function single | #1 |
| mhc cii | #1 |
| salivary glands antigen | #1 |
| experimental collagen | #1 |
| cii immunization | #1 |
| heterologous collagen | #1 |
| cii antigen presentation | #1 |
| enhanced autoimmunity | #1 |
| psicoch2 | #1 |
| cia animal epitopes | #1 |
| cii chronic | #1 |
| resistance collageninduced arthritis | #1 |
| cii treatment | #1 |
| backcrosses nzb mice | #1 |
| type collagen cxi | #1 |
| new therapy arthritis | #1 |
| c3hq mice | #1 |
| collagen dendritic cells | #1 |
| da1f | #1 |
| concentrations rat cii | #1 |
| early onset development | #1 |
| elimination carbohydrates | #1 |
| arthritis pepsin | #1 |
| glycosylated epitope | #1 |
| endos hydrolyzed igg | #1 |
| severity ides | #1 |
| keratinocytes dth reaction | #1 |
| cii h2q | #1 |
| fecq4 | #1 |
| differential susceptibility cia | #1 |
| f1 hybrids disease | #1 |
| h2r h2q | #1 |
| myelomonocytic arthritis interleukin2 | #1 |
| aq molecule | #1 |
| position 264 | #1 |
| male mice arthritis | #1 |
| hladr1transgenic mice | #1 |
| cii u1 | #1 |
| hydrocarbon oil structure | #1 |
| striking phenotypic similarities | #1 |
| phytol arthritis | #1 |
| arthritogenic mab ciic1 | #1 |
| serum chromosome | #1 |
| hufcgammariia | #1 |
| arthritis pnipaam | #1 |
| critical restriction site | #1 |
| immune cartilage | #1 |
| experimental autoantibodies | #1 |
| cii256 270 | #1 |
| cix cartilage | #1 |
| aplec locus | #1 |
| cells mgps | #1 |
| h‐2q | #1 |
| hla–dr1 | #1 |
| loci controlling diabetes | #1 |
| arthritis‐susceptibility loci | #1 |
| nzw parental | #1 |
| function targeted deletion | #1 |
| dr4 glycopeptides | #1 |
| induced relapsing | #1 |
| 371115tetramethyl2hexadecene1ol | #1 |
| collagen arthritis progesterone | #1 |
| dapia6 | #1 |
| nox2complex | #1 |
| arthritogenic antibodies | #1 |
| dba mouse epitopes | #1 |
| transgenic nadph oxidase | #1 |
| mhc genetic region | #1 |
| caia monoclonal | #1 |
| pepsin arthritis | #1 |
| p47phoxv232 | #1 |
| rheumatoid collagen | #1 |
| ii‐induced arthritis | #1 |
| mice cryogels | #1 |
| oxidative burst inducers | #1 |
| cia collagen | #1 |
| oxa nzb mice | #1 |
| rat type collagen | #1 |
| cia7 chromosome | #1 |
| ciic1 fab | #1 |
| homologous type pia | #1 |
| peptides aq | #1 |
| cii induce | #1 |
| cia ros | #1 |
| cii256270 | #1 |
| phagocyte oxidative burst | #1 |
| pristane hydrocarbon oils | #1 |
| rats rheumatoid | #1 |
| arthritis mutant strains | #1 |
| diagnostic accuracy acpa | #1 |
| autoimmunogenic hydrocarbon oils | #1 |
| lew avridineinduced arthritis | #1 |
| anticii antibody response | #1 |
| congenic polymorphism | #1 |
| mice ros | #1 |
| autoimmune response cii | #1 |
| immunization rat | #1 |
| frequency igaproducing cells | #1 |
| cii 256 | #1 |
| plasminogendeficient mice arthritis | #1 |
| pia2–8 | #1 |
| autoantibody formation cia | #1 |
| rats pia9 alleles | #1 |
| function acpas | #1 |
| ncf1 | #1 |
| ztmrhd | #1 |
| immunization autologous peptide | #1 |
| established sialadenitis | #1 |
| immunological transmitter | #1 |
| myeloid effector functions | #1 |
| ncf1 mutant mice | #1 |
| cageeffects | #1 |
| arthritis anticii abs | #1 |
| mechanism autoimmune | #1 |
| cii swr mice | #1 |
| mir144 tlr2 expression | #1 |
| ym1 pneumonitis | #1 |
| arthritis susceptibility mice | #1 |
| arthritis suppression | #1 |
| b10qbalb | #1 |
| models collagen | #1 |
| heterologous peptide response | #1 |
| congenic mice vdr | #1 |
| oestradiol dth | #1 |
| pepsin cii | #1 |
| effects fab2 | #1 |
| controlling onset | #1 |
| cxi collagen fibers | #1 |
| pregq2 fragment | #1 |
| h2q mice | #1 |
| arthritis amino | #1 |
| caia acute arthritis | #1 |
| cxi rats | #1 |
| cii experimental arthritis | #1 |
| immunization cii | #1 |
| antibody binding vivo | #1 |
| ftirm ciic1 | #1 |
| eae39 | #1 |
| eae3 chromosome | #1 |
| arthritis rheumatoid arthritis | #1 |
| pia cia13 pia7 | #1 |
| clever1 type macrophages | #1 |
| dancf1da rats | #1 |
| cells caia | #1 |
| ides treatment severity | #1 |
| tlr3 flss | #1 |
| genes animal models | #1 |
| ciiinduced | #1 |
| fab2 ciic1 | #1 |
| gergaagiagpk | #1 |
| cii pepsin | #1 |
| haplotype ltab | #1 |
| emission tomography mannan | #1 |
| collagen 256 | #1 |
| immunodominant cii | #1 |
| c1iii type collagen | #1 |
| h2q h2r | #1 |
| arthritis development severity | #1 |
| arthritis qtl pia7 | #1 |
| pia experimental arthritis | #1 |
| autoimmune diseases cnvs | #1 |
| strains b10q | #1 |
| sterically privileged | #1 |
| cxi | #1 |
| beta 10b mrl | #1 |
| collagen type cii | #1 |
| illness cia | #1 |
| l012 vivo imaging | #1 |
| cb11 fragment | #1 |
| chronic intervention | #1 |
| epitopes arthritis | #1 |
| acpa general population | #1 |
| arthritis qtl chip | #1 |
| cia12 | #1 |
| daxlewf1 | #1 |
| arthritis promoting | #1 |
| caia mab | #1 |
| acute phase arthritis | #1 |
| interacting subloci | #1 |
| vridine‐induced arthritis | #1 |
| cii citrullinated | #1 |
| saline arthritis | #1 |
| ncf1 ptpn22 | #1 |
| stromal cells osteoclasts | #1 |
| nzb dth | #1 |
| genetic control sialadenitis | #1 |
| lathyritic cii | #1 |
| genetic variants ncf1 | #1 |
| oestradiol suppression | #1 |
| c3hnb h2p | #1 |
| cia9 | #1 |
| cia caia model | #1 |
| ciic1 antibody | #1 |
| ncf1 lyme arthritis | #1 |
| immunization heterologous peptide | #1 |
| innate‐associated disease | #1 |
| proteolipoprotein peptide | #1 |
| phagocytic nox2 complex | #1 |
| cii immunization mice | #1 |
| cii cb fragments | #1 |
| argltgrpgda | #1 |
| ul1 vivo | #1 |
| paamcryogel | #1 |
| cell‐deficient mice | #1 |
| kgf chondrocytes | #1 |
| arthritis collagen arthritis | #1 |
| valphachain | #1 |
| ncf1m1j m1j mice | #1 |
| tregs ros | #1 |
| inbred dba pepsin | #1 |
| new arthritis therapy | #1 |
| nadph activation | #1 |
| chlorophyll component | #1 |
| b10qc5δ | #1 |
| b10q dba 1f1 | #1 |
| oxoethyl6h | #1 |
| ciif4 cartilage explants | #1 |
| presence sex hormones | #1 |
| oestrogen‐induced suppression | #1 |
| cii cia | #1 |
| genetic crossbreeding | #1 |
| congenic | #1 |
| riiis alleles eae2 | #1 |
| histology vaccination | #1 |
| cii recognition | #1 |
| polyi arthritis | #1 |
| autoimmune diseases identification | #1 |
| lewis rat cia | #1 |
| anticardiolipin antibodies p005 | #1 |
| b10q mice | #1 |
| cia b10q | #1 |
| rabeximod | #1 |
| ncf1m1j mice ncf1 | #1 |
| rabeximod inflammatory cells | #1 |
| h2p susceptibility | #1 |
| day ciispecific cells | #1 |
| proteins gay | #1 |
| cia homologous cii | #1 |
| hybridomas multispecific antibodies | #1 |
| pc117 extracellular structures | #1 |
| collagen‐induced | #1 |
| cathelicidin expression blood | #1 |
| dependent autoimmune arthritis | #1 |
| anti collagen | #1 |
| ncf1 339 | #1 |
| p47phox mutant | #1 |
| cia mtx | #1 |
| cia mip | #1 |
| mhc cia | #1 |
| arthritis castration | #1 |
| h‐2b | #1 |
| placental mhc class | #1 |
| arthritis | #1 |
| cia12 pia4 | #1 |
| activation cii | #1 |
| position ros production | #1 |
| rt1bβ | #1 |
| stages arthritis | #1 |
| hydrolyzed igg | #1 |
| c3hnb | #1 |
| cia | #1 |
| ala261gly262 | #1 |
| transgenic nadph | #1 |
| oestrogen induced | #1 |
| cii ecm | #1 |
| nodp nod | #1 |
| role ncf1 | #1 |
| immune priming events | #1 |
| rats ncf1 allele | #1 |
| arthritis transfer | #1 |
| cii histocompatibility complex | #1 |
| anticlever1 antibody treatment | #1 |
| contrast nodq | #1 |
| human cii cartilage | #1 |
| nod nss1 loci | #1 |
| ciic1 mabs | #1 |
| satellite encephalomyelitis | #1 |
| pia model | #1 |
| lymphocytes collagen | #1 |
| phytol rna | #1 |
| normal cartilage arthritis | #1 |
| rats adjuvant oil | #1 |
| biodegradation cryogels | #1 |
| tolerance arthritis | #1 |
| cia31 | #1 |
| cxi arthritis | #1 |
| chronic active arthritis | #1 |
| collagen cxi | #1 |
| glut4dependent glucose transport | #1 |
| macrophages cii | #1 |
| cnbr‐fragment | #1 |
| cii disease | #1 |
| disease collagen | #1 |
| joint inflammatory phase | #1 |
| arthritis animal mice | #1 |
| cii259 | #1 |
| disease transgenic models | #1 |
| macrophages cii degradation | #1 |
| major epitopes | #1 |
| olive oil arthritis | #1 |
| arthritis pia | #1 |
| bb2bb3 | #1 |
| female preponderance development | #1 |
| monoclonal cartilage cattle | #1 |
| cii specific | #1 |
| arthritis encephalomyelitis | #1 |
| wo2012127214 | #1 |
| thymectomy transgenes | #1 |
| oxazolone inflammatory response | #1 |
| environments mice | #1 |
| cii monoclonal arthritis | #1 |
| presence arthritogenic mabs | #1 |
| muscle nox2 | #1 |
| arthritis induced | #1 |
| act389949 agonist | #1 |
| qtl animal genes | #1 |
| chemical cartilage | #1 |
| fpr act389949 | #1 |
| recombinants rt1u | #1 |
| arthritis b6n mice | #1 |
| pristane macrophages | #1 |
| lack arthritis | #1 |
| oxidases receptors | #1 |
| homologous cii | #1 |
| cii heterologous cii | #1 |
| leukosialin rats | #1 |
| arthritis b10q mice | #1 |
| melatonin release pinealectomy | #1 |
| ncf1mutation | #1 |
| ym1deficient mice | #1 |
| b10q mice authors | #1 |
| prevents arthritis | #1 |
| ncf1 deficient | #1 |
| antibody responses cii | #1 |
| ncf1da | #1 |
| inbred dba cii | #1 |
| disease susceptibility castration | #1 |
| cia experimental arthritis | #1 |
| animal models acpa | #1 |
| rats rt1 | #1 |
| inbred strains severity | #1 |
| therapeutic cleavage igg | #1 |
| cii ros | #1 |
| pathway arthritis | #1 |
| disease c4bp | #1 |
| induction cii | #1 |
| antibody induced | #1 |
| cii saline | #1 |
| animal epitopes | #1 |
| rns type collagen | #1 |
| mice cii immunization | #1 |
| ciic1scfv | #1 |
| tlr3 expression tnfα | #1 |
| glycosylated cii | #1 |
| tissue attack | #1 |
| cia21 cia22 | #1 |
| concentrations cii | #1 |
| induction oia | #1 |
| oestrogen cia | #1 |
| pia9 | #1 |
| dba1 mice | #1 |
| intracellular processing cii | #1 |
| tlr expression synovium | #1 |
| cells galactosylated peptide | #1 |
| idd5 loci | #1 |
| locus arthritis | #1 |
| animal models arthritis | #1 |
| citrullinated cii | #1 |
| pia11 | #1 |
| transient joint inflammation | #1 |
| arthritis epitopes | #1 |
| eae2 eae3 | #1 |
| nodq locus | #1 |
| non‐mhc genes | #1 |
| comp cxi | #1 |
| mice deficient ncf1 | #1 |
| mannan immune | #1 |
| cell tolerance cii | #1 |
| polychondritis autoimmune disease | #1 |
| mab mab ciic1 | #1 |
| gia expansion | #1 |
| joint proteins | #1 |
| arthritis estrogen treatment | #1 |
| cia cells | #1 |
| comp mabs | #1 |
| estrogen manifestations | #1 |
| cia ul1 mab | #1 |
| c3hnb mice | #1 |
| locus cia development | #1 |
| susceptibility collageninduced arthritis | #1 |
| genetic background rats | #1 |
| arthritis mcaia | #1 |
| ros mip | #1 |
| peritonitis transgenic | #1 |
| cii256 | #1 |
| cia5 region | #1 |
| polyi pia rats | #1 |
| collageninduced arthritis loci | #1 |
| antibody response cii | #1 |
| disease glycoproteins | #1 |
| rats pia | #1 |
| arthritis arthritis loci | #1 |
| chromosomes eae loci | #1 |
| macrophages hladr1transgenic mice | #1 |
| ciiglycopeptides | #1 |
| dba 1 mouse | #1 |
| post‐partum exacerbation | #1 |
| administration antibodies hyaluronanreceptor | #1 |
| c3hq mice cii | #1 |
| cell recognition cii | #1 |
| caia gene segments | #1 |
| ppt medium | #1 |
| inbred dba prolactin | #1 |
| cii cells | #1 |
| innate immunity mip | #1 |
| b10q mice ncf1 | #1 |
| cia5 cia21 | #1 |
| cii mhc | #1 |
| 256 270 | #1 |
| specificity ros rns | #1 |
| relapsing arthritis | #1 |
| susceptible cia | #1 |
| tolerance immunodominant | #1 |
| cartilage explants m2139 | #1 |
| mhc influence | #1 |
| cii polymer | #1 |
| cii dendritic cells | #1 |
| anticii autoantibodies | #1 |
| riiis segment chromosome | #1 |
| region eae2 | #1 |
| kgf cia | #1 |
| bb2bb3 regulation | #1 |
| functional ncf1 macrophages | #1 |
| cells cb11 | #1 |
| plasminogen deficiency cia | #1 |
| damage type collagen | #1 |
| cii rheumatoid autoantibodies | #1 |
| pia model rats | #1 |
| experimental autoimmunity cells | #1 |
| arthritis estrus cycle | #1 |
| compia | #1 |
| citrulline collagen | #1 |
| selected anti‐t‐cell | #1 |
| deficient neonatal | #1 |
| congenic strains cia | #1 |
| response cii | #1 |
| model rheumatoid | #1 |
| antibodies consensus motif | #1 |
| 339 polymorphism | #1 |
| rheumatoid arthritis cia | #1 |
| sialadenitis strains | #1 |
| inflammation living mice | #1 |
| methodspurified | #1 |
| collagen autoantibody | #1 |
| kupffer cells mir144 | #1 |
| comp cii | #1 |
| synovial membranes joints | #1 |
| vivo monoclonal | #1 |
| immunization mouse cii | #1 |
| swr mice immunization | #1 |
| epitope cartilage | #1 |
| experimental arthritis antibodies | #1 |
| pristaneinduced arthritis | #1 |
| rat rt1ba genes | #1 |
| enhanced autoimmunity arthritis | #1 |
| arthritis animals | #1 |
| arthritis control mice | #1 |
| cii mab | #1 |
| milk titers | #1 |
| immunisation cells | #1 |
| cii responsiveness | #1 |
| arthritis estrogen | #1 |
| engagement fcgammar | #1 |
| tracheolaryngeal | #1 |
| m1j | #1 |
| pia rats arthritis | #1 |
| cia experimental autoantibodies | #1 |
| fumia | #1 |
| copy variation ncf1 | #1 |
| eae2 locus | #1 |
| hg6pi | #1 |
| rats rt1f mhc | #1 |
| rats congenic arthritis | #1 |
| ncf1 mutation | #1 |
| transgenic mice mhcii | #1 |
| terpenes toll | #1 |
| pia3 | #1 |
| pristane hexadecane | #1 |
| isolated fragment chromosome | #1 |
| cii induced | #1 |
| nonglycosylated epitope | #1 |
| patients china cohort | #1 |
| satellite encephalomyelitis autoimmune | #1 |
| u1 antibodies patients | #1 |
| severe arthritis immunization | #1 |
| specific cii | #1 |
| arthritis toe stiffness | #1 |
| double deficiency qa2 | #1 |
| nod incidence | #1 |
| cia32 | #1 |
| ncf1 m1j | #1 |
| chromosome cia | #1 |
| citrullinated variants | #1 |
| hyaluronanreceptor cd44 | #1 |
| thps cii | #1 |
| inbred strains cia | #1 |
| glycoprotein alpha1microglobulin | #1 |
| carbohydrates cii | #1 |
| pia7 | #1 |
| ncf1m1j | #1 |
| loci eae39 | #1 |
| nox2derived ros | #1 |
| constant light order | #1 |
| mcia1 | #1 |
| cii ncf1 | #1 |
| arthritis development immunisation | #1 |
| mice ncf1 | #1 |
| mice l012 | #1 |
| j1 epitope | #1 |
| socalled collagen antibody | #1 |
| targeted mutation ncf4 | #1 |
| cia f1 males | #1 |
| ncf1 knockout | #1 |
| existence periodontitis | #1 |
| specific antibody protection | #1 |
| cii olive oil | #1 |
| immunization rat cii | #1 |
| ciispecific monoclonal | #1 |
| cii arthritis | #1 |
| lpr mice granulocytes | #1 |
| ftirm mice | #1 |
| beta 10b beta | #1 |
| rheumatoid arthritis eae | #1 |
| onset animals arthritis | #1 |
| animal genes cia | #1 |
| rats arthritis | #1 |
| ftirm cii | #1 |
| 15a11 | #1 |
| b10q b10riii | #1 |
| chromosome 17 mhc | #1 |
| ncf1 nos2 | #1 |
| recognition lysine | #1 |
| cia cartilage | #1 |
| mediating arthritis | #1 |
| 270 peptide | #1 |
| autologous cii | #1 |
| acute arthritis neutrophils | #1 |
| phosphatase 22 | #1 |
| surface redox levels | #1 |
| wt ncf1 | #1 |
| development inflammatory attack | #1 |
| rats clec4b | #1 |
| loci sialadenitis | #1 |
| major antigenic epitope | #1 |
| qa2 gene clusters | #1 |
| estrogen physiological doses | #1 |
| aq class | #1 |
| dth nzb mice | #1 |
| strains developed | #1 |
| genome b10riii | #1 |
| disease genotype immunoglobulin | #1 |
| fibroblasts ifnbetadeficient mice | #1 |
| re04001activatedfpr1 | #1 |
| oils induce | #1 |
| oia induction | #1 |
| ncf1 polymorphism | #1 |
| cartilage specific | #1 |
| immunologic animals arthritis | #1 |
| experimental arthritis articular | #1 |
| pia cia | #1 |
| arthritis severity rats | #1 |
| olive oil cii | #1 |
| congenic strains rats | #1 |
| antitlr3 antibody | #1 |
| epitope type | #1 |
| peptide agonist fmlf | #1 |
| rheumatoid arthritis immunization | #1 |
| mab cb268 | #1 |
| monoclonal arthritis arthritis | #1 |
| qtl positional cloning | #1 |
| susceptible strain cross | #1 |
| reproductive performance identification | #1 |
| macrophages mannans | #1 |
| col2259 | #1 |
| cb11 sequence cii | #1 |
| cii cxi | #1 |
| cii cix | #1 |
| severe arthritis | #1 |
| data act389949 | #1 |
| chromosome congenic strains | #1 |
| decreasing activation | #1 |
| role nox2derived ros | #1 |
| cells ncf1 | #1 |
| vivo experimental arthritis | #1 |
| mice arthritis | #1 |
| cii severity | #1 |
| cia h2p | #1 |
| partial advanced | #1 |
| urokinase enzyme | #1 |
| insulitis nodq | #1 |
| dimethyl6n | #1 |
| arthritis gene regions | #1 |
| pristane tlr3 expression | #1 |
| autoantibodies collagen | #1 |
| elevated th17 cells | #1 |
| collagen epitope expression | #1 |
| phase arthritis | #1 |
| avridine arthritis | #1 |
| eae2 resistant locus | #1 |
| genes congenic | #1 |
| animal models complexity | #1 |
| collagen type‐ii epitope | #1 |
| arthritis driven | #1 |
| congenic mice genes | #1 |
| c3bireceptors | #1 |
| experimental collagen type | #1 |
| nephritis nodq | #1 |
| severity arthritis | #1 |
| collagen cii | #1 |
| mice burkholderia cepacia | #1 |
| oestrogen treated | #1 |
| cell specificity cii | #1 |
| ncf1m1j mice function | #1 |
| arthritis cell | #1 |
| cia antigens haplotypes | #1 |
| function nox2 | #1 |
| qa2 ncf1 | #1 |
| glycosylation cell recognition | #1 |
| strong response epitopes | #1 |
| ncf1 association | #1 |
| galactosylated peptide | #1 |
| concentrations mouse cii | #1 |
| pathogenesis cia | #1 |
| ability gut protection | #1 |
| cia reduction | #1 |
| cholera toxin study | #1 |
| phytol molecular pathways | #1 |
| cartilage stability cartilage | #1 |
| h2g7 haplotype nod | #1 |
| developed severe | #1 |
| eae2 | #1 |
| t‐cell epitope cii260‐270 | #1 |
| cartilage cii | #1 |
| bcell activities | #1 |
| oxidases polymers | #1 |
| abetachains | #1 |
| b10q1 | #1 |
| inability collagen | #1 |
| arthritis mhc | #1 |
| pregq2 | #1 |
| epitopes vivo | #1 |
| pepsin immunization | #1 |
| developed arthritis | #1 |
| ciif4 adverse effects | #1 |
| cxi comp | #1 |
| collagen antibody arthritis | #1 |
| pc8 pc117 | #1 |
| rat cii response | #1 |
| rp autoimmune disease | #1 |
| cii 6 | #1 |
| ncf1deficient mice | #1 |
| psoriasis single locus | #1 |
| psiechch | #1 |
| b10q h2q | #1 |
| disease dba 1jpfp | #1 |
| hexadecane induce arthritis | #1 |
| mutant p47phox | #1 |
| tcell congenic arthritis | #1 |
| da1u rats expression | #1 |
| synthetic peptides cii | #1 |
| vivo treatment | #1 |
| caia induced | #1 |
| mir144 tlr2 | #1 |
| receptor γ pparγ | #1 |
| arthritis pristane | #1 |
| psoriasis spread | #1 |
| animal models polychondritis | #1 |
| rats comp | #1 |
| gene ncf1 | #1 |
| cuiiidaligands | #1 |
| fcbinding | #1 |
| protein ncf1m1j mice | #1 |
| tcell hybridomas cells | #1 |
| kgf treatment onset | #1 |
| bal cells work | #1 |
| fibroblast induced arthritis | #1 |
| ul1 ciif4 mab | #1 |
| antibodies cii | #1 |
| arthritis immunisation | #1 |
| arthritis autoantibody | #1 |
| cia pathogenesis | #1 |
| collagen reactive | #1 |
| pristaneinduced arthritis pia | #1 |
| psich2nh2 | #1 |
| dba 1 | #1 |
| inclusion negative predictive | #1 |
| rat comp arthritis | #1 |
| genes ncf1 | #1 |
| chromosome pia | #1 |
| rheumatoid arthritis autoimmunity | #1 |
| cii259273 peptide | #1 |
| cii carbohydrates | #1 |
| qtl chip | #1 |
| congenic c57bl mice | #1 |
| nod nss1 | #1 |
| fpr1 agonist neutrophils | #1 |
| expressions cyp7a1 | #1 |
| c57bl 10q | #1 |
| impact etoposide | #1 |
| macrophages autoimmune priming | #1 |
| development humanized models | #1 |
| sialadenitis congenic mice | #1 |
| genistein collagen | #1 |
| arthritis autoimmune | #1 |
| anti cii acpa | #1 |
| position cii256270 | #1 |
| drb10401 col2259 | #1 |
| pathogenesisis | #1 |
| mhc mbp | #1 |
| cells chronic arthritis | #1 |
| epitopes collagen | #1 |
| liver histone deacetylase | #1 |
| tcell experimental cartilage | #1 |
| c57bl strains loci | #1 |
| pia5 | #1 |
| mice h2q | #1 |
| transgenic tolerance tlymphocytes | #1 |
| nox2 agonists | #1 |
| rheumatoid arthritis complexity | #1 |
| cd200 btla | #1 |
| haplotypes h2q | #1 |
| mice developed | #1 |
| arthritis onset severity | #1 |
| suppression collagen | #1 |
| healthy nzw | #1 |
| dominant hypersensitivity dth | #1 |
| arthritis protection | #1 |
| oxidative burst disease | #1 |
| adjuvanticity autoimmunity | #1 |
| response splenocytes | #1 |
| melatonin cia | #1 |
| features arthritis | #1 |
| dendritic cells collagen | #1 |
| ciic1 ciif4 | #1 |
| ciispecific cells | #1 |
| function p47phox | #1 |
| e3xda | #1 |
| cia40 | #1 |
| cxi 6 | #1 |
| cii h2p | #1 |
| dba 1jpfp cia | #1 |
| loci arthritis | #1 |
| cia il10 | #1 |
| severity cia | #1 |
| major locus cia | #1 |
| pia8 | #1 |
| cia mhc | #1 |
| pia experimental chromosomes | #1 |
| phenotypes ncf1m1j mice | #1 |
| cia13 | #1 |
| arthritis rat strains | #1 |
| arthritis experimental | #1 |
| positional identification | #1 |
| g6pi peptide | #1 |
| pristaneinduced arthritis rats | #1 |
| ncf1339 allele | #1 |
| impact topoisomerase antagonist | #1 |
| cii antibodies | #1 |
| peripheral cells alphachains | #1 |
| ncf1m1j mutation | #1 |
| bond requirements | #1 |
| cii peptides | #1 |
| major epitopes patients | #1 |
| marginal ankylosis | #1 |
| streptococcal endo | #1 |
| cia induced | #1 |
| physiological doses development | #1 |
| arthritis congenic | #1 |
| chronicity arthritis | #1 |
| ciispecific cells day | #1 |
| day cii immunisation | #1 |
| effects ciif4 | #1 |
| type collagen cia | #1 |
| innate rats | #1 |
| nod loci genes | #1 |
| oestrogen‐induced | #1 |
| ciic1 m2139 | #1 |
| dth dominant hypersensitivity | #1 |
| arthritis genetics | #1 |
| cia recognition | #1 |
| hfdmets expression | #1 |
| cia rat | #1 |
| selfcii | #1 |
| incidence nod | #1 |
| polymer adjuvant activity | #1 |
| citrullinated type | #1 |
| arthritis naive mice | #1 |
| cii severe arthritis | #1 |
| collagen antibodies | #1 |
| human gpi protein | #1 |
| vpba pnipaam | #1 |
| antitype collagen | #1 |
| experimental carcinogens | #1 |
| induction postpartum flare | #1 |
| fecq3 | #1 |
| lew mol strain | #1 |
| mice cii epitopes | #1 |
| g6pi chronic arthritis | #1 |
| cii261 | #1 |
| cii | #1 |
| lew1w rt1u | #1 |
| act389949 | #1 |
| rat cb11 immunization | #1 |
| type collagens rats | #1 |
| large numbers hybridomas | #1 |
| cia caia | #1 |
| treatment pia | #1 |
| pristane induced | #1 |
| nox2derived ros mice | #1 |
| citrullinated type collagen | #1 |
| b10dr4ncf1 mice | #1 |
| realtime pcr flss | #1 |
| cartilage explants ciic1 | #1 |
| ncf1 ncf1m1j mutation | #1 |
| severity pia | #1 |
| cii molecule | #1 |
| nox2 complex | #1 |
| tlr3 tlr3 expression | #1 |
| predominant selection | #1 |
| development collageninduced arthritis | #1 |
| disease th1 immunity | #1 |
| chick cii cii | #1 |
| collagen reactivity cxi | #1 |
| rheumatoid arthritis cii | #1 |
| polymorphic fragment | #1 |
| chemical collagen | #1 |
| arthritismodulating | #1 |
| 2 months beta | #1 |
| sialadenitis nodq | #1 |
| ncf1 mutated | #1 |
| rat pristaneinduced arthritis | #1 |
| citrullination cii | #1 |
| differences ncf1 | #1 |
| nrc ova | #1 |
| cartilage antibody | #1 |
| collagens antibody | #1 |
| cii development | #1 |
| glycosylated cii259 | #1 |
| rat cii arthritis | #1 |
| cii sera | #1 |
| obs electrophoresis | #1 |
| cia2 arthritis | #1 |
| celldependent disease | #1 |
| diabetes sialadenitis | #1 |
| ciipeptide cells | #1 |
| pia3 pia4 | #1 |
| act389949 fpr | #1 |
| comp experimental autoantibodies | #1 |
| igg1 igg2b isotypes | #1 |
| beta 812 | #1 |
| chemiluminescent probe l012 | #1 |
| chronic pristane | #1 |
| compsufficient mice | #1 |
| ncf1 sle | #1 |
| mannan joints | #1 |
| ros experimental arthritis | #1 |
| mice ncf4 | #1 |
| arthritis development cross | #1 |
| cxi pia | #1 |
| tlr3 upregulation flss | #1 |
| murine psoriasis model | #1 |
| b10b | #1 |
| cii260‐270 | #1 |
| pepsin lewis | #1 |
| mice chronic arthritis | #1 |
| dba 1 background | #1 |
| cii vivo | #1 |
| alphachains cell surface | #1 |
| ciid3 | #1 |
| protective alleles eae2 | #1 |
| dnp epitopes lysine | #1 |
| immunization heterologous | #1 |
| caia mutant mice | #1 |
| pc4 pc8 | #1 |
| induced arthritis rats | #1 |
| rats cxi | #1 |
| cii cartilage | #1 |
| rats severity | #1 |
| arthritogenic antibody | #1 |
| nfr origin | #1 |
| promoter regions antigens | #1 |
| rat pia | #1 |
| inflammatory phase cia | #1 |
| estrogen differential outcome | #1 |
| nonglycosylated peptide | #1 |
| clec4b ncf1 | #1 |
| act389949 fpr2 | #1 |
| rats mhc genes | #1 |
| aq molecules | #1 |
| oestrogen lupus disease | #1 |
| arthritis caia | #1 |
| mutation ptdins3pbinding site | #1 |
| mhc‐congenic mouse strains | #1 |
| arthritis incidence severity | #1 |
| dth nzb | #1 |
| ros antigens | #1 |
| autoimmune accelerating | #1 |
| dapia3 | #1 |
| chromosome caia | #1 |
| cii ciif4 | #1 |
| tlr3 pristane | #1 |
| ltabncr3 | #1 |
| mice b10q | #1 |
| ros continental ancestry | #1 |
| eae39 control disease | #1 |
| driven psoriatic arthritis | #1 |
| arthritis intraperitoneal injection | #1 |
| neonatal mortality milk | #1 |
| ecm mab | #1 |
| partial advanced intercross | #1 |
| inflammatory phase arthritis | #1 |
| arthritis collagen | #1 |
| pia4 chromosome | #1 |
| cells synthetic glycopeptides | #1 |
| animal epitopes injections | #1 |
| presence mhv | #1 |
| denatured cii | #1 |
| loci cia2 | #1 |
| evokes peptide | #1 |
| etoposide topoisomerase antagonist | #1 |
| h2q c3hnb | #1 |
| arthritis ncf1 | #1 |
| immunization mouse | #1 |
| qa2 natural mutations | #1 |
| mbpc5a | #1 |
| animals arthritis | #1 |
| hiit nox2 activity | #1 |
| immunization lathyritic cii | #1 |
| anti type | #1 |
| arthritis ul1 | #1 |
| p47phox ncf1 | #1 |
| fecq4 fragment | #1 |
| ncf1 mutation mice | #1 |
| arthritis loci | #1 |
| cells autologous cii | #1 |
| nodq nod | #1 |
| h2p cia | #1 |
| adaptive immunity fcγrs | #1 |
| cia melatonin | #1 |
| native cii | #1 |
| mabs cii | #1 |
| nox2 complex–derived ros | #1 |
| anticd4 treatment immunization | #1 |
| nox2 complex addition | #1 |
| collagen hybridomas | #1 |
| congenic fragment | #1 |
| day acute arthritis | #1 |
| cia21 lymph nodes | #1 |
| minimal glycopeptide core | #1 |
| ros nox2 complex | #1 |
| insulitis strains | #1 |
| dominant susceptibility loci | #1 |
| arthritis monoclonal arthritis | #1 |
| preformed cartilage | #1 |
| immunization heterologous cii | #1 |
| pv cd4 cells | #1 |
| cells arthritis progression | #1 |
| cb268 | #1 |
| rats pristane | #1 |
| rat cb10 cb11 | #1 |
| pristane cell death | #1 |
| spleen pristane injection | #1 |
| rt1l haplotypes | #1 |
| arthritis ides | #1 |
| sialadenitis arthritis | #1 |
| arthritis injection | #1 |
| ncf4 nox2 complex | #1 |
| functional ncf1 | #1 |
| eae39 locus cia | #1 |
| fcγr3 | #1 |
| antigenic adjuvant | #1 |
| fecq3 locus | #1 |
| pparγ cbrh7919 cells | #1 |
| hdac3 pparγ | #1 |
| da1u rat liver | #1 |
| peptide characterisation | #1 |
| caia kgf | #1 |
| b10qacb | #1 |
| sod3 peritonitis | #1 |
| eae39 study | #1 |
| psa mip | #1 |
| cryogel matrix cells | #1 |
| mouse cii reactivity | #1 |
| cia21 | #1 |
| specificity arthritis | #1 |
| cix cii | #1 |
| macrophage ros | #1 |
| cii experimental autoantigens | #1 |
| expression liver receptor | #1 |
| cia compdeficient mice | #1 |
| hyaluronanreceptor | #1 |
| b10riii | #1 |
| upregulation tlr3 | #1 |
| cia5 qtl | #1 |
| nzb mice trait | #1 |
| ncf1 mutant | #1 |
| h2p h2q | #1 |
| experimental chromosomes | #1 |
| cells cia | #1 |
| deficient ncf1 | #1 |
| glycosylation hla | #1 |
| ciilysdnp mice | #1 |
| cd2 human cells | #1 |
| collagen iiinduced arthritis | #1 |
| nodq nod nodp | #1 |
| dominant hypersensitivity | #1 |
| rheumatoid drug evaluation | #1 |
| mip cia | #1 |
| autologous peptide cells | #1 |
| congenic arthritis rats | #1 |
| kgf thymus | #1 |
| eae2 chromosome | #1 |
| ncf4 mip | #1 |
| genes antibodies | #1 |
| h2p h2q haplotype | #1 |
| chondrocytes kgf | #1 |
| alpha type collagen | #1 |
| ros autoimmune diseases | #1 |
| lpscaia | #1 |
| pia blocking arthritis | #1 |
| pristane stimulation | #1 |
| ncf1 ros | #1 |
| rats terpenes | #1 |
| pinealectomy exposure | #1 |
| chronic arthritis mice | #1 |
| ifnbeta arthritis | #1 |
| spread induced psoriasis | #1 |
| inflammatory arthritis assessment | #1 |
| cxi cii | #1 |
| cii articular cartilage | #1 |
| induced arthritis cia | #1 |
| swr nfr | #1 |
| caia cia | #1 |
| development collagen | #1 |
| fibβ36 | #2 |
| development combination | #2 |
| alterations neuroendocrine profile | #2 |
| sle cgd | #2 |
| biologicals 24 months | #2 |
| mice collagen | #2 |
| enhanced arthritis | #2 |
| arthritis heterologous cia | #2 |
| elastaseinduced emphysema nox2 | #2 |
| igsecretors | #2 |
| glut4dependent | #2 |
| das28 24 months | #2 |
| conditions igke promoter | #2 |
| sequence analysis indel | #2 |
| type collagen cii | #2 |
| rheumatoid binding | #2 |
| l10d9 antibody cxi | #2 |
| dxea strain tgfbeta | #2 |
| chronic relapsing disease | #2 |
| eae protein rna | #2 |
| oestradiol cia | #2 |
| macrophagespecific nox2 development | #2 |
| dxeb | #2 |
| l10d9 antibody | #2 |
| arthritogenic mab cii | #2 |
| liver mice rna | #2 |
| c2ta genetic polymorphisms | #2 |
| collagen citrullination adhesion | #2 |
| glycan activation | #2 |
| severity collagen arthritis | #2 |
| wildtype mice macrophages | #2 |
| granulomas cgd mice | #2 |
| functional ncf1 variants | #2 |
| mitochondria polymorphism | #2 |
| glycopeptide complexes | #2 |
| anti cii | #2 |
| disease 111 | #2 |
| genotypes ovx | #2 |
| oestrogen myelin | #2 |
| etoposide serum concentrations | #2 |
| selective fpr1 | #2 |
| mannan induced | #2 |
| c129s mutant disulfide | #2 |
| ncf1 ean6 | #2 |
| cells arthritis | #2 |
| matrilin vivo | #2 |
| transgenic oxidases zymosan | #2 |
| rats lymphocytes | #2 |
| arthritogenic challenge | #2 |
| redox regulation ptpn22 | #2 |
| cii depletion | #2 |
| b10g | #2 |
| matrilin 1 | #2 |
| cii injection | #2 |
| autoimmunity autoantibodies | #2 |
| suggestive locus | #2 |
| fpr1 signaling | #2 |
| early onset severity | #2 |
| smash recommendations | #2 |
| ciif4 | #2 |
| neutrophil functions modulation | #2 |
| adjuvant rats | #2 |
| mbp peptide eae | #2 |
| mhciii | #2 |
| alp monoclonal arthritis | #2 |
| synovial immune reactions | #2 |
| murine locus eae2 | #2 |
| citrullinated peptides development | #2 |
| staphylococcal infections mice | #2 |
| ability arthritis | #2 |
| collagen antibody | #2 |
| da1u rats | #2 |
| cia mice mice | #2 |
| macrophages enhances | #2 |
| immunological requirements | #2 |
| sle nadph oxidase | #2 |
| igke | #2 |
| cgd mice kynurenine | #2 |
| intrinsic tolerance | #2 |
| binding cartilage | #2 |
| mhc congenic | #2 |
| arthritis fb | #2 |
| cartilage respiratory tract | #2 |
| immunocap isac performance | #2 |
| citc1359 | #2 |
| ovx ncf1 mice | #2 |
| design glycopeptides | #2 |
| vaccination strategy c5a | #2 |
| arthritis ethanol | #2 |
| salt intake vivo | #2 |
| lymphoproliferative gene | #2 |
| antibodies fibß62 | #2 |
| citcii311 | #2 |
| mph ros | #2 |
| apc naïve cells | #2 |
| nox2 macrophages | #2 |
| cytosolic ros production | #2 |
| rats da1u | #2 |
| h2q | #2 |
| raloxifene estradiol treatment | #2 |
| antibodies development | #2 |
| lack functional nox2 | #2 |
| oestrogen pregnancy | #2 |
| disease humanized mice | #2 |
| mice susceptible | #2 |
| c5ay35 | #2 |
| raloxifene oestradiol | #2 |
| arthritogenic | #2 |
| lymphocytelike | #2 |
| rp animal ear | #2 |
| antibody‐mediated arthritis | #2 |
| tregs mph | #2 |
| granulomas macrophages | #2 |
| mice genistein treatment | #2 |
| ere activation treatment | #2 |
| kinloch | #2 |
| tolerance cii | #2 |
| castrated mice day | #2 |
| cxi l10d9 antibody | #2 |
| cia arthritis | #2 |
| anticcp2negative | #2 |
| pristane rats | #2 |
| ccp2 diagnostic accuracy | #2 |
| ptpn22 disulfide | #2 |
| transgenic osteoporosis oestradiol | #2 |
| putative vulnerability locus | #2 |
| pristane injection | #2 |
| arthritis mice | #2 |
| flow cytometry ovx | #2 |
| tracheolaryngeal cartilage rp | #2 |
| cia anti | #2 |
| homologous cia | #2 |
| acpa reactivities | #2 |
| eosinophilia arthritis | #2 |
| pnipaam vpba | #2 |
| neutrophil fpr2 | #2 |
| nadph oxidase elevations | #2 |
| 18fbicyclo610nonyne | #2 |
| antileukoproteinase alp | #2 |
| mabs comp | #2 |
| injection w3 13 | #2 |
| ean6 | #2 |
| maintenance induced resistance | #2 |
| allelic variant type | #2 |
| autoimmune congenic arthritis | #2 |
| ros tregs | #2 |
| cd8 cells incidence | #2 |
| ß62 | #2 |
| agonist fpr2 | #2 |
| das28 values p001 | #2 |
| rt1bb | #2 |
| sequences mbp89 | #2 |
| antibody response development | #2 |
| hladr2dq6 | #2 |
| h2q mice mice | #2 |
| chitosanagarosegelatin | #2 |
| re04 | #2 |
| lew mol | #2 |
| monodeoxygenation | #2 |
| severity collagen | #2 |
| rats da1u rats | #2 |
| micro dams transgenic | #2 |
| symptoms antibodies | #2 |
| new immunomodulatory drug | #2 |
| multiple antibody reactivities | #2 |
| igkeegfp lentivirus expression | #2 |
| ifngamma spinal cord | #2 |
| gender rats | #2 |
| mbp 87110 peptide | #2 |
| liver histone | #2 |
| eae cia | #2 |
| circulating medium | #2 |
| analyses comp | #2 |
| tgfbeta spinal cord | #2 |
| iaexpressing cells | #2 |
| rno12 | #2 |
| fibα563 | #2 |
| antibodies disease onset | #2 |
| peptides chronic eae | #2 |
| snecs neutrophils | #2 |
| hiit skeletal muscle | #2 |
| c2ta genetic | #2 |
| anticcp2negative presence | #2 |
| caia oestradiol | #2 |
| control subjects samples | #2 |
| induction p47phoxmutated mph | #2 |
| antileukoproteinase modulation | #2 |
| mbp89 peptides | #2 |
| sialadenitis animals | #2 |
| positive anticcp2 test | #2 |
| glycopeptides histocompatibility | #2 |
| h12919 | #2 |
| w3 13 | #2 |
| cpg2088 | #2 |
| matrilin cartilage proteins | #2 |
| antibodies cartilage | #2 |
| igke promoter | #2 |
| cii citrullination | #2 |
| oestrogen ean | #2 |
| heterologous collagens arthritis | #2 |
| psoriatic disease models | #2 |
| l10d9 antibody cartilage | #2 |
| ncf1 oxidation | #2 |
| dominant suppressive | #2 |
| adjuvant oils arthritis | #2 |
| collagen ii‐induced arthritis | #2 |
| cia animals | #2 |
| cia monkeys | #2 |
| psychosocial stress hpaaxis | #2 |
| arthritis oia | #2 |
| fibα580 | #2 |
| mbp89 | #2 |
| knockout illness | #2 |
| caia | #2 |
| animal granulomatous disease | #2 |
| nadph oxidase deficiency | #2 |
| epitope glycosylation | #2 |
| das28 acpa reactivities | #2 |
| chronic autoimmune polyarthritis | #2 |
| dxea strain | #2 |
| igke promoter expression | #2 |
| b10qncf1 mice cia | #2 |
| galactosyl moiety | #2 |
| b10qf1 | #2 |
| percentage peripheral cells | #2 |
| paws mice | #2 |
| cms eae | #2 |
| collagen arthritis cii | #2 |
| cep1 fibß62 | #2 |
| arthritis gender | #2 |
| comp cartilage | #2 |
| p47phoxmutated | #2 |
| cartilage proteins sera | #2 |
| citcii | #2 |
| multiple sclerosis maps | #2 |
| anticd4 treatment | #2 |
| antibody cartilage | #2 |
| rats heterologous cii | #2 |
| influence chromosome | #2 |
| rats utility | #2 |
| cell tolerance c5a | #2 |
| cd19 cells egfp | #2 |
| egfp cd19 cells | #2 |
| altered formation | #2 |
| immunization mouse collagen | #2 |
| skg model | #2 |
| receptor‐specific manner | #2 |
| g6pi arthritis | #2 |
| exclusive reactivity | #2 |
| comp titers | #2 |
| diseases collagen | #2 |
| higher levels anas | #2 |
| oestradiol induction phase | #2 |
| mice bacterial infections | #2 |
| arthritis g6pi | #2 |
| snp position | #2 |
| cia disease | #2 |
| α3xi | #2 |
| prophylactic treatment linomide | #2 |
| neuroendocrine profile | #2 |
| rats disease onset | #2 |
| anticii antibody | #2 |
| immunosuppressive leukocytes | #2 |
| autoimmune recognition | #2 |
| disease genotype hybridization | #2 |
| arthritis treatment | #2 |
| myelin ppd | #2 |
| arthritis antibody response | #2 |
| ros peroxide | #2 |
| mab cii | #2 |
| eno5 | #2 |
| incidence insulitis | #2 |
| fpr1 agonist | #2 |
| experimental cloning | #2 |
| implanted melanoma | #2 |
| nox2 neuropathological alterations | #2 |
| hiit skeletal | #2 |
| tcells recognition | #2 |
| human animal models | #2 |
| binding sites autoimmune | #2 |
| ptpn22 c129s | #2 |
| derived ros | #2 |
| beta 10b | #2 |
| disease development presence | #2 |
| mbp peptides immunization | #2 |
| antibodies cep1 | #2 |
| shared epitope cxi | #2 |
| disease cyclosporin treatment | #2 |
| ptpn22 ncf1 | #2 |
| hydroxyethylene | #2 |
| tlymphocyte arthritis arthritis | #2 |
| ptpn22 protein disulfide | #2 |
| autoimmune membrane proteins | #2 |
| antitoxin immunoglobulin | #2 |
| dr4 cii259 | #2 |
| ros source | #2 |
| granulomas ros | #2 |
| tregs mph ros | #2 |
| integrin‐binding‐domain | #2 |
| mhc iii | #2 |
| m2139 ciif4 | #2 |
| 111 vivo treatment | #2 |
| i‐a molecule | #2 |
| oxidation increased severity | #2 |
| genetic regions psoriasis | #2 |
| sialadenitis mice | #2 |
| fil307 | #2 |
| transgenic protein processing | #2 |
| ros granulomas | #2 |
| bmd caia | #2 |
| animal model arthritis | #2 |
| wtc5a | #2 |
| immunization sch | #2 |
| genetic encephalomyelitis | #2 |
| clever1 tumor | #2 |
| 034positive | #2 |
| animal haplotypes | #2 |
| igkeegfp lentivirus | #2 |
| aetiology2–4 | #2 |
| sera rheumatoid arthritis | #2 |
| single nucleotide rats | #2 |
| cii ciic1 | #2 |
| dancf1da | #2 |
| nox2 complex sle | #2 |
| mog rats | #2 |
| rats ifngamma | #2 |
| rats arthritogenic challenge | #2 |
| hkatpasecontaining vesicles | #2 |
| pathogenic igg antibodies | #2 |
| h2q response | #2 |
| suppressive oestrogen | #2 |
| epitopes rat | #2 |
| caia eae | #2 |
| models autoimmune | #2 |
| disease promoting | #2 |
| chain l10d9 antibody | #2 |
| mabs collagen | #2 |
| lack ifngamma | #2 |
| nadph oxidase 2 | #2 |
| collagen arthritis immunization | #2 |
| ala261 | #2 |
| linomide homologous cia | #2 |
| microscopic scoring arthritis | #2 |
| collageninduced arthritis mice | #2 |
| fibß62 | #2 |
| immunization mbp89 | #2 |
| mrl mice stages | #2 |
| arthritis models rats | #2 |
| arthritis female | #2 |
| dxeb strain immunization | #2 |
| species susceptible haplotypes | #2 |
| ides treatment | #2 |
| arthritis progression | #2 |
| eae dxea strain | #2 |
| oestrogen suppressive | #2 |
| toe stiffness | #2 |
| celldependent phase | #2 |
| c2ta mhcii expression | #2 |
| symptoms anti ccp2 | #2 |
| mhcii experimental arthritis | #2 |
| utility comp | #2 |
| igg glycosylation arthritis | #2 |
| congenic polychondritis | #2 |
| da1u | #2 |
| eae caia | #2 |
| oxidation c129s | #2 |
| macrophagespecific nox2 | #2 |
| 12 590 | #2 |
| ciic1 | #2 |
| mph induction | #2 |
| ncf1gene | #2 |
| ncf1 mutants | #2 |
| agonist study | #2 |
| arthritis raloxifene | #2 |
| pia rat | #2 |
| rats polymorphism | #2 |
| cia mechanisms | #2 |
| cartilage respiratory | #2 |
| chromosome rats | #2 |
| mog79 | #2 |
| mrl joints stages | #2 |
| antipan | #2 |
| human lung nox2 | #2 |
| arthritis scoring | #2 |
| pia rats | #2 |
| class immunoenzyme | #2 |
| c57bl 10 background | #2 |
| titres ccp2 | #2 |
| l10d9 | #2 |
| lymphocytes animals | #2 |
| mycobacteria granulomas | #2 |
| cartilage‐specific autoimmunity | #2 |
| fpr1 neutrophils | #2 |
| cii311 | #2 |
| granulocytes alp | #2 |
| congenic mice autoimmune | #2 |
| 18ffluoromannan | #2 |
| caia effector phase | #2 |
| antibody fine | #2 |
| arthritis development rats | #2 |
| chronic arthritis treatment | #2 |
| terpenes animals | #2 |
| m2139 | #2 |
| cell dependent | #2 |
| induction cia | #2 |
| comp cia | #2 |
| increased severity development | #2 |
| nodq | #2 |
| osteoclastogenesis endogenous dna | #2 |
| endoglycosidase treatment | #2 |
| arthritogenic capacity | #2 |
| fibroblast induced | #2 |
| incidence nephritis | #2 |
| b10qncf1 mice | #2 |
| osteoclasts flow cytometry | #2 |
| cia day | #2 |
| epitope‐specific recognition | #2 |
| c1epitope | #2 |
| vivo cii | #2 |
| citrullinated peptides multiplex | #3 |
| cvrelated death association | #3 |
| lew1f | #3 |
| cd4∶cd8 lineage commitment | #3 |
| disease disease development | #3 |
| cdk6 padi4 | #3 |
| mice environments | #3 |
| cii reactive | #3 |
| c57bl mice illness | #3 |
| cvrelated death | #3 |
| genes disease development | #3 |
| nadph oxidase complex | #3 |
| natural alleles genes | #3 |
| db1 treatment | #3 |
| aureus arthritis mice | #3 |
| fibβ74 | #3 |
| hydrocarbon oils | #3 |
| onset combination | #3 |
| antibodies citc1iii | #3 |
| arthritis review | #3 |
| fibβ74 onset | #3 |
| fibα591 vim60 | #3 |
| mice copolymers | #3 |
| antibodies vim60 | #3 |
| antigens keratinocytes | #3 |
| rodents6 | #3 |
| isotypes acpas | #3 |
| combination acpa | #3 |
| chromosome eae17 | #3 |
| apc cia | #3 |
| mnc salivary glands | #3 |
| class antigens keratinocytes | #3 |
| cartilage proteins | #3 |
| immunization addition | #3 |
| dnfb ears | #3 |
| hdac1 pathogenesis | #3 |
| cd8 cells ean | #3 |
| ciic1 cii | #3 |
| pathogenesis pia | #3 |
| macroporous gel particles | #3 |
| development acpas | #3 |
| pia | #3 |
| eae16 | #3 |
| cia strains | #3 |
| inflamed synovial tissues | #3 |
| acpa titers | #3 |
| stroke cvrelated death | #3 |
| h2aalpha | #3 |
| ctla4 deletion | #3 |
| monoclonal cartilage sections | #3 |
| type collagen vivo | #3 |
| incidence antinuclear antibodies | #3 |
| acpa subspecificities | #3 |
| eae17 chromosome | #3 |
| arthritis autoimmunity | #3 |
| nerve terminallike profiles | #3 |
| pia6 | #3 |
| cep1 filaggrin | #3 |
| nox2 cgd | #3 |
| sialadenitis | #3 |
| dual manner | #3 |
| restricted role | #3 |
| lupus nets | #3 |
| twins acpas | #3 |
| arthritis levels | #3 |
| swedish patients antibodies | #3 |
| targeting toll | #3 |
| arthritis effects | #3 |
| disease anti lymphocyte | #3 |
| autoimmune models | #3 |
| induced immunospecific tolerance | #3 |
| ean mca | #3 |
| antigens collagen | #3 |
| presence drb104 | #3 |
| arthritis resistance | #3 |
| rats mog | #3 |
| cells naïve mice | #3 |
| antibodies citrullinated | #3 |
| response immune response | #3 |
| arthritis susceptible | #3 |
| pristane‐induced arthritis | #3 |
| eae5r1 | #3 |
| transgenic osteoporosis | #3 |
| reactive idiotope | #3 |
| ifnbetadeficient mice | #3 |
| rats disease | #3 |
| development collagen arthritis | #3 |
| minimal adjuvant requirement | #3 |
| anticollagen antibodies | #3 |
| mice development | #3 |
| fibβ62 81b | #3 |
| glycosylated type | #3 |
| hdac1 rheumatoid arthritis | #3 |
| rheumatoid cloning | #3 |
| subspecificities occurrence | #3 |
| early phase disease | #3 |
| cryogel bioreactor | #3 |
| dthreaction | #3 |
| antibodies induce | #3 |
| c2ta | #3 |
| rt11 rats | #3 |
| ros deficiency | #3 |
| autoimmunity cartilage | #3 |
| allopregnancy | #3 |
| pnippam | #3 |
| disease genotype immunity | #3 |
| dancf1e3 | #3 |
| cia hdac1 | #3 |
| type c2ta | #3 |
| pfp mice | #3 |
| female preponderance | #3 |
| rheumatoid autoimmune | #3 |
| cd4∶cd8 lineage | #3 |
| development arthritis | #3 |
| cii elisa | #3 |
| keratinocytes langerhans cells | #3 |
| lew ztm | #3 |
| neutrophil cytosolic factor | #3 |
| advanced intercross eae5 | #3 |
| cii species | #3 |
| mca ean | #3 |
| rt1a tap2 | #3 |
| animal glycosylation humans | #3 |
| citcii355 | #3 |
| rheumatoid arthritis complement | #3 |
| ctla4 adult mice | #3 |
| levels fibα591 | #3 |
| arthritogenic mab | #3 |
| macrophages involvement | #3 |
| antibodies specific sets | #3 |
| fibα591 | #3 |
| eae1 | #3 |
| mmc mice | #3 |
| mice rheumatoid | #3 |
| nox2 pathogenesis | #3 |
| anticollagen antibody | #3 |
| ncf1 cldn4 | #3 |
| mhc class betachain | #3 |
| antigen monoclonal arthritis | #3 |
| immuniozation | #3 |
| differences citrullinated peptides | #3 |
| disease w3 13 | #3 |
| osteoclasts release | #3 |
| 81b | #3 |
| species lymphocytes | #3 |
| h2p mice | #3 |
| bcg ros | #3 |
| height disease | #3 |
| db1 treatment day | #3 |
| complex genetic control | #3 |
| common mouse model | #3 |
| endogenous ifnbeta | #3 |
| allogeneic pregnancy | #3 |
| cytotoxic t‐lymphocyte | #3 |
| clever1 macrophages | #3 |
| eae5 ncf1 | #3 |
| fibα573 fibβ74 | #3 |
| multiple sclerosis hladr2 | #3 |
| genotype knowledge | #3 |
| eae31 | #3 |
| disease height | #3 |
| citc1iii filaggrin | #3 |
| disease immunization | #3 |
| oxidase 2 | #3 |
| mice constant light | #3 |
| ifngammali neurons | #3 |
| igl genes | #3 |
| hfdmets rats | #3 |
| ncf4 rs729749 | #3 |
| acpas plasma | #3 |
| hladrb104 cochranmantelhaenszel test | #3 |
| occurrence subspecificities | #3 |
| cvrelated death adjustment | #3 |
| citrullinated cyclic | #3 |
| subspecificities associations | #3 |
| genetic influence susceptibility | #3 |
| chronic collagen | #3 |
| activated cells mice | #3 |
| ifngammali | #3 |
| binding aq | #3 |
| h2qbearing | #3 |
| vivo control mice | #3 |
| arthritis susceptibility | #3 |
| experimental arthritis | #3 |
| crossreactive idiotope | #3 |
| models arthritis | #3 |
| loci antibodies | #3 |
| citrulline inflammation | #3 |
| dxea | #3 |
| dce spe | #3 |
| human cii | #3 |
| major cell epitope | #3 |
| acpa combination | #3 |
| arthritogenicity | #3 |
| fibα573 | #3 |
| acpa multiplex | #3 |
| patients monoclonal chimeric | #3 |
| neutrophils eae | #3 |
| role ros | #3 |
| arthritis model | #3 |
| antigen presentation mhcii | #3 |
| wildtype mice granulomas | #3 |
| cyp7a1 abca1 | #3 |
| twins acpapositive | #3 |
| anti‐type | #3 |
| ifngamma neurons | #3 |
| rs729749 ncf4 | #3 |
| spe dce | #3 |
| fibα573 fibα591 | #3 |
| acpas twins | #3 |
| recombination rt1a | #3 |
| rats rheumatoid arthritis | #3 |
| female immunoenzyme | #3 |
| model arthritis | #3 |
| hladrb104 mann whitney | #3 |
| origin suggestive linkage | #3 |
| rheumatoid crosses | #3 |
| complex autoimmune diseases | #3 |
| disease development contribution | #3 |
| treatment arthritis | #3 |
| carriers hladrb104 | #3 |
| acpas fine specificities | #3 |
| eae17 genetic heterogeneity | #3 |
| rs729749 | #3 |
| day disease duration | #3 |
| experimental cell | #3 |
| citc1iii | #3 |
| low production | #3 |
| acpas human serum | #3 |
| acpapositive twins | #3 |
| rtlu | #3 |
| cbrh7919 cells | #3 |
| disease risk subsets | #3 |
| acpa specificities presence | #3 |
| processing cii | #3 |
| cia animals arthritis | #3 |
| points acs | #3 |
| autoimmunity pia | #3 |
| acpas genetic factors | #3 |
| citrullinated peptides time | #3 |
| arthritis animal model | #3 |
| citc1iii fibα573 | #3 |
| oxidases reactive | #3 |
| 95 cvrelated death | #3 |
| eae5 pia4 | #3 |
| cystatin cdeficient mice | #3 |
| vim60 | #3 |
| eae17 | #3 |
| total abrogation | #3 |
| experimental genetic | #4 |
| collagen glycopeptides | #4 |
| lnchc | #4 |
| mice etoposide | #4 |
| immunodominant cell | #4 |
| cell response immunization | #4 |
| macrophages mycobacteria | #4 |
| candidate genes rats | #4 |
| arthritis collageninduced arthritis | #4 |
| adjuvant oil | #4 |
| subsets presence | #4 |
| k8 k8 mice | #4 |
| il‐4‐deficient mice | #4 |
| genetic association vav1 | #4 |
| mutation ncf1 | #4 |
| multispecific antibodies | #4 |
| pristane‐induced | #4 |
| fibβ62 | #4 |
| cia lia | #4 |
| diseases rheumatoid | #4 |
| treg cells ctla4 | #4 |
| genistein addition | #4 |
| mhc eae | #4 |
| experimental arthritis humans | #4 |
| antibody response mog | #4 |
| species regulate | #4 |
| pathogenesis histone | #4 |
| catabolism kynurenine | #4 |
| fpr2 recognition | #4 |
| tnfα p38 mapk | #4 |
| mp‐lpr | #4 |
| autoimmunity rats | #4 |
| tsc mice | #4 |
| anti‐t‐cell | #4 |
| rs682626 | #4 |
| ox8 | #4 |
| pathogenic antibody | #4 |
| peptide mbp | #4 |
| tcell activation development | #4 |
| experimental cattle cells | #4 |
| parathyroid antibodies | #4 |
| immune response cii | #4 |
| cii ifa | #4 |
| immunoglobulin deficient | #4 |
| elevated th1 | #4 |
| endos igg | #4 |
| antigen sequence deletion | #4 |
| dth mrl | #4 |
| estrogen levels levels | #4 |
| cii peptide | #4 |
| fcγr regulation | #4 |
| onset clinical arthritis | #4 |
| citrullinated peptides autoantibodies | #4 |
| autoimmune experimental phenotype | #4 |
| cells maternal origin | #4 |
| cyclic software | #4 |
| potent immunomodulator | #4 |
| glands sialadenitis | #4 |
| cia6 | #4 |
| cd4 cells stage | #4 |
| cii animal epitopes | #4 |
| stages disease development | #4 |
| estrus cycling | #4 |
| response arthritis | #4 |
| epitope collagen | #4 |
| rheumatoid arthritis rats | #4 |
| knowledge genetic association | #4 |
| mrl dth | #4 |
| rs12979659 | #4 |
| α1ii chain | #4 |
| dae3 | #4 |
| interaction monoclonal antibody | #4 |
| rp sle | #4 |
| vav1 rheumatoid arthritis | #4 |
| autoimmune mrl | #4 |
| mrl b6 | #4 |
| strains arthritis | #4 |
| acpas serum | #4 |
| cellular transfer | #4 |
| congenic c57bl | #4 |
| elimination cd8 cells | #4 |
| arthritis mouse | #4 |
| cia mouse | #4 |
| c129s | #4 |
| estrogen cia | #4 |
| arthritis comp | #4 |
| inpp4b474r 548p | #4 |
| cia suppression | #4 |
| bxsb chromosome | #4 |
| cytosolic ros | #4 |
| collagen immune | #4 |
| dead cell remnants | #4 |
| autoantibodies type collagen | #4 |
| krönke | #4 |
| experimental arthritis cii | #4 |
| antibodies citrullinated peptides | #4 |
| collagen type | #4 |
| locus mouse chromosome | #4 |
| cathelicidins ll37 | #4 |
| mip mice | #4 |
| arthritis defined | #4 |
| development sialadenitis | #4 |
| lxrα pparγ | #4 |
| cells cryogel column | #4 |
| cryogel matrix | #4 |
| glend2 | #4 |
| placental mhc | #4 |
| arthritis severity | #4 |
| collagen rheumatoid | #4 |
| inbred dba peptides | #4 |
| ethylene isosteres | #4 |
| antitype collagen antibodies | #4 |
| sh3gl1 | #4 |
| cells cryogel | #4 |
| strain eae | #4 |
| citrullinated protein antibodies | #4 |
| cia b10q mice | #4 |
| congenic rats rats | #4 |
| affinity case | #4 |
| type collagen rat | #4 |
| dth reaction | #4 |
| synovial endothelium | #4 |
| smoking antibodies | #4 |
| positional cloning genes | #4 |
| type collagen arthritis | #4 |
| cb10 fragment | #4 |
| type collagen autoimmunity | #4 |
| variance animals arthritis | #4 |
| shared autoimmunity | #4 |
| type‐ii collagen | #4 |
| normal mouse igg | #4 |
| cgd hyperinflammation | #5 |
| autologous type | #5 |
| oxidative radicals | #5 |
| glycopeptide | #5 |
| experimental breeding | #5 |
| tsst1producing | #5 |
| ly female | #5 |
| rats developed | #5 |
| development acpa | #5 |
| uterus cells | #5 |
| collagen anti | #5 |
| osteoclasts stromal cells | #5 |
| low dose tolerance | #5 |
| autoimmune disease models | #5 |
| streptococcus pyogenes ides | #5 |
| nox animal models | #5 |
| lipidomic remodeling | #5 |
| glycopeptide fragment | #5 |
| regulating rat | #5 |
| mice acpa | #5 |
| arthritogenic cells | #5 |
| c‐glycoside analogue | #5 |
| cd8 deficiency | #5 |
| ovalbumin pepsin | #5 |
| monoclonal antibody alpha | #5 |
| subsets rheumatoid arthritis | #5 |
| ii‐induced | #5 |
| citrullinated peptides ccp | #5 |
| tlr3 expression | #5 |
| dba 1 mice | #5 |
| avridineinduced arthritis | #5 |
| wellknown role | #5 |
| glycopeptidomimetics | #5 |
| tubule cells kidney | #5 |
| overexpression hdac3 | #5 |
| collageninduced arthritis cia | #5 |
| cia type collagen | #5 |
| type collagen cix | #5 |
| il4deficient mice | #5 |
| immunized animals controls | #5 |
| immunization male | #5 |
| commonly model | #5 |
| severe arthritis mice | #5 |
| multiplex array | #5 |
| citrullinated peptides | #5 |
| classical adjuvant | #5 |
| nox o2• h2o2 | #5 |
| severe sialadenitis | #5 |
| lethal inflammatory disorder | #5 |
| b‐cell epitope | #5 |
| antibodies filaggrin | #5 |
| pineal gland development | #5 |
| tlr3 macrophages | #5 |
| α10i | #5 |
| tcell mrl | #5 |
| asparaginelinked glycan | #5 |
| puccetti | #5 |
| swr mouse | #5 |
| multiplex analyses | #5 |
| lew1n | #5 |
| ros mca | #5 |
| mrvalues | #5 |
| biomarkers 2 polyradiculoneuropathy | #5 |
| antileukoproteinase | #5 |
| position type collagen | #5 |
| smoking prior | #5 |
| backcrossed | #5 |
| absence c5 | #5 |
| rt1eu | #5 |
| epitope cii | #5 |
| eae5 | #5 |
| symptoms development | #5 |
| arthritis onset | #5 |
| interaction cartilage | #5 |
| hydroxynorvaline | #5 |
| egfp flow cytometry | #5 |
| cartilage type | #5 |
| cbrh7919 | #5 |
| igg endos | #5 |
| chick cii | #5 |
| nox complex | #5 |
| immunological involvement | #5 |
| oestradiol vehicle | #5 |
| higher levels melatonin | #5 |
| exercise hiit | #5 |
| tbb infection | #5 |
| dba mouse | #5 |
| painlike behavior | #5 |
| ros macrophages | #5 |
| pathogenesis autoimmune arthritis | #5 |
| congenic nod | #5 |
| arthritis rats | #5 |
| aureus arthritis | #5 |
| symptom onset frequency | #5 |
| immunization type collagen | #5 |
| oia | #5 |
| raloxifene disease activity | #5 |
| tcell hybridomas | #5 |
| field nox | #5 |
| measurement nox activity | #5 |
| multiparous mice | #5 |
| o2• h2o2 nox | #5 |
| resistance cia | #5 |
| recovery ean | #5 |
| beta 11 cells | #5 |
| cgd mice | #5 |
| cia model | #5 |
| apc cii | #5 |
| symptoms rheumatoid arthritis | #5 |
| chromosome cia7 | #5 |
| patients acpa levels | #5 |
| delayed immunization rats | #5 |
| isotypes patients | #6 |
| female lymphocyte | #6 |
| staphylococcus aureus arthritis | #6 |
| ccp2 positive | #6 |
| pv loss | #6 |
| joints rats | #6 |
| cells affinity surface | #6 |
| mrna tgfbeta | #6 |
| tsst1 mice | #6 |
| complex mhc | #6 |
| eae mhc | #6 |
| cia cd4 cells | #6 |
| dominant suppression | #6 |
| metabolic nuclear receptors | #6 |
| k8 mice | #6 |
| knockout receptors igg | #6 |
| nox2 mediates | #6 |
| pyramidal neurons loss | #6 |
| arthritis autoantibodies | #6 |
| cartilage collagens | #6 |
| murine loci | #6 |
| c57bl 6 background | #6 |
| collagen cia | #6 |
| anti ccp2 | #6 |
| lys270 | #6 |
| peptides arthritis | #6 |
| acpa anti | #6 |
| mice congenic | #6 |
| rheumatoid arthritis collagen | #6 |
| collagen cells | #6 |
| collagen arthritis | #6 |
| autoimmunity arthritis | #6 |
| arthritis antibodies | #6 |
| induced psoriasis | #6 |
| transgenic mice arthritis | #6 |
| activity neuroinflammation | #6 |
| functional selective | #6 |
| hdac1 class | #6 |
| rheumatoid arthritis model | #6 |
| ltab | #6 |
| acpa specificities | #6 |
| recombinant rat interferongamma | #6 |
| immunization peptides | #6 |
| betaoestradiol | #6 |
| glycoproteins nadph | #6 |
| erosive polyarthritis | #6 |
| mice sialadenitis | #6 |
| pristane squalene | #6 |
| cia26 | #6 |
| arthritis models | #6 |
| cell recognition | #6 |
| active arthritis | #6 |
| animal genetic | #6 |
| contrasting roles | #6 |
| monoclonal encephalomyelitis autoimmune | #6 |
| mhcii alleles | #6 |
| mice investigated | #6 |
| b10 mouse | #6 |
| autoimmune experimental genes | #6 |
| rcramp | #6 |
| rheumatoid arthritis comp | #6 |
| affinity ligand protein | #6 |
| loci controlling | #6 |
| relapsing polychondritis rp | #6 |
| glycopeptide specificity | #6 |
| data ros | #6 |
| l3t4positive cells | #6 |
| treatment oestradiol | #6 |
| controls arthritis | #6 |
| igg autoantibodies sera | #6 |
| macrophages mph | #6 |
| experimental postmenopausal | #6 |
| develop arthritis | #6 |
| heterogeneous stock mice | #6 |
| pathogenic events | #6 |
| cd4∶cd8 | #6 |
| disease protective | #6 |
| impact cia | #7 |
| macrophages alternative activation | #7 |
| autoimmune human | #7 |
| nonarthritogenic | #7 |
| conventional environment | #7 |
| collagen arthritis rats | #7 |
| autoantibodies citrullinated peptides | #7 |
| region syntenic | #7 |
| citrullinated peptide antigens | #7 |
| autoimmunity collagen | #7 |
| acpa titres | #7 |
| effector phase | #7 |
| murine psoriasis | #7 |
| chronic phase arthritis | #7 |
| snecs | #7 |
| arthritis genes | #7 |
| congenic mouse | #7 |
| collagen epitope | #7 |
| psoriasiform skin disease | #7 |
| rats phases | #7 |
| role raloxifene | #7 |
| transgenic class | #7 |
| induction arthritis | #7 |
| type collagen | #7 |
| antibodyinduced arthritis | #7 |
| hydrolases polymorphism | #7 |
| regulatory cells macrophages | #7 |
| antigens differentiation arthritis | #7 |
| symptoms disease onset | #7 |
| cia mice | #7 |
| responses cii | #7 |
| impaired induction | #7 |
| cryogel column | #7 |
| response immunization | #7 |
| chronic experimental | #7 |
| mbp peptide | #7 |
| autoantibodies lymphocytes | #7 |
| ciireactive cells | #7 |
| arthritis type collagen | #7 |
| isomerase peptide | #7 |
| glycosylated collagen | #7 |
| collagen arthritis cia | #7 |
| protective influences | #7 |
| yaa gene | #7 |
| aplec | #7 |
| cii apc | #7 |
| oestrogen rats | #7 |
| 3xi | #7 |
| cii anti | #7 |
| locus chromosome | #7 |
| periodontitis arthritis | #7 |
| antibodies citrullinated antigens | #7 |
| mediated vasculitis | #7 |
| strains disease | #7 |
| castrated females | #7 |
| mice constant darkness | #7 |
| cognate activation | #7 |
| mouse collagen | #7 |
| cia5 | #7 |
| analysis crosses | #7 |
| g6pi | #7 |
| congenic strains | #7 |
| cab3 | #7 |
| raassociated molecules | #7 |
| arthritis strains | #7 |
| rheumatoid arthritis role | #7 |
| polychondritis relapsing | #7 |
| animal immunization injections | #7 |
| ean animals | #7 |
| persistent joint pain | #8 |
| autoantibodies subset | #8 |
| mice techniques | #8 |
| autologous peptide | #8 |
| antigenspecific priming | #8 |
| chronic autoimmune arthritis | #8 |
| rheumatoid autoimmunity | #8 |
| parathyroid glands receptors | #8 |
| eae genetic encephalomyelitis | #8 |
| chromosomes loci | #8 |
| ptpn22620w | #8 |
| patients type collagen | #8 |
| dominant cell epitope | #8 |
| rheumatoid chromosome | #8 |
| rt1f | #8 |
| cia2 | #8 |
| rats mhc | #8 |
| onset day day | #8 |
| arthritis lymphocytes | #8 |
| hdac3 expression | #8 |
| incidence cia | #8 |
| haematogenously | #8 |
| 42 rats | #8 |
| eae3 | #8 |
| supermacroporous cryogel | #8 |
| hybridomas antibodies | #8 |
| mice ifnbeta | #8 |
| α1‐microglobulin | #8 |
| ifa cii | #8 |
| antibodies acpas | #8 |
| clinical signs ean | #8 |
| cosphox | #8 |
| destructive effects | #8 |
| onset incidence | #8 |
| medium mem | #8 |
| illness igg | #8 |
| diseases loci | #8 |
| antibody vivo | #8 |
| underlying genes | #8 |
| inflamed synovia | #8 |
| expression hdac3 | #8 |
| hlase alleles | #8 |
| murine locus | #8 |
| polymeric cryogels | #8 |
| b10 background | #8 |
| autoimmune congenic mice | #8 |
| oia2 | #8 |
| non‐mhc | #8 |
| experimental autoimmune disease | #8 |
| neutrophil cytosolic | #8 |
| mumt mice | #8 |
| oxidized peptides | #8 |
| lyme arthritis severity | #8 |
| hladrb11001 | #8 |
| 297 cases | #8 |
| induced neuropathology | #8 |
| t‐cell priming | #8 |
| humans experimental arthritis | #8 |
| ros interplay | #8 |
| sialadenitis mrl | #8 |
| heterologous peptide | #8 |
| murinised | #8 |
| mbp mog | #8 |
| autoantibodies collagen type | #8 |
| treatment monoclonal | #8 |
| experimental binding | #8 |
| cia animal model | #8 |
| typeii collagen | #8 |
| fcγr2b | #8 |
| murine collagen | #9 |
| serum interferon | #9 |
| inbred lew tlymphocytes | #9 |
| differentiation autoimmune | #9 |
| mouse peptide | #9 |
| autoimmunogenic | #9 |
| postmenopausal arthritis | #9 |
| cia transgenic mice | #9 |
| rt1u | #9 |
| reduced arthritis | #9 |
| experimental arthritis rats | #9 |
| ox19 | #9 |
| b10riii mice | #9 |
| intranasal animals arthritis | #9 |
| early joint erosions | #9 |
| illness receptor | #9 |
| acpas | #9 |
| animal models urgent | #9 |
| experimental genes | #9 |
| hitr | #9 |
| acpas patients | #9 |
| rheumatoid autoantibodies | #9 |
| loci rats | #9 |
| rats rat | #9 |
| psychological tyrosine | #9 |
| inbred dba mice | #9 |
| class allele | #9 |
| pristane | #9 |
| collagen complement | #9 |
| mammalian disease models | #9 |
| arthritis skg mice | #9 |
| posttranslational glycosylation | #9 |
| ean myelin | #9 |
| alpha1inhibitor3 | #9 |
| rheumatoid joints | #9 |
| specific sets | #9 |
| 2 nadph | #9 |
| arthritis cross | #9 |
| idiotype‐specific | #9 |
| antibody alpha | #9 |
| oligomeric matrix | #9 |
| hgpi325 | #9 |
| patients acpas | #9 |
| development autoimmune arthritis | #9 |
| effects mabs | #9 |
| histone 1 hdac1 | #9 |
| induced metabolic syndrome | #9 |
| variants acpa | #9 |
| disease strains | #9 |
| antibodies vivo | #9 |
| collagen female | #9 |
| eae immunization | #9 |
| bovine cii | #9 |
| specific nox2 | #9 |
| adaptive inflammation | #9 |
| nodp | #9 |
| bound carbohydrates | #9 |
| oil adjuvants | #9 |
| il10 role | #9 |
| avridine | #9 |
| response mouse | #9 |
| human immunopeptidome | #9 |
| h2ap | #10 |
| mice nadph | #10 |
| alpha collagen chains | #10 |
| immunization rats | #10 |
| mice cii | #10 |
| severe erosive | #10 |
| knockout nadph | #10 |
| antibody collagen | #10 |
| genetic experiments | #10 |
| cell‐deficient | #10 |
| rheumatoid arthritis dr4 | #10 |
| extracellular cartilage | #10 |
| mice genistein | #10 |
| cells development | #10 |
| stock mice | #10 |
| cartilage collagen fibrils | #10 |
| dense fractions | #10 |
| abp gene | #10 |
| tertbutylacrylamide | #10 |
| animal models | #10 |
| collagen autoimmunity | #10 |
| beta 11 | #10 |
| monoclonal arthritis | #10 |
| citrullinated antigen | #10 |
| experimental cartilage | #10 |
| cells increased production | #10 |
| endogenous collagen | #10 |
| reactivity acpas | #10 |
| pain animal models | #10 |
| cii mice | #10 |
| onset chromosome | #10 |
| cartilage arthritis | #10 |
| rats lewis rats | #10 |
| development severity | #10 |
| passive transfer experiments | #10 |
| cartilage oligomeric | #10 |
| prl effects | #10 |
| acpa diagnosis | #10 |
| activation male | #10 |
| autoimmune disease humans | #10 |
| native collagen type | #10 |
| mutated mice | #10 |
| mbp peptides | #10 |
| acutephase response rats | #10 |
| axotomized motor neurons | #10 |
| oestrogen | #10 |
| o2• h2o2 | #10 |
| ifnbeta mice | #10 |
| cd4 cells spleen | #10 |
| monoclonal antigens rats | #10 |
| hlase smoking | #10 |
| antibodies specific | #10 |
| nih heterogeneous stock | #10 |
| presence acpa | #10 |
| inbred dba | #10 |
| antibody type collagen | #11 |
| mice cd1 | #11 |
| stromal cells macrophages | #11 |
| 84–102 | #11 |
| species respiratory | #11 |
| mhc control | #11 |
| rat collagen | #11 |
| cells pia | #11 |
| antigen variability | #11 |
| chondrocytes ecm | #11 |
| ptpn22 smoking | #11 |
| monoclonal rheumatoid factors | #11 |
| inflammatory arthritis role | #11 |
| rat liver rats | #11 |
| loci regulating | #11 |
| isotypes | #11 |
| cia30 | #11 |
| arthritis absence | #11 |
| potential autoantigens | #11 |
| mice mhc | #11 |
| lentiviral vector expression | #11 |
| antibodies association | #11 |
| dss wt | #11 |
| nodb10h2b mice | #11 |
| cia7 | #11 |
| rat arthritis | #11 |
| fragments anti | #11 |
| chronic arthritis | #11 |
| liver receptor lxrα | #11 |
| development rheumatoid | #11 |
| gad6 | #11 |
| naïve cells cells | #11 |
| tailbase | #11 |
| individuals onset | #11 |
| 2xi | #11 |
| antibodies structures | #12 |
| matrilin | #12 |
| bovine type collagen | #12 |
| cii patients | #12 |
| α1ii | #12 |
| increased litter size | #12 |
| study arthritis | #12 |
| cross rats | #12 |
| associations antibodies | #12 |
| mutated mouse | #12 |
| mutation nadph | #12 |
| loci disease | #12 |
| role arthritis | #12 |
| encephalomyelitis induced | #12 |
| immunodominant | #12 |
| lung macrophages mice | #12 |
| stages pathogenesis | #12 |
| natural polymorphism | #12 |
| autoimmune monoclonal antigens | #12 |
| rats cia | #12 |
| type collagen immunization | #12 |
| major haplotype | #12 |
| lymphoid cells development | #12 |
| structure antibodies | #12 |
| hydroxylysines | #12 |
| myelin ean | #12 |
| mbp response | #12 |
| illness sex characteristics | #12 |
| onset symptoms | #12 |
| fpr2 agonists | #12 |
| animal immunohistochemistry | #12 |
| genetic contamination | #12 |
| mice comp | #12 |
| frequencies antibodies | #12 |
| chronic erosive arthritis | #12 |
| backgroundantibodies | #12 |
| cell responses cii | #12 |
| rats expression | #12 |
| psoriasis mouse model | #12 |
| riiis | #12 |
| psoriasis arthritis | #12 |
| peptide study | #12 |
| natural loss | #12 |
| pia1 | #12 |
| serum concentrations comp | #12 |
| icmediated | #12 |
| qa2 | #12 |
| stage cia | #12 |
| nonselfdiscrimination | #12 |
| reduces severity | #12 |
| treatment experimental arthritis | #12 |
| hladrb1 ptpn22 | #13 |
| bcelldeficient mice | #13 |
| mouse strains | #13 |
| 24dinitro1fluorobenzene | #13 |
| oxidative regulation | #13 |
| immunohistochemistry interferon | #13 |
| complement complement activation | #13 |
| anticii | #13 |
| macroscopic scoring | #13 |
| multispecific | #13 |
| ccp2 antibodies | #13 |
| mannan | #13 |
| oxidase nox2 | #13 |
| nonobese diabetic mouse | #13 |
| epitope immunization | #13 |
| genes mouse chromosome | #13 |
| factor isotypes | #13 |
| expression egfp | #13 |
| lew1w | #13 |
| t‐cell epitope | #13 |
| behavioral alterations rats | #13 |
| arthritis knowledge | #13 |
| dba molecular | #13 |
| species deficiency | #13 |
| dr1 transgenic | #13 |
| idd5 | #13 |
| l012 | #13 |
| mtec aire | #13 |
| strains incidence | #13 |
| ho4 | #13 |
| advanced intercross | #13 |
| levels nabs | #13 |
| joints blood | #13 |
| doses ici | #13 |
| development type collagen | #13 |
| native type collagen | #13 |
| major loci | #13 |
| cyclic citrullinated | #13 |
| citrullinated | #13 |
| b10p | #13 |
| antibodies citrullinated proteins | #13 |
| rfigg | #13 |
| sequence collagen | #13 |
| μ chain | #13 |
| nos2derived | #13 |
| cells salivary glands | #13 |
| cell epitope | #13 |
| blymphocyte female humans | #14 |
| presence mcv | #14 |
| collagen disease | #14 |
| candidate autoantigens | #14 |
| specific inflammation | #14 |
| humans nadph | #14 |
| gut protection | #14 |
| deficient production | #14 |
| arlacel | #14 |
| mhc class region | #14 |
| protein collagen | #14 |
| murine collageninduced arthritis | #14 |
| involvement cells | #14 |
| nasal inhalation | #14 |
| immune regulators | #14 |
| autoimmunity animals | #14 |
| sirt1 mmp9 | #14 |
| efficient promotion | #14 |
| cia expression | #14 |
| antifilaggrin antibodies | #14 |
| collagen comp | #14 |
| osteoclasts vivo | #14 |
| autoimmune arthritis | #14 |
| molecular disease models | #14 |
| smallmolecule compound | #14 |
| arthritic paws | #14 |
| experimental interferon | #14 |
| b6n mice | #14 |
| loci rheumatoid | #14 |
| immunized rat | #14 |
| peptides anti | #14 |
| aggregated nets | #14 |
| macrophages immune response | #14 |
| loci interaction | #14 |
| thr233 | #14 |
| cultured human chondrocytes | #15 |
| immune complex formation | #15 |
| integrated bioprocess | #15 |
| rt1a | #15 |
| arthritis development | #15 |
| antigenic epitope | #15 |
| regulation adaptive immunity | #15 |
| citrullinated peptides patients | #15 |
| treatment cia | #15 |
| 2 weight | #15 |
| ros cii | #15 |
| mice immunization | #15 |
| mice type collagen | #15 |
| tflask | #15 |
| congenic rats | #15 |
| dcii | #15 |
| type collagen development | #15 |
| aire mtec | #15 |
| rheumatoid arthritis presence | #15 |
| murine cia | #15 |
| anticollagen | #15 |
| lentiviral gene delivery | #15 |
| osteoporosis development | #15 |
| rats monoclonal antigens | #15 |
| arthritis role | #15 |
| monoclonal arthritis rats | #15 |
| translationally modified | #15 |
| raloxifene estradiol | #15 |
| apcs macrophages | #15 |
| involvement pathogenesis | #15 |
| polychondritis | #15 |
| antibodies arthritis | #15 |
| amps development | #15 |
| cdr regions | #15 |
| exaggerates | #15 |
| mhc class molecule | #15 |
| experimental allergic neuritis | #15 |
| neuritis rats | #15 |
| presence anticarp antibodies | #15 |
| monolithic cryogel | #15 |
| nodb10h2b | #15 |
| rat genetics | #15 |
| matrilin proteins | #16 |
| males onset | #16 |
| rats experimental arthritis | #16 |
| epitopes mice mice | #16 |
| pparγ lxrα | #16 |
| oligomeric matrix protein | #16 |
| mhcii ciita | #16 |
| cep1 | #16 |
| n305 | #16 |
| anti‐t | #16 |
| disease mice mice | #16 |
| subspecificities | #16 |
| acute inflammation mice | #16 |
| arthritis cii | #16 |
| rno10 | #16 |
| levels natural antibodies | #16 |
| class transplantation | #16 |
| lethal inflammatory | #16 |
| mhc genes | #16 |
| rheumatoid arthritis genes | #16 |
| hla–drb1 shared epitope | #16 |
| antinuclear autoimmunity | #16 |
| fewer osteoclasts | #16 |
| congenic mice mice | #16 |
| rheumatoid factor production | #16 |
| rt1 | #16 |
| genes animals | #16 |
| arthritis severity mice | #16 |
| autologous collagen | #16 |
| h2p | #16 |
| mumt | #16 |
| staphylococcal arthritis | #16 |
| development rheumatoid arthritis | #16 |
| indirect genetic predisposition | #16 |
| lew1 | #16 |
| nonglycosylated form | #16 |
| ethanol development | #17 |
| periodontitis antibodies | #17 |
| arthritis rheumatoid autoantibodies | #17 |
| progesterone development | #17 |
| animals congenic | #17 |
| strains lymphocytes | #17 |
| leuphe | #17 |
| polyphosphate4 | #17 |
| cells female mice | #17 |
| rt1av1 | #17 |
| collagen induced arthritis | #17 |
| genistein mice | #17 |
| rats lewis | #17 |
| rheumatoid arthritis subsets | #17 |
| mice rheumatoid arthritis | #17 |
| onset rheumatoid arthritis | #17 |
| spleen peyers patches | #17 |
| inbred lew | #17 |
| skg | #17 |
| allergic neuritis | #17 |
| cartilage collagen | #17 |
| native denatured | #17 |
| cells collagen | #17 |
| triplehelical conformation | #17 |
| nox2 derived | #17 |
| collagen specific | #17 |
| human fcγriia | #17 |
| cells presenting cells | #17 |
| clever1 | #17 |
| cab4 | #17 |
| disease duration onset | #18 |
| hybridomas mice mice | #18 |
| keratinocytes induction | #18 |
| autoimmune illness | #18 |
| phenotypic feature | #18 |
| arthritis anti | #18 |
| galactose moiety | #18 |
| collagen autoantibodies | #18 |
| ealkene | #18 |
| cuiiida | #18 |
| short‐term administration | #18 |
| addition ros | #18 |
| ros data | #18 |
| joint inflammatory | #18 |
| langerhans cells cells | #18 |
| anti cd44 | #18 |
| cartilage type collagen | #18 |
| salivary glands mice | #18 |
| h2z | #18 |
| purified anti | #18 |
| day arthritis | #18 |
| defined epitope | #18 |
| humanized transgenic mice | #18 |
| expression lxrα | #18 |
| moginduced eae | #18 |
| dra0101 | #18 |
| day immunization | #18 |
| adjuvant arthritis rats | #18 |
| genes spleen | #18 |
| mrl mp mice | #19 |
| protective alleles | #19 |
| suppression dth | #19 |
| protein comp | #19 |
| future utility | #19 |
| supermacroporous | #19 |
| patients polychondritis | #19 |
| peyers patches spleen | #19 |
| blood monocytes neutrophils | #19 |
| beta oestradiol | #19 |
| castrated female rats | #19 |
| single intradermal injection | #19 |
| cd4 transgenic | #19 |
| mice congenic mice | #19 |
| elisa cia | #19 |
| three‐dimensional culture | #19 |
| vivo elimination | #19 |
| cia eae | #19 |
| new avenues | #19 |
| rats snp | #19 |
| tbetarii gene | #19 |
| gly262 | #19 |
| mice develop | #19 |
| collagen response | #19 |
| inflammatory attack | #19 |
| citrullinated proteins acpa | #19 |
| trimolecular complex | #19 |
| monkeys rodents | #20 |
| nox1deficient mice | #20 |
| progesterone oestrogen | #20 |
| fls tnfα | #20 |
| ciita mhcii | #20 |
| imaging reactive | #20 |
| pvg1av1 | #20 |
| rt1d | #20 |
| 5r5 | #20 |
| mbp rats | #20 |
| matrilin1 | #20 |
| human rheumatoid arthritis | #20 |
| underlying gene | #20 |
| antibody treatment | #20 |
| ncr3 | #20 |
| prominent infiltration | #20 |
| enhanced tcr | #20 |
| 5p14 | #20 |
| mice cia | #20 |
| response mbp | #20 |
| experimental autoimmunity | #20 |
| loci chromosomes | #20 |
| development disease | #20 |
| knockout mice transgenic | #20 |
| stress phospholipids | #20 |
| mhc class alleles | #20 |
| glycosylated | #20 |
| role nox | #20 |
| littermate | #20 |
| highly susceptible | #20 |
| inflammation mice | #20 |
| serm raloxifene | #20 |
| positional cloning | #21 |
| cia treatment | #21 |
| ean rats | #21 |
| rats development | #21 |
| drb11001 | #21 |
| muscle ros | #21 |
| α1acidglycoprotein | #21 |
| illness autoimmune | #21 |
| genes controlling | #21 |
| arthritis pregnancy | #21 |
| supermacroporous cryogels | #21 |
| pathogenesis rheumatoid | #21 |
| nox2 mice | #21 |
| n141 | #21 |
| conserved haplotype | #21 |
| olahsd | #21 |
| serum levels comp | #21 |
| igg fcgammar | #21 |
| linomide treatment | #21 |
| n286 | #21 |
| experimental rheumatoid | #21 |
| diseases lymphocytes | #21 |
| cells adaptive immune | #21 |
| granule mobilization | #21 |
| chronic relapsing | #21 |
| triplehelical peptides | #21 |
| mice mutant strains | #21 |
| nitratenitriteno pathway | #21 |
| suppressor cytotoxic cells | #21 |
| individual acpa | #21 |
| onset severity | #21 |
| nox2 activity | #21 |
| ul1 | #22 |
| semiallogenic | #22 |
| association pv | #22 |
| rats nonalcoholic steatohepatitis | #22 |
| response myelin | #22 |
| induced eae | #22 |
| ccp negative | #22 |
| c57bl mice subfamily | #22 |
| mice independent | #22 |
| 81a | #22 |
| animal epitopes humans | #22 |
| antiidiotypic antibody | #22 |
| cultured hepatic cells | #22 |
| vh j558 | #22 |
| samples onset | #22 |
| 270 | #22 |
| identification susceptibility genes | #22 |
| rats loss | #22 |
| determinant selection | #22 |
| experimental phenotype | #22 |
| mace association | #23 |
| monoclonal antigens autoimmune | #23 |
| rats inbred lew | #23 |
| complex influences | #23 |
| immunopeptides | #23 |
| animal genes | #23 |
| citrullinated antigens | #23 |
| citrullinated epitopes | #23 |
| 4npa | #23 |
| diseases autoimmunity | #23 |
| cells presentation | #23 |
| inflammation absence | #23 |
| anti‐cd5 | #23 |
| comp | #23 |
| antibodies acpa | #23 |
| b10r | #23 |
| lymphocytes amino | #23 |
| onset cia | #23 |
| tgfbeta resistance | #23 |
| phage clones | #23 |
| arthritis type | #23 |
| loss collagen | #23 |
| experimental chromatography | #23 |
| cryogel beads | #23 |
| citrullinated protein | #23 |
| experimental autoimmune diseases | #23 |
| peptide activation | #23 |
| mbp eae | #23 |
| 17 betaoestradiol | #23 |
| cells b10 | #23 |
| castration rats | #23 |
| experimental lupus | #24 |
| levels comp | #24 |
| 339 | #24 |
| mediated arthritis | #24 |
| monoclonal anti | #24 |
| rat induction | #24 |
| flss patients | #24 |
| animal epistasis | #24 |
| secondary immune response | #24 |
| new mouse | #24 |
| subloci | #24 |
| experimental cells | #24 |
| mice nox2 | #24 |
| loci chromosome | #24 |
| c57bl 10 mice | #24 |
| cells c3h | #24 |
| autoantibodies rheumatoid | #24 |
| inflammation arthritis | #24 |
| mouse models development | #24 |
| antinuclear apoptosis | #24 |
| ftirm | #24 |
| severity ali | #24 |
| postpartum flare | #24 |
| controls anti | #24 |
| y35 | #24 |
| chronic autoimmune diseases | #24 |
| severity chronicity | #24 |
| cells immunization | #25 |
| cell hybridomas | #25 |
| massive infiltration | #25 |
| arthritis experimental arthritis | #25 |
| monocytes nadph | #25 |
| autoantibody response | #25 |
| specific epitopes | #25 |
| common autoimmune disease | #25 |
| cix | #25 |
| rno4 | #25 |
| rat mhc | #25 |
| arginine arthritis | #25 |
| congenic animals | #25 |
| proteinarginine deiminase type | #25 |
| autoimmune messenger | #25 |
| 8 antibodies | #25 |
| autoimmune diseases humans | #25 |
| parasitemia survival | #25 |
| collagen cartilage | #25 |
| interleukin2 mice receptors | #25 |
| relapsing polychondritis | #25 |
| production monoclonal | #25 |
| tolerized rats | #25 |
| b6 balb | #25 |
| complex male | #25 |
| inbred lew rats | #25 |
| immunodominant epitope | #25 |
| beta lymphocytes | #25 |
| ros | #25 |
| bnda | #25 |
| immunization development | #25 |
| murine lyme arthritis | #25 |
| post translationally | #26 |
| cb11 | #26 |
| igg2a mice | #26 |
| cells joints | #26 |
| polychondritis rp | #26 |
| mice gammadelta cells | #26 |
| glutamax | #26 |
| eae development | #26 |
| hydrocarbon oil | #26 |
| anti citrullinated | #26 |
| local exposure | #26 |
| helperinducer animals antibodies | #26 |
| viable chondrocytes | #26 |
| granulocytes cells | #26 |
| autoantibodies citrullinated proteins | #26 |
| nitrophenylalanine | #26 |
| gene regions | #26 |
| perforin deficiency | #27 |
| interleukin21 tlymphocytes | #27 |
| ccp2 | #27 |
| innate interleukin10 | #27 |
| individuals antibodies | #27 |
| immunodominant response | #27 |
| physiological level | #27 |
| c1i | #27 |
| antibodies type | #27 |
| rheumatoid factor isotypes | #27 |
| immunospecific | #27 |
| nonmhc genes | #27 |
| trypsination | #27 |
| hladrb1 shared epitope | #27 |
| disease immunoglobulin | #27 |
| pointmutation | #27 |
| pannus tissue | #27 |
| intercrossed | #27 |
| cia3 | #28 |
| chronicity | #28 |
| nr8383 | #28 |
| antily6g | #28 |
| mediated effects | #28 |
| severity day | #28 |
| antibodies mab | #28 |
| w3 25 | #28 |
| animal models neurodegeneration | #28 |
| eae susceptibility | #28 |
| lysine position | #28 |
| onset day | #28 |
| antigenspecific tolerance | #28 |
| mrna ifngamma | #28 |
| ros induction | #28 |
| rat strain | #28 |
| upregulation cytokines | #28 |
| anti rat | #28 |
| autoimmune inflammatory | #28 |
| protein peptides | #28 |
| cartilage vivo | #28 |
| peptide anti | #29 |
| chronic dss | #29 |
| acpa | #29 |
| smoking presence | #29 |
| glucose transport capacity | #29 |
| phenomes | #29 |
| cfa cia | #29 |
| suboptimal doses | #29 |
| presence synovial fluid | #29 |
| absence inflammation | #29 |
| membrane lymphocytes | #29 |
| rfigm | #29 |
| 246trinitrophenyl | #29 |
| antibody producing cells | #29 |
| parotid secretory protein | #29 |
| ls2616 | #29 |
| immunopathogenicity | #29 |
| mice mab | #29 |
| ros production macrophages | #29 |
| hiit exercise | #29 |
| development experimental | #30 |
| ctla4 mice | #30 |
| linkage disease | #30 |
| acpa fine | #30 |
| vgenes | #30 |
| chain collagen | #30 |
| metabolic syndrome rats | #30 |
| alphabetat | #30 |
| dba mice | #30 |
| plasminogendeficient mice | #30 |
| cultivation cells | #30 |
| increased salt | #30 |
| 11 cells | #30 |
| vpba | #30 |
| vivo exercise | #30 |
| chronic autoimmune | #30 |
| paws | #30 |
| hlase | #30 |
| treatment raloxifene | #30 |
| translational rats | #30 |
| variable heavy chain | #30 |
| synovial cells patients | #30 |
| adult thymectomy | #30 |
| disease immunity | #30 |
| immunization | #31 |
| selfprotein | #31 |
| rats autoimmune | #31 |
| acute‐phase response | #31 |
| phytol | #31 |
| drugs addition | #31 |
| pristaneinduced lupus | #31 |
| ige cd23 | #31 |
| apc development | #31 |
| disease development | #31 |
| expressing cells | #31 |
| hiit training | #31 |
| comparative genetic analysis | #31 |
| perpetuated | #31 |
| monoclonal antibody production | #31 |
| human type collagen | #31 |
| synovial fluid blood | #31 |
| trimolecular | #31 |
| common chain | #31 |
| littermate controls | #31 |
| psoriasis model | #31 |
| nox2 nox1 | #31 |
| role osteoclastogenesis | #32 |
| influence genes | #32 |
| cells uterus | #32 |
| nonb cells | #32 |
| nadph oxidases nox | #32 |
| ros rns | #32 |
| epitope antibodies | #32 |
| cell ratio | #32 |
| rt11 | #32 |
| 11 cell | #32 |
| differentiation arthritis | #32 |
| h2aq | #32 |
| receptor preference | #32 |
| genomewide genotyping | #32 |
| polymorphic genes | #32 |
| mucosal tolerance | #32 |
| steen | #32 |
| ra33 | #32 |
| specificity function | #32 |
| type antibody | #32 |
| beta mice | #32 |
| acpa rheumatoid arthritis | #32 |
| nodes mice | #32 |
| caia mice | #32 |
| bound peptides | #32 |
| methods serum samples | #32 |
| congenic mice | #32 |
| arthritis therapy | #32 |
| hladrb104 | #32 |
| presence acpas | #32 |
| multiplex analysis | #33 |
| epitopes antibodies | #33 |
| role vav1 | #33 |
| delayed type | #33 |
| induced immunization | #33 |
| autoimmune demyelinating disease | #33 |
| type cross | #33 |
| skews | #33 |
| arthritic mice | #33 |
| autoantibody activity | #33 |
| rheumatoid joint | #33 |
| tcell receptor | #33 |
| cytosolic factor | #33 |
| antigenpresenting cells cells | #33 |
| modified collagen | #33 |
| tolerance immunization | #33 |
| fpr1 | #34 |
| joint pathology | #34 |
| neurodegeneration role | #34 |
| cells dendritic cells | #34 |
| promiscuous expression | #34 |
| heterogeneous stock | #34 |
| nox2 deficiency | #34 |
| natural antibodies nabs | #34 |
| patients animal models | #34 |
| c4bp | #34 |
| interferon activity | #34 |
| chronic polyarthritis | #34 |
| nets neutrophils | #35 |
| infectious disease models | #35 |
| 1xi | #35 |
| monoclonal rheumatoid | #35 |
| patients populations | #35 |
| destructive arthritis | #35 |
| vdr cells | #35 |
| development chronic | #35 |
| psoriasiform skin | #35 |
| accessible sites | #35 |
| autoreactive | #35 |
| acs stroke | #35 |
| phagotope | #35 |
| hybridomas | #35 |
| major regulators | #35 |
| triple helical | #35 |
| complex arthritis | #35 |
| plasminogen deficiency | #35 |
| antiarthritis | #35 |
| antirat | #35 |
| arthritis disease | #35 |
| tolerance tlymphocytes | #36 |
| female histocompatibility | #36 |
| induction tregs | #36 |
| cartilage joints | #36 |
| nk cells recognition | #36 |
| flow cytometry expression | #36 |
| specificity sera | #36 |
| dinitro1 | #36 |
| arthritis cartilage | #36 |
| oxidases rna | #36 |
| techniques mice | #36 |
| cii cfa | #36 |
| comparative genetics | #36 |
| variance animals antibodies | #36 |
| dth | #36 |
| h2r | #36 |
| phagocyte | #36 |
| protein specific | #36 |
| h2g7 | #36 |
| animals antigen | #36 |
| recombinant vaccine | #37 |
| susceptibility autoimmune diseases | #37 |
| spontaneous arthritis | #37 |
| genetic control | #37 |
| acpa positive | #37 |
| c129 | #37 |
| oxidases oxidation | #37 |
| peptides binding | #37 |
| lymphocytes disease | #37 |
| dba1 | #37 |
| role gamma interferon | #37 |
| rich lipid | #37 |
| immunopathological features | #37 |
| mif pathogenesis | #37 |
| encephalomyelitis | #37 |
| joint cartilage | #37 |
| synthetic glycopeptides | #37 |
| cii protein | #37 |
| target autoantigens | #38 |
| innovative tools | #38 |
| human blood neutrophils | #38 |
| cochranmantelhaenszel test | #38 |
| nitrogen species | #38 |
| cldn4 | #38 |
| animal models pain | #38 |
| snat | #38 |
| sialophorin | #38 |
| antibodies animals | #38 |
| wasting syndrome | #39 |
| ym1 | #39 |
| b6n | #39 |
| autoreactive cells | #39 |
| nzw | #39 |
| data myelin | #39 |
| endoβnacetylglucosaminidase | #39 |
| clonal expansion cells | #39 |
| measurement activity | #39 |
| benoist | #39 |
| cell tolerance | #39 |
| acpa response | #39 |
| ccia | #39 |
| nfr | #39 |
| oestrogen treatment | #39 |
| resultsrats | #39 |
| allogeneically | #39 |
| positive rheumatoid | #40 |
| addition impact | #40 |
| polyclonal cell activation | #40 |
| rt1c | #40 |
| genetic complexity | #40 |
| antigens arthritis | #40 |
| peptide cell | #40 |
| isostere | #40 |
| adjuvant induced | #40 |
| disease animal models | #40 |
| aq | #41 |
| ncii | #41 |
| effects experiments | #41 |
| genes loci | #41 |
| autoimmune | #41 |
| rats anti | #41 |
| rat myelin | #41 |
| congenic mapping | #41 |
| priming phase | #41 |
| autoimmune inflammatory diseases | #41 |
| severity incidence | #41 |
| mhc haplotype | #41 |
| immunocap isac | #41 |
| cartilage bone destruction | #42 |
| drb1 shared | #42 |
| spleen weight | #42 |
| antibody isotypes | #42 |
| pineal gland melatonin | #42 |
| th17 axis | #42 |
| articular collagen | #42 |
| fibroblasts mice | #42 |
| mhc class class | #42 |
| species receptors | #42 |
| ptpn22 locus | #42 |
| expected onset | #42 |
| p38 mapk nfκb | #42 |
| collagen | #43 |
| lew lymphocytes | #43 |
| arthritis data | #43 |
| anticitrullinated | #43 |
| cd11bly6g | #43 |
| immunodominant epitopes | #43 |
| treatment autoimmune diseases | #43 |
| anticyclic | #43 |
| congeneic | #43 |
| mice autoimmune | #43 |
| kgf treatment | #43 |
| lew rats | #43 |
| crosses genetic | #43 |
| pc8 | #43 |
| type‐ii | #43 |
| spinal glia | #43 |
| rats sex | #43 |
| autoreactive cell | #43 |
| mice mice autoimmune | #44 |
| addition order | #44 |
| epitopes lymphocyte | #44 |
| mice adulthood | #44 |
| neuritis ean | #44 |
| defensins humans | #44 |
| homozygous form | #44 |
| mathis | #44 |
| chloro23 | #44 |
| genetic linkage analysis | #44 |
| inflammation animals | #44 |
| c4bbinding protein c4bp | #44 |
| peptide induced | #44 |
| provocations | #44 |
| potent suppression | #45 |
| phagotopes | #45 |
| susceptibility arthritis | #45 |
| nzb | #45 |
| chromosome development | #45 |
| relapsing disease | #45 |
| disease histocompatibility | #45 |
| outbred rats | #45 |
| genetic encoding | #45 |
| alphachains | #46 |
| cocrystallisation | #46 |
| carp antibodies | #46 |
| specific tolerance | #46 |
| affinity purified | #46 |
| rat2 | #46 |
| c227 | #46 |
| locus controlling | #46 |
| eae mbp | #46 |
| posttranslationally | #46 |
| lower severity | #46 |
| isosteres | #46 |
| mhc class humans | #46 |
| disease induction | #46 |
| neuritis autoimmune | #46 |
| posttranslational rats receptors | #47 |
| f1 hybrid mice | #47 |
| diagnostic accuracy diagnosis | #47 |
| rheumatoid factors | #47 |
| antibody reactivities | #47 |
| complex mediated | #47 |
| intercrosses | #47 |
| idiotypic antibody | #47 |
| protective allele | #47 |
| association hladrb1 alleles | #47 |
| lupus disease | #48 |
| mice carrying | #48 |
| collagen glycosylation | #48 |
| mice nzb | #48 |
| cia rats | #48 |
| f1 crosses | #48 |
| humanized model | #48 |
| experimental arthritis mice | #48 |
| collagen peptide | #48 |
| γchains | #48 |
| antibody specificity | #48 |
| peptide recognized | #48 |
| synovial lining layer | #48 |
| tlr12 | #48 |
| acetylchitobiose | #48 |
| experimental crosses | #49 |
| bystander activation | #49 |
| class major | #49 |
| mice caia | #49 |
| sex genes | #49 |
| polyvinylcaprolactam | #49 |
| histone hdacs | #49 |
| tcell stimulation | #49 |
| mouse cartilage | #49 |
| monoclonal autoimmune diseases | #49 |
| comp levels | #49 |
| immune nervous | #49 |
| dependent chronic | #50 |
| loci animals | #50 |
| disease rats | #50 |
| animal cell culture | #50 |
| mice tolerance | #50 |
| alagly | #50 |
| inflammation kynurenine | #50 |
| cytometry analyses | #50 |
| monoclonal epitopes | #50 |
| glutamine uptake | #50 |
| parathyroid cells | #50 |
| complex region | #50 |
| antigenantibody | #50 |
| ciiia | #50 |
| glycosylated form | #50 |
| anticarbamylated protein | #50 |
| fewer cells | #51 |
| tracheal cartilage | #51 |
| evidence animal models | #51 |
| aire mice | #51 |
| cells ova | #51 |
| antibodies cells | #51 |
| runting | #51 |
| autoantibodies rheumatoid arthritis | #51 |
| lentiviral particles | #51 |
| rheumatoid factor activity | #51 |
| delayed immunization | #51 |
| c57bl 6j background | #51 |
| derived type | #51 |
| tolerized | #51 |
| inbred c57bl autoimmune | #51 |
| macrophages skin | #52 |
| antigenpresenting cells | #52 |
| ptpn22 | #52 |
| matrix protein | #52 |
| model collagen | #52 |
| xor activity | #52 |
| protein antibodies | #53 |
| melatonin day | #53 |
| production reactive | #53 |
| patients rheumatic conditions | #53 |
| carbamylated proteins | #53 |
| lysosomal compartments | #53 |
| triple helical structure | #53 |
| induced autoimmunity | #53 |
| aged peptides | #53 |
| physiological doses | #53 |
| arthritis induction | #53 |
| cartilage erosion | #53 |
| antibodies epitopes | #53 |
| gastric parietal cell | #53 |
| development individuals | #54 |
| predating | #54 |
| imitating | #54 |
| carbamylated protein | #54 |
| animals autoimmune | #54 |
| yaa | #54 |
| nodes lymphocyte | #54 |
| antigens myelomonocytic arthritis | #54 |
| strain rats | #54 |
| melatonin animals | #54 |
| major epitope | #54 |
| crossbreeding | #54 |
| rats social isolation | #54 |
| complex genetic disease | #55 |
| susceptibility autoimmune disease | #55 |
| macrophage mannose receptor | #55 |
| autoimmune reactions | #55 |
| inflammatory manifestations | #55 |
| autoimmune nzb | #55 |
| arthritis genetic | #55 |
| mhc | #56 |
| cells salivary | #56 |
| animals antibody | #56 |
| labels superoxide | #56 |
| new animal | #56 |
| selfreactive cells | #56 |
| alpha1microglobulin | #56 |
| cd1 mice | #57 |
| antibodies bind | #57 |
| vivo depletion | #57 |
| collagen sequence | #57 |
| development autoimmune | #57 |
| igg abs | #57 |
| arthritis pathogenesis | #57 |
| animals antirheumatic | #57 |
| antibodies | #57 |
| oestrogen progesterone | #58 |
| urokinase activity | #58 |
| rat type | #58 |
| schafer | #58 |
| peptide response | #58 |
| chronic eae | #58 |
| cartilage matrix protein | #59 |
| encephalitogenicity | #59 |
| anticarp antibodies | #59 |
| resistance eae | #59 |
| anti cd8 | #59 |
| oligoclonal igg bands | #59 |
| hydroxylase diet | #59 |
| genes mhc | #59 |
| anti cell | #59 |
| articular joints | #59 |
| dichotomous effects | #60 |
| alternative activation macrophages | #60 |
| hpaaxis | #60 |
| immunohistopathology | #60 |
| macrophage mannose | #60 |
| inflammatory cells macrophages | #60 |
| protein peptide | #60 |
| assay epitopes | #60 |
| joint erosions | #60 |
| experimental rats rats | #61 |
| serum comp | #61 |
| epitope spreading | #61 |
| cells innate immune | #61 |
| alpha1m | #61 |
| differentiation myelomonocytic arthritis | #61 |
| major histocompatibility | #61 |
| species reactive | #61 |
| incidence severity | #61 |
| experimental evoked potentials | #61 |
| toxin1 | #62 |
| syngeneically | #62 |
| fpr2 | #62 |
| autoantibody formation | #62 |
| antigens class histocompatibility | #62 |
| basic characterization | #62 |
| interferon‐β | #62 |
| mice susceptibility | #62 |
| placenta uterus | #62 |
| reduced oxidative | #62 |
| adaptive immune | #62 |
| cyclic sensitivity | #62 |
| peptide specific | #63 |
| mog1 | #63 |
| protein disease | #63 |
| igaproducing cells | #63 |
| collagen cell | #63 |
| specificity tumor | #63 |
| mice polyi | #63 |
| induced experimental | #63 |
| delayed interferon | #63 |
| transfer animals | #63 |
| rats strain | #63 |
| hypersensitivity dth | #63 |
| nadph oxidases | #63 |
| constant darkness | #63 |
| duval | #63 |
| specific stages | #63 |
| post‐partum | #63 |
| glycoprotein myelin | #63 |
| tolerance model | #64 |
| freund adjuvant | #64 |
| maternal origin | #64 |
| lower capacity | #64 |
| secondary immune | #64 |
| role apc | #64 |
| major subset | #65 |
| hindpaws | #65 |
| model chronic | #65 |
| induced suppression | #65 |
| flss | #65 |
| autoimmunity humans | #65 |
| weight variation | #65 |
| histocompatibility complex | #65 |
| rheumatoid synovial cells | #66 |
| acute arthritis | #66 |
| resemblances | #66 |
| negative rheumatoid | #66 |
| experimental lymphocytes | #66 |
| hladr2 | #66 |
| thy1 antigen | #66 |
| phagocytosis oxidative burst | #66 |
| multispecificity | #66 |
| spontaneous disease | #66 |
| chromosomes mammalian | #66 |
| peripheral joints | #66 |
| experimental allergic | #67 |
| mice cell | #67 |
| fibrinogen genotype | #67 |
| development cell | #67 |
| experimental encephalomyelitis | #67 |
| mice induced | #67 |
| myelomonocytic arthritis | #67 |
| key interactions | #67 |
| dendritic cells epitopes | #67 |
| endos | #67 |
| strains susceptible | #67 |
| rheumatoid arthritis susceptibility | #67 |
| iggrf | #68 |
| class region | #68 |
| rheumatoid chromosomes | #68 |
| female sex hormones | #68 |
| tolerized mice | #68 |
| severity periodontitis | #68 |
| cells mhc class | #68 |
| frequent infections | #68 |
| individuals positive | #68 |
| complex class | #68 |
| helper phenotype | #68 |
| sodium diethyldithiocarbamate | #68 |
| anti carp | #68 |
| vertebrate immune | #69 |
| zap‐70 | #69 |
| frequency antibodies | #69 |
| rheumatoid disease | #69 |
| lymphocytes chronic | #69 |
| direct damage | #69 |
| relapsing | #69 |
| cells mouse | #69 |
| immunoglobulin interferon | #70 |
| translationally | #70 |
| mrl mice | #70 |
| role cells | #70 |
| presence rheumatoid factor | #70 |
| response type | #70 |
| prolonged graft survival | #70 |
| ztm | #71 |
| cartilage mice | #71 |
| swr | #71 |
| human psoriasis | #71 |
| isolated rats | #71 |
| cb10 | #71 |
| expression pparγ | #71 |
| susceptibility female | #71 |
| naïve mice | #72 |
| napdh | #72 |
| lathyritic | #72 |
| interphalangeal joints | #72 |
| autoimmunity lymphocytes | #72 |
| study antibodies | #72 |
| dark agouti rats | #72 |
| antibodies binding | #72 |
| delayedtype hypersensitivity dth | #72 |
| mrl lpr | #73 |
| type ifn signature | #73 |
| treatment stages | #73 |
| knockout protein processing | #73 |
| environmental lighting | #73 |
| bovine type | #73 |
| membrane animals | #73 |
| oxidase complex | #73 |
| species ros | #73 |
| antigens class | #74 |
| pregnancyinduced | #74 |
| igarf | #74 |
| hypersensitivity delayed | #74 |
| peptides sequences | #74 |
| cartilage explants | #74 |
| effects development | #75 |
| diabetes arthritis | #75 |
| genetic disease models | #75 |
| inbred dba receptors | #75 |
| dth mice | #75 |
| cell reactivity | #75 |
| oestradiol | #75 |
| acpapositive | #75 |
| type collagens | #76 |
| rat splenocytes | #76 |
| anti carbamylated | #76 |
| disease rheumatoid arthritis | #76 |
| peptide mhc | #76 |
| collagen chains | #77 |
| cell deficient | #77 |
| new animal model | #77 |
| eae induced | #77 |
| nerve conduction velocity | #77 |
| rats eae | #77 |
| development insulitis | #77 |
| lpr mrl | #77 |
| cyp7a1 | #77 |
| oligomeric | #77 |
| rt1n | #77 |
| inbred mouse strains | #77 |
| pain inflammation | #77 |
| regulatory vaccines | #77 |
| rats respiratory | #78 |
| pythons | #78 |
| clinical arthritis | #78 |
| autoantigenic | #78 |
| cartilage integrity | #78 |
| mhc expression | #78 |
| pathogenesis rheumatoid arthritis | #78 |
| 1ii | #79 |
| susceptibility disease | #79 |
| shared epitope | #79 |
| mononuclear lung | #79 |
| inflammatory autoimmune | #79 |
| autoimmune experimental epitopes | #79 |
| chromosome study | #80 |
| erosive arthritis | #80 |
| oxidases | #80 |
| detection autoantibodies | #80 |
| class antigen expression | #81 |
| dr1 antigen | #81 |
| estrogen suppression | #81 |
| arthritis cells | #81 |
| spleen study | #81 |
| aspartic acid position | #81 |
| mrl mp | #81 |
| mog mbp | #81 |
| expression ll37 | #81 |
| inflammatory phase | #81 |
| hnrnpa2 | #81 |
| mhcii expression | #81 |
| induced leukocyte | #81 |
| sex linkage | #81 |
| type macrophages | #81 |
| 14weeks | #82 |
| nadphoxidase | #82 |
| pannus formation | #82 |
| mice igg | #83 |
| cell independent | #83 |
| tlymphocyte genes | #83 |
| bcg infection | #83 |
| drug encephalomyelitis | #83 |
| expression mhc | #83 |
| strains animals | #84 |
| naïve cells | #84 |
| epidermal cells | #84 |
| rat cardiac allografts | #84 |
| reactive cells | #84 |
| spontaneous development | #84 |
| multiple sclerosis evidence | #84 |
| arthritis day | #84 |
| cells recognize | #85 |
| inflammation joints | #85 |
| knockout receptors | #85 |
| homopentamer | #85 |
| class molecule | #85 |
| inflammation joint | #85 |
| antiifngamma | #85 |
| monoclonal antibodies mab | #86 |
| preclinical stage | #86 |
| animal humans | #86 |
| contribution genes | #86 |
| classical humans | #86 |
| gfoger | #86 |
| phagocyte nadph | #86 |
| anti cd4 | #86 |
| severe eae | #86 |
| mutant strains | #86 |
| estrogen induced | #87 |
| alpha1acid glycoprotein | #87 |
| mhc class gene | #87 |
| smash | #87 |
| inbred rat strains | #87 |
| inguinal lymph nodes | #88 |
| narac | #88 |
| thps | #88 |
| copy variation | #88 |
| levels anti | #88 |
| fine specificities | #88 |
| experimental autoimmune | #89 |
| arthritic | #89 |
| peptide immunization | #89 |
| mabs mab | #89 |
| depletion cd8 cells | #89 |
| mice antibodies | #89 |
| genetic quantitative | #89 |
| mediated mechanisms | #90 |
| genistein treatment | #90 |
| susceptible | #90 |
| arthritis compared | #90 |
| autoimmune inbred c57bl | #90 |
| rheumatoid arthritis cells | #90 |
| adjuvant arthritis | #90 |
| monkeys mice | #90 |
| pineal hormone melatonin | #90 |
| ilc2 activation | #90 |
| cells apc | #91 |
| backgroundan | #91 |
| activation cd4 cells | #91 |
| protein induced | #91 |
| cattle collagen | #91 |
| synovial fluid serum | #91 |
| histological sections | #91 |
| difco | #92 |
| anticitrullinated protein | #92 |
| experimental mouse models | #92 |
| humans immunodominant | #92 |
| abdominal region | #92 |
| nod mhc | #92 |
| knockout myelin | #93 |
| xor | #93 |
| 290 patients | #93 |
| cellspecific | #93 |
| natural polymorphisms | #93 |
| mice melatonin | #93 |
| animals autoantibodies | #93 |
| galactosylated | #94 |
| activated cells cells | #94 |
| endosomal acidification | #94 |
| macrophages development | #94 |
| fcγrs | #94 |
| autosomal genes | #94 |
| induced sarcoma | #95 |
| moderateintensity exercise | #95 |
| binding integrins | #95 |
| chronic phase disease | #95 |
| cell alpha | #96 |
| fetal rejection | #96 |
| nonglycosylated | #96 |
| data rats | #96 |
| pregnancy disease | #96 |
| ifnbeta | #96 |
| lung emphysema | #96 |
| romani | #96 |
| messenger tolllike receptor | #96 |
| macrophages stimulation | #96 |
| citrullinated fibrinogen | #97 |
| il33r | #97 |
| macrophages fibroblasts | #97 |
| cathelicidins | #97 |
| complex mice | #97 |
| rheumatoid lymphocytes | #97 |
| hydroxylysine | #97 |
| antiimmunoglobulin | #97 |
| genetic female genes | #97 |
| acpa igg | #98 |
| autoimmune experimental | #98 |
| swr mice | #98 |
| ean | #98 |
| rheumatoid cartilage | #98 |
| autoimmune rats | #98 |
| collagen cytokines | #99 |
| interleukin‐4 | #99 |
| alternative pathways | #99 |
| rat chromosomes | #99 |
| tlymphocyte immunity | #100 |
| peptides cells | #100 |
| tap2 | #100 |
| ccp anti | #100 |
| inducer animals | #100 |
| thy1 antigens | #100 |
| invading pathogens | #100 |
| protein antibody | #100 |
| cultured crosses | #100 |
| rats monoclonal antibodies | #100 |
| susceptible strain | #101 |
| safety drugs | #101 |
| fprs | #101 |
| cell determinants | #101 |
| singlenucleotide polymorphism | #101 |
| bone degradation | #101 |
| eira | #101 |
| diarthrodial | #101 |
| mouse monoclonal antibodies | #102 |
| findings treatment | #102 |
| brucei infection | #102 |
| eae animal encephalomyelitis | #102 |
| candidate autoantigen | #102 |
| agalactosyl | #103 |
| drb10401 | #103 |
| ros homeostasis | #103 |
| hla dr1 | #103 |
| pathogenesis emphysema | #103 |
| oxidative burst | #103 |
| arthritic disease | #104 |
| thelper cells | #104 |
| skg mice | #104 |
| mhcii | #104 |
| haplotypes histocompatibility | #104 |
| synchrotron infrared | #104 |
| male mice mice | #104 |
| nonarthritic | #104 |
| mutation mice | #104 |
| f1 males | #104 |
| dmaam | #105 |
| hybridoma cell | #105 |
| autoreactivity | #105 |
| fcγr | #105 |
| development antibodies | #105 |
| osteoclasts mice | #105 |
| vivo macrophages | #105 |
| type 22 | #105 |
| arthritis hla | #106 |
| limited cross | #106 |
| 273 | #106 |
| proteoglycan loss | #106 |
| disease dose | #106 |
| primed cells | #106 |
| tcell immunity | #106 |
| c3h mice | #107 |
| nzb mice | #107 |
| cells synovial | #107 |
| development autoimmune disease | #108 |
| littermates | #108 |
| fpr | #108 |
| study tolerance | #108 |
| structural polymorphism | #109 |
| delayedtype hypersensitivity | #109 |
| citrullinated proteins | #109 |
| enthesophytes | #109 |
| presentation cells | #109 |
| reactive cell | #109 |
| type hypersensitivity | #109 |
| monoclonal igg | #109 |
| autoantibodies autoantigens | #109 |
| autoimmune encephalomyelitis | #110 |
| carcinoma tumors | #110 |
| mog eae | #111 |
| toxic shock syndrome | #111 |
| female hypersensitivity | #111 |
| backcross | #111 |
| inbred dba microscopy | #111 |
| cartilage | #111 |
| experimental female | #111 |
| dba 1j mice | #111 |
| streptococcal cell wall | #111 |
| alphabeta receptors antigen | #112 |
| amide bond | #112 |
| humoral autoimmunity | #112 |
| extensive literature search | #112 |
| anti idiotypic antibodies | #112 |
| presymptomatic individuals | #112 |
| trait loci | #113 |
| tcra | #113 |
| restricted cell | #113 |
| mice collageninduced arthritis | #113 |
| adjuvant properties | #113 |
| autoimmune c57bl mice | #113 |
| xid mice | #113 |
| oligoclonality | #113 |
| db1 | #113 |
| adjuvantinduced arthritis | #114 |
| ifngammaproducing cells | #114 |
| mice disease | #115 |
| drb10402 | #115 |
| proinflammatory cytokine | #115 |
| autoantigens autoimmunity | #115 |
| anti mcv | #115 |
| rats collagen | #115 |
| susceptibility eae | #116 |
| experimental epitopes | #116 |
| glycopeptides | #116 |
| pathogenesis autoimmune diseases | #116 |
| immunosorbents | #116 |
| glyco | #116 |
| ccp patients | #116 |
| lymphocyte female | #116 |
| lutz | #116 |
| transgenic peptides receptors | #116 |
| antibodies reactive | #117 |
| mice type | #117 |
| antiarthritic | #117 |
| tolerance induced | #117 |
| encephalomyelitis autoimmune | #117 |
| fluorescence nf | #117 |
| congenic lines | #117 |
| rats immunized | #118 |
| class expression | #118 |
| myelin oligodendrocyte | #118 |
| pineal hormone | #118 |
| α enolase | #118 |
| samples individuals | #118 |
| alpha1acid | #118 |
| psoriasiform dermatitis | #118 |
| cd4 tcells | #119 |
| psa rheumatoid arthritis | #119 |
| radiological damage | #119 |
| rheumatoid arthritis review | #119 |
| response cells | #119 |
| 05m | #119 |
| protein mbp | #120 |
| neutrophils nets | #120 |
| chondrocyte cultures | #121 |
| vivo animal models | #121 |
| experimental animal models | #121 |
| pharmacological potential | #122 |
| genes age | #122 |
| treatment progesterone | #122 |
| t‐lymphocyte | #122 |
| acpa negative | #122 |
| transfer arthritis | #122 |
| immune complex deposition | #122 |
| patients acpa | #122 |
| transgenic neurons receptors | #122 |
| c5b | #123 |
| nox2 activation | #123 |
| cell monoclonal | #123 |
| type cytokines | #123 |
| alphabeta cells | #123 |
| symptoms associations | #123 |
| cartilage surface | #124 |
| tlr4 stimulation | #124 |
| inbred mouse | #124 |
| blocking antigens | #125 |
| immunodominant peptide | #125 |
| oxidases neutrophils | #125 |
| disease mechanisms | #125 |
| preimmunized | #125 |
| cryogel | #125 |
| qtl genes | #125 |
| helperinducer | #125 |
| general mechanisms | #125 |
| genetic rats | #125 |
| allelic variations | #125 |
| nzb nzw | #126 |
| nonobese diabetic | #126 |
| female immunization | #126 |
| cyclic polymorphism | #126 |
| pnipaam | #126 |
| microarray detection | #127 |
| atp8 | #127 |
| absence cells | #127 |
| animal enzyme | #127 |
| knockout murine | #127 |
| deiminases | #128 |
| chronic inflammatory disease | #128 |
| anticitrullinated peptide | #128 |
| dominant epitope | #128 |
| lining layer | #128 |
| rats patients | #129 |
| spleen rats | #129 |
| bxsb | #129 |
| multiple epitopes | #129 |
| cells eae | #130 |
| vivo absence | #130 |
| oestradiol testosterone | #130 |
| psd1 | #130 |
| disease induced | #130 |
| nos2 | #130 |
| onset arthritis | #131 |
| lipomannan | #131 |
| epitope specific | #131 |
| intercross | #132 |
| kgf | #132 |
| linomide | #132 |
| mineral oils | #132 |
| disease cgd | #132 |
| induction regulatory cells | #132 |
| pronociceptive | #132 |
| rat chromosome | #133 |
| leukosialin | #133 |
| ggaa | #133 |
| reduced severity | #133 |
| patients cytokines | #134 |
| accentuate | #134 |
| eae | #134 |
| plasma synovial fluid | #134 |
| myocellular | #134 |
| mice estrogen | #134 |
| knockout receptors antigen | #134 |
| interstitial collagens | #134 |
| species animals | #134 |
| peptides cyclic | #135 |
| igg immune complexes | #135 |
| spinal glial | #135 |
| macrophages dendritic | #136 |
| intracellular reactive | #136 |
| immunizing | #136 |
| chronic autoimmune disease | #136 |
| immunopathological | #137 |
| stimulated muscle | #137 |
| receptor upregulation | #137 |
| innate lymphocytes | #137 |
| ditiocarb | #138 |
| mice deficient | #138 |
| dmannitol | #139 |
| immunomodulatory drug | #139 |
| autoimmune mice | #139 |
| control development | #139 |
| tcrdelta | #140 |
| producing cell | #141 |
| oligoclonal expansion | #141 |
| thermoresponsive polymer | #141 |
| or113 | #142 |
| gamma lymphocyte | #142 |
| interferon‐γ | #142 |
| single subcutaneous injection | #142 |
| genetic factors development | #142 |
| smfish | #142 |
| phadia | #142 |
| rejection tolerance | #142 |
| cell hybridoma | #143 |
| phosphate isomerase | #143 |
| mice beta | #143 |
| tcell alphabeta receptors | #143 |
| class haplotypes | #143 |
| mhc haplotypes | #144 |
| rheumatoid arthritis | #144 |
| rat strains | #144 |
| synovial hyperplasia | #144 |
| tcr gamma delta | #145 |
| severe chronic | #145 |
| inbred buf rats | #145 |
| tnf production | #145 |
| lyme arthritis | #145 |
| treatment ici | #145 |
| syngenic | #145 |
| neonatal growth | #146 |
| rats induced | #146 |
| ccp antibodies | #147 |
| systemic challenge | #147 |
| gammainterferon | #147 |
| cellular heterogeneity | #147 |
| pregnancy levels | #147 |
| function cells | #147 |
| cell surface antigen | #148 |
| interestingly | #148 |
| redox regulation | #148 |
| phagocyte nadph oxidase | #148 |
| autoimmune disease | #148 |
| α2i | #148 |
| human autoimmune diseases | #149 |
| complex diseases | #149 |
| mhc binding | #150 |
| larsen score | #150 |
| drb104 | #150 |
| mice animals | #151 |
| humans hybridomas | #151 |
| receptor rats | #151 |
| levels antibodies | #151 |
| epicutaneously | #151 |
| differential gene expression | #151 |
| alphabeta receptors | #152 |
| pepsin | #153 |
| arthritic animals | #153 |
| key player | #153 |
| levels pregnancy | #153 |
| mononuclear cells | #153 |
| joint inflammation | #154 |
| critical event | #154 |
| immune priming | #154 |
| selfpeptides | #154 |
| daf1 | #154 |
| fcgammar | #154 |
| c4bbinding protein | #154 |
| expression class | #154 |
| male rats rats | #154 |
| f1 mice | #155 |
| infiltrating cells | #155 |
| arthritis rheumatoid | #155 |
| padi4 | #155 |
| autoantibodies autoimmune | #155 |
| serum synovial fluid | #155 |
| mace acs | #155 |
| stabilin1 | #156 |
| mhc region | #156 |
| specificities | #156 |
| suppressive role | #156 |
| murine keratinocytes | #157 |
| adjuvanticity | #157 |
| downstream signals | #157 |
| genetic diabetes mellitus | #158 |
| hypersensitivity reaction | #158 |
| analysis structure | #158 |
| parentals | #158 |
| arthritis infectious | #159 |
| meaib | #159 |
| inbred c3h mice | #159 |
| animals autoimmunity | #159 |
| consensus motif | #159 |
| systemic mice mice | #159 |
| benzylated | #161 |
| specific autoimmunity | #161 |
| nursed | #161 |
| day onset | #161 |
| gamma interferon | #161 |
| factors anti | #161 |
| knockout severity | #161 |
| rheumatoid autoantigens | #162 |
| psors1 | #162 |
| epitope | #162 |
| anti ccp | #162 |
| cd152 | #162 |
| binding collagen | #162 |
| arthritis inflammation | #162 |
| βarrestin recruitment | #162 |
| chains humans | #163 |
| onset disease | #163 |
| mouse type | #163 |
| laboratory rats | #163 |
| rats induction | #164 |
| striking similarities | #164 |
| endobetanacetylglucosaminidase | #164 |
| agalactosyl igg | #164 |
| autoantibody responses | #164 |
| genes qtl | #164 |
| mrl | #164 |
| progesterone effects | #164 |
| animal humans immunity | #165 |
| cells macrophages | #165 |
| nonimmunized | #166 |
| epitope alleles | #166 |
| pathogenic pathways | #166 |
| tolerance induction | #166 |
| melatonin mice mice | #166 |
| seronegative | #167 |
| nox2 | #167 |
| human autoimmunity | #167 |
| tlymphocyte humans | #167 |
| class mice | #167 |
| ag7 | #167 |
| mice cd4 cells | #168 |
| genetic backgrounds | #168 |
| cd1 | #168 |
| phase disease | #168 |
| denoted | #169 |
| p12 | #169 |
| oxazole | #169 |
| acpa levels | #169 |
| cryogels | #170 |
| lymph node cells | #170 |
| pathogenesis arthritis | #170 |
| joints male | #170 |
| inherited disorder | #170 |
| experimental animal | #170 |
| mirp | #170 |
| oxazolone | #171 |
| ros nitric oxide | #171 |
| encephalomyelitis eae | #171 |
| rheumatoid | #172 |
| lst1 | #172 |
| rat placenta | #172 |
| autoimmunity cell | #172 |
| single nucleotide polymorphism | #172 |
| autoimmune eae | #172 |
| peripheral lymphoid organs | #172 |
| sod3 | #173 |
| monoclonal autoantibodies | #173 |
| inbred dba models | #173 |
| studies pain | #174 |
| resistant rats | #174 |
| presence autoantibodies | #174 |
| class gene | #174 |
| nasal cartilage | #174 |
| ifn signature | #175 |
| maternal decidua | #175 |
| mice mutation | #175 |
| understanding pathogenesis | #175 |
| mammalian crosses | #176 |
| tryptophan catabolism | #176 |
| skin disease | #176 |
| new mouse model | #176 |
| strains molecular | #176 |
| moab | #176 |
| secondary challenge | #176 |
| lymphotoxinα | #177 |
| hladrb1 alleles | #178 |
| histocompatibility | #178 |
| ctla‐4 | #178 |
| protein anti | #179 |
| nod genes | #179 |
| immunized | #179 |
| dextran sulphate sodium | #179 |
| alternative pathway complement | #179 |
| mice role | #179 |
| cgd patients | #180 |
| complex disease | #180 |
| epitopes female | #180 |
| arthritis methods | #180 |
| autoimmunity disease | #181 |
| molecular adaptations | #181 |
| alleles arthritis | #181 |
| genetic influence | #181 |
| hormone melatonin | #182 |
| arginine deiminases | #182 |
| immunoglobulin mice mice | #185 |
| cells lymph nodes | #186 |
| antigen processing presentation | #186 |
| multistep process | #186 |
| rats reactive | #186 |
| dba | #187 |
| drb1 chains | #187 |
| tcell recognition | #187 |
| b10 | #187 |
| substrains | #188 |
| chondritis | #188 |
| molecular peptide | #188 |
| mtec | #189 |
| cells disease | #189 |
| inflamed joint | #190 |
| synovial membranes | #190 |
| hnrnpa2b1 | #190 |
| positionally | #190 |
| oligodendrocyte glycoprotein | #191 |
| cross‐reactivity | #192 |
| autoantibody profiles | #192 |
| ly1 | #192 |
| passive mice mice | #193 |
| fmlf | #193 |
| glycoprotein peptide | #194 |
| cyclic predictive | #194 |
| proteins myelin | #194 |
| chapter 16 | #195 |
| mhv | #195 |
| perpetuate | #195 |
| mice mutant | #195 |
| mhc class expression | #196 |
| lewis rat | #196 |
| oophorectomized | #196 |
| myelin glycoprotein | #196 |
| tcell response | #196 |
| acutephase response | #197 |
| multiplex assay | #197 |
| pannus | #197 |
| evidence development | #197 |
| early appearance | #198 |
| genetic links | #198 |
| swedish patients | #198 |
| igmrf | #198 |
| rat genome | #199 |
| interleukin17 | #199 |
| dr4 antigen | #199 |
| hla association | #200 |
| citrullinated peptide | #200 |
| cell collagen | #200 |
| pathogenesis autoimmune | #201 |
| myelin proteins myelin | #202 |
| dendritic cells macrophages | #202 |
| myelin proteolipid protein | #202 |
| acpa status | #202 |
| instigation | #202 |
| mice cells | #203 |
| complete elimination | #203 |
| class molecules | #204 |
| immunization immunoglobulin | #204 |
| 2 complex | #204 |
| spleen staining | #204 |
| dth response | #205 |
| native collagen | #205 |
| suppresses | #205 |
| nonparametric tlymphocytes | #205 |
| macrophages mice | #205 |
| ides | #205 |
| defb4 | #206 |
| wild rats | #206 |
| betaestradiol | #206 |
| alternative complement pathway | #207 |
| mice peptide | #207 |
| intranasal challenge | #207 |
| insulitis diabetes | #207 |
| noxs | #207 |
| desmoglein 3 | #207 |
| induced upregulation | #207 |
| interleukin4 mice mice | #207 |
| parental strains | #207 |
| severity disease | #208 |
| naive mice | #208 |
| highest probability | #208 |
| vivo patients | #208 |
| antigen presenting | #208 |
| immunization mice | #208 |
| immunoglobulin vh | #209 |
| disease rheumatoid | #209 |
| cotwins | #209 |
| valuable tools | #210 |
| susceptible strains | #210 |
| citrullinated vimentin | #210 |
| vav1 | #210 |
| highfatdiet | #210 |
| specific antibodies | #210 |
| hla dr4 | #211 |
| glucose6 phosphate | #211 |
| natural antibodies | #211 |
| diseases genetic | #211 |
| purified protein derivative | #211 |
| cells immobilized | #212 |
| large numbers | #212 |
| association rheumatoid arthritis | #212 |
| psoriasiform | #213 |
| mice injected | #213 |
| antibody binding | #213 |
| tsst1 | #214 |
| mhc class antigens | #215 |
| antigen induced | #215 |
| central tolerance | #215 |
| cytofluorometric | #215 |
| triethylsilane | #215 |
| inbred rat | #215 |
| training hiit | #216 |
| lower level | #216 |
| dissect | #216 |
| cd23 | #217 |
| induced autoimmune | #217 |
| rats immunization | #217 |
| inflammatory infiltrates | #217 |
| lentiviral vector | #217 |
| joints mice | #217 |
| resistant strain | #217 |
| antigen tcell | #218 |
| treatment onset | #218 |
| autoimmunity | #219 |
| fcrγ | #219 |
| k8 | #219 |
| peptide antibodies | #219 |
| granuloma formation | #219 |
| bone erosions | #220 |
| peptidylarginine deiminases | #220 |
| cells autoimmune | #220 |
| hyl | #220 |
| pinealectomy | #221 |
| cells dendritic | #221 |
| redox signaling | #221 |
| targeted deletion | #221 |
| cyclosporin treatment | #221 |
| agouti rats | #221 |
| fine specificity | #221 |
| rheumatoid factor | #221 |
| cartilage damage | #222 |
| cybb | #222 |
| thymectomized | #222 |
| monoclonal antigens differentiation | #222 |
| wkymvm | #222 |
| carbamylated | #223 |
| experimental autoimmune neuritis | #223 |
| igg2a | #223 |
| multiplex | #223 |
| inflammation vivo | #224 |
| expressing | #224 |
| interleukin‐10 | #225 |
| established disease | #225 |
| cells antigen | #225 |
| lew | #225 |
| clinical scoring | #225 |
| disease locus | #226 |
| pathogenic antibodies | #226 |
| j1 | #227 |
| macrophagelike cells | #227 |
| delayed type hypersensitivity | #228 |
| presenting cells | #228 |
| arthritis objective | #228 |
| presence anti | #229 |
| cell selection | #229 |
| eae rats | #230 |
| site inflammation | #230 |
| ls1 | #231 |
| human rheumatoid | #231 |
| reactive oxygen | #232 |
| monoclonal immunohistochemistry | #232 |
| role eosinophils | #233 |
| synovial joints | #233 |
| production ros | #233 |
| lack expression | #233 |
| ameliorated | #233 |
| lower numbers | #234 |
| centimorgan | #234 |
| chronic psychosocial stress | #235 |
| chromosome 14 | #235 |
| mhc gene | #235 |
| staphylococcal infection | #235 |
| immune complex | #236 |
| specificity animals | #236 |
| pathological mechanisms | #237 |
| control strain | #237 |
| autoimmune chronic | #238 |
| progression arthritis | #238 |
| trait locus | #239 |
| c5 | #239 |
| inbred dba tlymphocytes | #240 |
| study plasma | #241 |
| strong influence | #242 |
| joint pain | #242 |
| class genetic | #243 |
| protected | #243 |
| positive anti | #243 |
| multicomponent | #243 |
| monoclonal antigen | #243 |
| hla drb1 | #243 |
| treatment autoimmune | #244 |
| estrus cycle | #244 |
| common denominator | #244 |
| crosses | #244 |
| cutaneous infection | #244 |
| inflammation cartilage | #244 |
| binding antibodies | #245 |
| development emphysema | #246 |
| rt1l | #246 |
| allelic differences | #246 |
| antibodies anti | #247 |
| antibody response | #247 |
| florescence | #247 |
| normal cartilage | #247 |
| new model | #247 |
| inbred strain | #247 |
| activity assays | #248 |
| efficient expression | #248 |
| induced chronic | #249 |
| oxygen species | #249 |
| arthritic joints | #250 |
| mouse rat | #250 |
| picryl | #250 |
| node cells | #250 |
| inflammation score | #250 |
| fragments rats | #250 |
| conditional knockout mice | #251 |
| hyperinflammation | #251 |
| treatment rats | #251 |
| nadph oxidase | #251 |
| develops | #251 |
| mice lack | #252 |
| response disease | #252 |
| mice lymphocytes | #252 |
| role model | #252 |
| dark agouti | #252 |
| onset clinical | #254 |
| dinitrofluorobenzene | #254 |
| cartilage matrix | #254 |
| class mhc | #254 |
| lpr mice | #254 |
| lacking | #254 |
| proteins glycoproteins | #254 |
| inbred c3h | #255 |
| autoimmune response | #255 |
| inflammatory disorder | #256 |
| specific neutralizing | #256 |
| anti arthritic | #256 |
| specific subgroups | #256 |
| postmenopausal bone | #256 |
| disease cell | #257 |
| additive interaction | #258 |
| class mhc molecules | #259 |
| mir144 | #260 |
| chronic granulomatous | #260 |
| relationship immunologic | #260 |
| lymphocytes helper | #261 |
| autoimmune neuritis | #261 |
| mice expressing | #261 |
| mediated suppression | #261 |
| secondary osteoporosis | #261 |
| denatured | #261 |
| immunologic animals | #262 |
| selfantigen | #263 |
| pregnancy mice | #265 |
| crossreactive | #265 |
| genetic techniques | #265 |
| primary immunization | #265 |
| tolerance mice | #265 |
| mouse strain | #265 |
| cysteine proteases | #267 |
| rats animals | #267 |
| vim2 | #267 |
| antigen specific | #267 |
| lentiviral gene | #268 |
| xid | #268 |
| posttranslational modifications | #268 |
| mann whitney | #269 |
| pathogenic roles | #269 |
| complement c5 | #270 |
| oxpl | #270 |
| melatonin effects | #271 |
| monosodium urate crystals | #271 |
| castrated | #271 |
| selfantigens | #271 |
| amino acid transporters | #273 |
| experimental model | #273 |
| lewis rats | #274 |
| inhibitory peptide | #275 |
| tcells | #275 |
| synovial lining | #275 |
| hdac1 | #275 |
| nasally | #275 |
| macrophages dendritic cells | #276 |
| fcgr3b | #276 |
| producing cells | #277 |
| rheumatoid arthritis association | #277 |
| viral female hepatitis | #277 |
| deiminase type | #277 |
| metabolic properties | #278 |
| recognize | #278 |
| interferongamma | #279 |
| gp70 | #279 |
| colon length | #279 |
| induced tolerance | #280 |
| dinucleotide phosphate | #280 |
| recipient mice | #281 |
| inflammatory conditions | #281 |
| neonatal mice | #281 |
| passive transfer | #281 |
| immunological receptors antigen | #281 |
| hemiacetal | #282 |
| inbred nod | #283 |
| igg2b | #283 |
| isoflavone genistein | #283 |
| disease susceptibility | #283 |
| factor production | #283 |
| aire | #284 |
| increased serum levels | #284 |
| severe colitis | #284 |
| helper inducer | #284 |
| aureus strain | #285 |
| complete protection | #285 |
| endophilin | #285 |
| idiotope | #285 |
| publication animals antibodies | #285 |
| theilovirus | #285 |
| maintained | #285 |
| emulsified | #286 |
| hla dr2 | #287 |
| tlr9 mice | #288 |
| melatonin mice | #288 |
| melatonin release | #288 |
| myelin basic protein | #288 |
| antibody production | #288 |
| mice immunized | #289 |
| cells autoimmunity | #289 |
| ctla4 expression | #291 |
| disease cells | #291 |
| synovial cells | #291 |
| autoimmune mechanisms | #292 |
| rheumatic conditions | #292 |
| increased copy | #293 |
| cytokines disease | #293 |
| induced ros | #293 |
| collagen receptors | #293 |
| mouse genes | #294 |
| unique model | #294 |
| antigen processing | #295 |
| c3h | #295 |
| c57bl 6 mice | #295 |
| gastric parietal | #295 |
| immunological receptors | #296 |
| tissue‐specific | #296 |
| 6week | #296 |
| nerve conduction | #296 |
| murine dendritic cells | #297 |
| phosphopyruvate | #297 |
| helical peptides | #297 |
| dnfb | #297 |
| cd19 cells | #298 |
| ppad | #298 |
| vivo imaging | #298 |
| gene selection | #298 |
| transplantation antigens | #299 |
| citrullination | #299 |
| solidphase synthesis | #299 |
| tcr beta | #300 |
| posttranslational rats | #301 |
| neutrophil extracellular traps | #301 |
| alphabeta | #302 |
| extraembryonic tissues | #302 |
| draining lymph | #302 |
| peptide antibody | #302 |
| epidemiological investigation | #303 |
| strains mice | #303 |
| pathogeneses | #303 |
| 1 interferon | #303 |
| animals antibodies | #303 |
| igg glycosylation | #304 |
| autoimmune diseases | #304 |
| conditioned disease models | #304 |
| cgd | #304 |
| cartilage development | #305 |
| cells tcr | #305 |
| mutant strains mice | #305 |
| immunological function | #305 |
| murine colitis | #306 |
| immunological studies | #306 |
| αgalcer | #306 |
| hcdr3 | #306 |
| gammaifn | #306 |
| inpp4b | #307 |
| immunisation | #307 |
| class histocompatibility | #307 |
| basal metabolic rate | #308 |
| chromosome 10 | #309 |
| basal metabolic | #309 |
| articular cattle cells | #310 |
| arthritis study | #310 |
| multiple sclerosis eae | #311 |
| perpetuation | #311 |
| disease symptoms | #312 |
| inflamed joints | #312 |
| synthetic peptide | #312 |
| alleles animals | #312 |
| exuberant | #313 |
| epitopes | #313 |
| c3bi | #313 |
| activatory | #314 |
| induced colitis | #314 |
| mice genes | #315 |
| r620w | #315 |
| intradermally | #315 |
| trypanosoma brucei brucei | #316 |
| onset rheumatoid | #318 |
| classical risk factors | #318 |
| tubule cells | #319 |
| genetic interactions | #319 |
| galactosyl | #319 |
| genomewide linkage analysis | #320 |
| mice subjected | #320 |
| deiminase | #320 |
| spleen bone marrow | #320 |
| cells specific | #323 |
| il21r | #323 |
| impact disease | #324 |
| ccp1 | #324 |
| expressing human | #324 |
| daf2 | #324 |
| expression cells | #325 |
| rat gene | #325 |
| specific cell | #325 |
| surprisingly | #326 |
| resembles | #327 |
| mgps | #327 |
| allelic variant | #328 |
| c57bl mice | #328 |
| publication adjuvants | #329 |
| constant light | #329 |
| immunoenzyme | #329 |
| complex genes | #330 |
| early arthritis | #331 |
| fcgammariia | #332 |
| glycoprotein mog | #332 |
| nucleotide polymorphism | #332 |
| rheumatoid synovial | #332 |
| anticcp | #333 |
| mouse hepatitis virus | #333 |
| 35ssulfate | #334 |
| susceptibility genes | #335 |
| joint tissues | #335 |
| mrl lpr mice | #335 |
| autoimmune inflammation | #336 |
| cell response | #338 |
| cells spleen | #340 |
| epitope specificity | #340 |
| delayed onset | #340 |
| rat | #341 |
| erosive | #341 |
| ros oxygen species | #341 |
| activation macrophages | #341 |
| adjuvants immunologic | #341 |
| incident cardiovascular events | #342 |
| specific autoimmune | #342 |
| animal enzyme inhibitors | #342 |
| 6weeks | #342 |
| diabetic mouse | #343 |
| drb1 alleles | #343 |
| sequence animals | #343 |
| rats injection | #343 |
| rapid spread | #343 |
| monoclonals | #344 |
| 182780 | #344 |
| favor | #345 |
| acpa positivity | #345 |
| energetic costs | #346 |
| intraperitoneal injection | #347 |
| pemphigus vulgaris pv | #348 |
| reduced capacity | #349 |
| neuritis | #349 |
| complement activity | #349 |
| igg autoantibodies | #350 |
| phenotype rats | #351 |
| methylcholanthrene | #352 |
| thymic selection | #352 |
| mice induction | #353 |
| immunoregulation | #353 |
| anti cyclic | #353 |
| c3h hej | #353 |
| arthritis synovial | #354 |
| autoantigens autoimmune | #354 |
| mice cd4 | #354 |
| splenic macrophages | #355 |
| dsg3 | #357 |
| cells autoantibodies | #358 |
| adjuvant activity | #358 |
| tbetarii | #358 |
| enos | #359 |
| injected | #359 |
| neuritogenic | #359 |
| tcrbeta | #360 |
| tlr3 | #361 |
| pvg | #361 |
| freund | #361 |
| murine lupus | #362 |
| hla transgenic | #362 |
| mouse chromosome | #363 |
| generation ros | #363 |
| determines | #363 |
| allergic encephalomyelitis | #363 |
| identification genes | #363 |
| hladr4 | #364 |
| recognized | #364 |
| cells anti | #364 |
| european journal | #366 |
| glycoproteins mice | #366 |
| immune deviation | #366 |
| sex chromosomes | #366 |
| psychosocial stress | #367 |
| antiidiotypic antibodies | #367 |
| affinity ligand | #368 |
| loci | #368 |
| ncf2 | #368 |
| 100 micrograms | #368 |
| toxic shock | #368 |
| autoimmune responses | #368 |
| nasal administration | #369 |
| histocompatibility antigens | #369 |
| pentameric | #369 |
| increased production | #370 |
| immune pathogenesis | #370 |
| clinical onset | #371 |
| serum transfer | #371 |
| regulate | #371 |
| newborn antibodies | #372 |
| role mif | #372 |
| alternative activation | #373 |
| autoantigens | #375 |
| rheumatoid cell | #375 |
| acutephase proteins | #376 |
| undifferentiated arthritis | #376 |
| glucose6 | #377 |
| gia | #379 |
| reparixin | #380 |
| oxidase deficiency | #381 |
| mouse monoclonal antibody | #381 |
| induced lupus | #381 |
| fia | #382 |
| fragments immunoglobulin | #382 |
| granulomatous | #383 |
| granulomatous disease | #384 |
| c1a | #384 |
| naive rats | #384 |
| specific loci | #384 |
| shock syndrome | #385 |
| postmenopausal bone loss | #385 |
| cell specificity | #386 |
| pc4 | #386 |
| filaggrin | #387 |
| backcrosses | #387 |
| antioxid | #387 |
| ptpn22 gene | #387 |
| inbred nod receptors | #388 |
| phase response | #388 |
| downregulating | #389 |
| greater 50 | #390 |
| ovulation rate | #390 |
| deficient | #390 |
| peptidylarginine | #391 |
| anaphylatoxin c5a | #391 |
| radiological progression | #391 |
| finetune | #392 |
| rf1 | #394 |
| il4 il10 | #394 |
| ameliorating | #395 |
| draining | #397 |
| induced metabolic | #397 |
| autoantibody levels | #397 |
| juvenile chronic arthritis | #398 |
| regulation animals | #399 |
| immunized mice | #399 |
| protein myelin | #399 |
| inflammatory reactions | #400 |
| reactive oxygen species | #400 |
| antibody formation | #401 |
| genes cells | #401 |
| biacore | #403 |
| inflammation demyelination | #403 |
| immunopeptidome | #403 |
| beta chain | #404 |
| fcγriib | #404 |
| basic protein | #405 |
| experimental | #405 |
| effects models | #407 |
| n31 | #407 |
| rheumatoid case | #407 |
| pam3csk4 | #408 |
| immunogenetics | #409 |
| major locus | #409 |
| intracellular processing | #410 |
| 3hproline | #410 |
| diabetes loci | #410 |
| hladrb1 | #412 |
| cell phenotypes | #412 |
| cd43 | #412 |
| susceptibility loci | #413 |
| titres | #413 |
| characteristic feature | #414 |
| reproductive performance | #414 |
| cultured collagen | #415 |
| igk | #415 |
| levels autoantibodies | #416 |
| female mice | #416 |
| spontaneous mutation | #417 |
| synovial inflammation | #417 |
| lupus mice | #417 |
| genetically modified mice | #418 |
| wtccc | #419 |
| class hdacs | #419 |
| molecular interactions | #419 |
| induced pain | #419 |
| ameliorate | #420 |
| hiit | #420 |
| tcell | #421 |
| lower affinity | #422 |
| dr4 | #422 |
| lipidomic | #423 |
| subsets animals | #424 |
| restricted | #424 |
| hyaline cartilage | #425 |
| congenic strain | #426 |
| inflammatory cells | #426 |
| regulatory animals | #426 |
| carbohydrate moiety | #429 |
| epitopes humans | #430 |
| nonimmunogenic | #430 |
| postimmunization | #430 |
| nod mouse | #430 |
| immunoregulatory | #431 |
| il10 mice | #433 |
| patients healthy individuals | #433 |
| cells antibodies | #434 |
| spontaneous autoimmune | #435 |
| factor 5 | #435 |
| cells beta | #436 |
| reactivities | #436 |
| decalcified | #437 |
| chromosomes chromosome | #437 |
| crystallizable | #437 |
| mass spectrometric analysis | #437 |
| mice effects | #438 |
| helperinducer tlymphocytes | #438 |
| specific antigens | #438 |
| immunised | #438 |
| joint swelling | #439 |
| cells | #439 |
| nod | #440 |
| wildtype mice | #440 |
| vitro techniques leukocytes | #441 |
| effector functions | #441 |
| normal rats rats | #441 |
| female immunoglobulin | #441 |
| mice activation | #442 |
| patients population | #442 |
| complete adjuvant | #442 |
| mhc class molecules | #443 |
| methylβcyclodextrin | #443 |
| tlr2 expression | #444 |
| myelin basic | #444 |
| genomewide scan | #445 |
| mouse models | #445 |
| systemic mice | #445 |
| mice humans | #445 |
| skeletal muscle function | #445 |
| ros production | #447 |
| induced mice | #448 |
| control mice | #448 |
| pain model | #448 |
| inbred strains receptors | #448 |
| complement factor | #449 |
| synovial tissue | #449 |
| tcell responses | #449 |
| innate adaptive | #450 |
| apcs | #451 |
| igg anti | #451 |
| reduced production | #452 |
| hybridoma cells | #452 |
| heterologous | #452 |
| differs | #454 |
| lglutamine | #456 |
| cells chronic | #456 |
| raloxifene | #457 |
| inbred c57bl tlymphocytes | #457 |
| eae cns | #459 |
| priming | #459 |
| rheumatoid cells | #459 |
| resembling | #459 |
| lung macrophages | #459 |
| antibodies monoclonal | #460 |
| neutrophil functions | #462 |
| 256 | #462 |
| autoantigen | #462 |
| gilt | #463 |
| fab fragments | #464 |
| autoantibody production | #465 |
| salivary glands | #466 |
| receptor tcr | #466 |
| cells lymph | #467 |
| titers | #469 |
| earlier onset | #469 |
| anticyclic citrullinated peptide | #474 |
| disease mice | #474 |
| antibody mediated | #474 |
| arthritic rats | #474 |
| cartilage cells | #475 |
| human autoimmune | #476 |
| mice exhibited | #477 |
| cluster genes | #477 |
| mediated inflammation | #478 |
| therapeutic vaccination | #478 |
| laboratory rat | #479 |
| female hla | #479 |
| apoptosis arthritis | #479 |
| deacetylase 1 | #480 |
| aggravated | #480 |
| quantitative trait loci | #480 |
| polymorphonuclear cells | #482 |
| anti idiotypic | #482 |
| immune reactions | #484 |
| immunologists | #485 |
| immunoglobulin male | #486 |
| tcralpha | #487 |
| oxyntic | #487 |
| jca | #487 |
| controlling | #487 |
| invariant natural | #488 |
| insulitis | #488 |
| specific immune | #488 |
| gland animals | #489 |
| normal mice | #490 |
| cytoplasmic calcium | #494 |
| nacetylglucosaminidase | #495 |
| conclude | #496 |
| gammadelta cells | #496 |
| early rheumatoid | #496 |
| h2b | #496 |
| reactive nitrogen | #496 |
| mbp | #498 |
| small effects | #498 |
| receptor 9 | #499 |
| biologicals | #500 |
| immunoenzyme techniques | #503 |
| autoreactive cd4 | #503 |
| nadph | #503 |
| pathogenic | #506 |
| immunofluorescence analysis | #507 |
| chondrocytes collagen | #507 |
| isopropyl | #508 |
| mineral oil | #508 |
| persistent pain | #508 |
| mab mabs | #508 |
| orosomucoid | #509 |
| immunization passive | #509 |
| gingipain | #509 |
| mhc class | #510 |
| mice knockout mice | #510 |
| c3h hej mice | #511 |
| differential gene | #511 |
| systemic spread | #511 |
| 812 | #511 |
| deficient mice | #511 |
| blymphocytes | #512 |
| mrp8 | #515 |
| hydroxyquinolines | #517 |
| behavioral alterations | #517 |
| antibody complex | #518 |
| u1 | #518 |
| inflammation | #519 |
| chronic granulomatous disease | #519 |
| suggestive linkage | #519 |
| tcr recognition | #520 |
| modified form | #521 |
| ttg | #522 |
| dextran sulfate sodium | #522 |
| pcorr | #522 |
| inflammation role | #523 |
| data peptide | #523 |
| p47phox | #524 |
| encephalitogenic | #524 |
| litter size | #524 |
| neutrophil granulocytes | #525 |
| mechanical hypersensitivity | #526 |
| mnc | #526 |
| tconv | #526 |
| maternal antibodies | #527 |
| spleen cells | #527 |
| disease acute | #527 |
| larsen | #528 |
| tolonium | #528 |
| primed | #528 |
| vaccinates | #528 |
| displayed | #529 |
| ifa | #529 |
| tolllike receptor tlr4 | #529 |
| rat rats | #529 |
| isac | #530 |
| autoantibody | #530 |
| pathogenesis sle | #530 |
| antigen presentation | #530 |
| cell antibodies | #530 |
| ratg | #531 |
| bred | #532 |
| epistatic | #532 |
| complex role | #533 |
| lyt2 | #533 |
| posttranslational receptors | #534 |
| resorptions | #536 |
| spleen lymphocytes | #536 |
| translational modification | #536 |
| urokinase | #537 |
| synovial | #537 |
| animals | #538 |
| cells inflammatory | #538 |
| experimental rats | #538 |
| joints | #540 |
| fibroblast synoviocytes | #540 |
| suppressive | #540 |
| antigen recognition | #540 |
| membrane attack complex | #541 |
| rheumatoid humans | #543 |
| specific autoantibodies | #544 |
| protein tyrosine phosphatase | #545 |
| regulating | #545 |
| hypomorphic | #546 |
| animal gene | #547 |
| shortcut | #547 |
| tlymphocytes | #547 |
| formyl peptide receptors | #548 |
| immunohistochemical methods | #548 |
| entheses | #548 |
| mog | #550 |
| immunoglobulin fab | #552 |
| mixed lymphocyte reaction | #553 |
| nox activity | #554 |
| breeder | #555 |
| cell epitopes | #557 |
| beta animals | #557 |
| stronger association | #557 |
| cells control | #558 |
| early onset | #559 |
| healthy mice | #560 |
| elispot assay | #561 |
| transgenic molecular | #562 |
| negative selection | #563 |
| ptdins3p | #563 |
| inbred strains | #563 |
| neutrophil depletion | #564 |
| therapeutic treatment | #565 |
| deeper layers | #565 |
| target tissue | #566 |
| earlier | #566 |
| immunoglobulin heavy chains | #566 |
| darkness | #566 |
| crucial | #567 |
| outbred | #568 |
| disease loci | #568 |
| interferon signature | #568 |
| mycobacteria | #569 |
| cells pathogenesis | #569 |
| neutrophilia | #569 |
| concomitantly | #570 |
| mice compared | #571 |
| btla | #572 |
| transgenic mouse models | #572 |
| keratin8 | #573 |
| col2 | #574 |
| presenting | #576 |
| pepstatins | #576 |
| terpenes | #577 |
| estrogen treatment | #577 |
| keratinocyte growth factor | #578 |
| prolactin prl | #578 |
| sera patients | #579 |
| ptm | #579 |
| triple helix | #580 |
| methotrexate mice | #581 |
| f1 hybrids | #581 |
| inflammatory joint | #583 |
| production ifngamma | #583 |
| hybridoma | #583 |
| time onset | #584 |
| lymphocyte antigens | #584 |
| exaggerated | #584 |
| antibody reactions | #585 |
| traps nets | #590 |
| environmental triggers | #591 |
| antigen antibody | #591 |
| lxrα | #592 |
| oligoclonal | #592 |
| immunological tolerance | #592 |
| transgenic models | #593 |
| noncollagenous | #593 |
| adaptive immunity | #594 |
| macrophages | #594 |
| autoimmune disorders | #594 |
| th1 cytokines | #595 |
| multiplexing | #595 |
| clonal expansion | #595 |
| xanthine oxidoreductase | #596 |
| cells study | #599 |
| tcell activation | #599 |
| develop | #600 |
| n85 | #602 |
| spite | #602 |
| th2 cytokines | #602 |
| augmented | #602 |
| common diseases | #603 |
| mouse monoclonal | #603 |
| pemphigus vulgaris | #603 |
| cells involved | #604 |
| cells male | #604 |
| phagosomal | #604 |
| oxa | #606 |
| animal rats | #606 |
| mice inbred | #606 |
| class humans | #607 |
| genotype hla | #608 |
| frozen sections | #608 |
| spleen animals | #609 |
| regulatory role | #610 |
| inefficiently | #610 |
| production ifn | #611 |
| naive | #611 |
| positive individuals | #612 |
| quantitative trait locus | #615 |
| acetophenones | #616 |
| class antigens | #616 |
| mutant strains receptors | #616 |
| idiotypic | #616 |
| autoantibodies | #616 |
| th1 type | #616 |
| alpha chains | #616 |
| exponential phase | #616 |
| oral immunization | #617 |
| nonobese | #617 |
| beta type | #618 |
| day mice | #619 |
| wistar restraint | #620 |
| promiscuous | #620 |
| consequent | #621 |
| receptor 3 | #621 |
| inflammatory role | #621 |
| nicotinamide adenine | #622 |
| receptors antigen | #624 |
| fluorine18 | #624 |
| chronic stage | #625 |
| loci identified | #625 |
| animal mice | #628 |
| cytoplasmic ca2 | #628 |
| local injection | #629 |
| inflammatory disease | #630 |
| cross reactions | #630 |
| healthy rats | #632 |
| reactive antibodies | #632 |
| development eae | #633 |
| fibromodulin | #634 |
| highintensity interval training | #634 |
| vivo binding | #635 |
| langerhans cells | #635 |
| nabs | #637 |
| ifn beta | #637 |
| cells inhibition | #638 |
| class genes | #638 |
| estrogens female | #640 |
| inflammation autoimmunity | #640 |
| biotinylated | #643 |
| mouse lung | #644 |
| cell binding | #645 |
| immune serum | #646 |
| haplotype | #649 |
| patients sera | #650 |
| antigen specificity | #650 |
| genetic disease | #652 |
| hexadecane | #654 |
| idiotypic antibodies | #654 |
| interphalangeal | #655 |
| antibody titres | #655 |
| new pathway | #658 |
| genetic linkage | #658 |
| axotomized | #659 |
| cyba | #660 |
| sialoprotein | #660 |
| acute inflammation | #661 |
| inbred cba mice | #661 |
| peptide binding | #661 |
| mutated | #662 |
| cartilage destruction | #663 |
| ifng | #664 |
| delayed hypersensitivity | #665 |
| animal ear | #665 |
| receptors igg | #666 |
| superantigens | #666 |
| 264 | #666 |
| lymphoid organs | #666 |
| reactive | #666 |
| activation mice | #669 |
| apeced | #670 |
| drb1 | #670 |
| disease autoimmune | #671 |
| purified proteins | #673 |
| cells induce | #674 |
| treatment protocol | #674 |
| pyramidal neurons | #675 |
| genetic epistasis | #675 |
| desmoglein | #675 |
| strikingly | #676 |
| adherent cells | #677 |
| germinal center | #677 |
| idiotypes | #677 |
| china cohort | #678 |
| igg response | #679 |
| major genes | #679 |
| il12p70 | #679 |
| thelper | #680 |
| lymphocytes mice | #682 |
| cells role | #682 |
| inbred c57bl mice | #683 |
| normal animals | #683 |
| puzzle | #683 |
| specific antibody | #684 |
| helper cell | #684 |
| intradermal injection | #686 |
| transgenic receptors | #687 |
| βarrestin | #688 |
| foot joints | #689 |
| delayed | #689 |
| subsets | #689 |
| rendered | #690 |
| early rheumatoid arthritis | #690 |
| production autoantibodies | #691 |
| disease genes | #692 |
| knockout polymorphism | #695 |
| muscle glucose | #695 |
| paam | #696 |
| igg antibodies | #696 |
| luminex | #697 |
| anas | #697 |
| mice model | #698 |
| disease hla | #698 |
| uterus | #700 |
| heavy chain genes | #701 |
| microspectroscopy | #703 |
| inbred | #704 |
| quantitative trait | #704 |
| complete freund | #706 |
| fibroblastlike synoviocytes | #707 |
| histopathological analysis | #707 |
| extracellular trap | #708 |
| estradiol female | #710 |
| specific cells | #710 |
| igl | #712 |
| posttranslational | #713 |
| spleens | #716 |
| predetermined | #716 |
| mice lacking | #717 |
| antibodies patients | #718 |
| acute bout | #718 |
| lymphocyte depletion | #719 |
| regulatory function | #720 |
| proliferative response | #720 |
| deficiency syndromes | #721 |
| buf | #721 |
| surrounding tissues | #722 |
| th1 th17 | #723 |
| macrophages mice mice | #725 |
| human hand | #725 |
| dmaema | #728 |
| cd1d | #728 |
| ccps | #729 |
| mhc molecules | #729 |
| th2 cytokine | #729 |
| cdk6 | #730 |
| animals antigens antigens | #732 |
| cholesterol metabolism | #732 |
| cns inflammation | #732 |
| administrated | #732 |
| excessive inflammation | #734 |
| finding | #735 |
| net formation | #736 |
| rats treatment | #736 |
| locus | #737 |
| cheeks | #739 |
| c57bl | #740 |
| operates | #740 |
| species specificity | #741 |
| cd5 cells | #741 |
| tissue destruction | #742 |
| nkt | #742 |
| cell responses | #743 |
| immunologic deficiency | #743 |
| vivo mice | #743 |
| treatment anti | #744 |
| role disease | #746 |
| mycobacterial infections | #747 |
| intensity interval | #749 |
| nonobese diabetic mice | #749 |
| autoantibodies autoimmunity | #749 |
| keratinocyte | #749 |
| transferred | #751 |
| preclinical phase | #751 |
| control disease | #753 |
| tlr activation | #755 |
| metabolomic | #755 |
| ere | #755 |
| hapten | #755 |
| mice anti | #757 |
| autoantibodies type | #758 |
| phenotypic differences | #758 |
| disease protection | #758 |
| hyperinflammatory | #759 |
| reacted | #759 |
| linkage region | #760 |
| knockout tlymphocytes | #760 |
| ifngamma production | #761 |
| ccp | #761 |
| polycytidylic | #762 |
| immunocap | #763 |
| gamma ifn | #765 |
| glut4 translocation | #767 |
| periarticular | #772 |
| cells apcs | #773 |
| redox signal | #773 |
| hkexchanging | #773 |
| peripheral tolerance | #774 |
| afflicted | #777 |
| diseases cell | #778 |
| fab fragment | #778 |
| interacted | #779 |
| inbred nzb | #780 |
| acid transporters | #781 |
| arthritis osteoarthritis | #782 |
| development autoimmunity | #782 |
| nox1 | #782 |
| pathogenic role | #782 |
| arthritis psa | #783 |
| chronic colitis | #784 |
| clinical scores | #786 |
| transgenic mutation | #789 |
| reduced incidence | #790 |
| transgenic receptors antigen | #790 |
| inflammatory lesions | #790 |
| peptide fragments | #790 |
| pineal gland | #791 |
| polyarthritis | #792 |
| cell gamma | #793 |
| cell humans | #794 |
| antibodies directed | #794 |
| neutrophil extracellular | #796 |
| neutrophil function | #796 |
| interval training | #796 |
| pathogen free | #797 |
| lymphocyte proliferation | #798 |
| genes immunoglobulin | #798 |
| carbohydrate moieties | #800 |
| matrix proteins | #801 |
| polyi | #801 |
| innate adaptive immunity | #802 |
| blymphocyte chain genes | #802 |
| thy1 | #802 |
| monoclonal binding | #802 |
| induces | #805 |
| redox control | #805 |
| helper cells | #805 |
| count male | #805 |
| multinucleated giant cells | #808 |
| backcrossing | #809 |
| bone erosion | #810 |
| function mutation | #811 |
| catabolism | #811 |
| resident cells | #812 |
| strains receptors | #812 |
| acc1 | #812 |
| febuxostat | #813 |
| nonreceptor type | #815 |
| ctb | #817 |
| arginines | #817 |
| leads | #820 |
| auricle | #820 |
| cd8 antigens | #821 |
| collagen cross | #821 |
| leukocyte infiltration | #822 |
| piece | #823 |
| colocalizes | #824 |
| humoral immune response | #824 |
| electroporated | #824 |
| genetic environmental | #825 |
| psoriasis psoriatic arthritis | #825 |
| prominently | #825 |
| response animals | #826 |
| muscle training | #826 |
| chondroid | #827 |
| growth factor beta | #829 |
| class antigen | #829 |
| effects immune | #830 |
| producing | #830 |
| cross reactivity | #834 |
| lpr | #841 |
| inbred c57bl | #841 |
| immunoglobulin mice | #842 |
| peyers patches | #842 |
| therapeutic approaches | #844 |
| diabetic nod | #844 |
| il25 | #845 |
| chronic active | #845 |
| mice transgenic | #846 |
| inflammatory arthritis | #846 |
| induce | #848 |
| intermingled | #850 |
| macroscopically | #851 |
| lymphocyte | #852 |
| antigen cell | #852 |
| new possibilities | #854 |
| leukocyte migration | #854 |
| ms275 | #855 |
| tcell receptors antigen | #855 |
| strongest association | #856 |
| importantly | #856 |
| alveolar mice mice | #856 |
| mcv | #858 |
| post translational | #861 |
| immune defence | #862 |
| treatment reduced | #865 |
| lyme | #866 |
| factor anti | #867 |
| knockin mice | #867 |
| mice reduced | #867 |
| mediated inflammatory | #867 |
| cross reactive | #868 |
| strongest | #868 |
| hinge region | #869 |
| lentiviral | #869 |
| parietal cells | #869 |
| lnc | #872 |
| immune tolerance | #873 |
| dextran sulfate | #873 |
| parasitemia | #874 |
| lower expression | #874 |
| elisas | #875 |
| cells expressing | #876 |
| granulomas | #877 |
| fcγri | #878 |
| synovial fluid patients | #878 |
| arthritis inflammatory | #879 |
| adoptive | #881 |
| antigen4 | #881 |
| pregnancy animal | #882 |
| systemic autoimmune diseases | #882 |
| testosterone treatment | #883 |
| fluid synovial | #884 |
| cartilaginous | #888 |
| standard therapies | #890 |
| genetic dissection | #891 |
| psoriasis vulgaris | #891 |
| basic | #893 |
| regulator | #895 |
| completely | #896 |
| inflammation mediators | #897 |
| intranasal administration | #897 |
| ctla4 antigen | #898 |
| interleukin1alpha | #898 |
| phosphatase receptor | #902 |
| partly | #904 |
| granulocytes | #904 |
| inception cohort | #905 |
| infiltrations | #906 |
| γδ cells | #906 |
| rats inbred | #907 |
| lipocalins | #908 |
| extracellular traps | #909 |
| immunohistochemical analyses | #910 |
| single injection | #911 |
| liu | #911 |
| immunoglobulin levels | #911 |
| chromosome 16 | #912 |
| lectin pathway | #913 |
| mitochondrial ros | #913 |
| pneumonitis | #914 |
| ciita | #914 |
| allelic variation | #915 |
| enolase | #915 |
| proliferate | #915 |
| immunemediated diseases | #916 |
| cytokine response | #923 |
| psoriatic arthritis psa | #924 |
| neutrophil chemotaxis | #924 |
| antibodies antibody | #924 |
| cd200 | #925 |
| fluorobenzene | #925 |
| chromosome mapping | #925 |
| nkt cells | #926 |
| phenotypic analysis | #926 |
| repertoires | #929 |
| burst | #930 |
| tissue transglutaminase | #931 |
| data role | #932 |
| citrulline | #933 |
| hydratase | #933 |
| alpha animals | #935 |
| macropinocytosis | #936 |
| alters | #937 |
| arthritides | #938 |
| lymphocyte activation | #938 |
| 1040 | #939 |
| synovia | #939 |
| immune reactivity | #940 |
| analysed | #940 |
| rns | #940 |
| vitro stimulation | #941 |
| collagen structure | #941 |
| genetic analysis | #941 |
| disease model | #941 |
| mediated autoimmune | #944 |
| sciatic nerves | #945 |
| association hla | #945 |
| mice mice | #947 |
| fluid patients | #948 |
| clinical observations | #948 |
| inflammatory pathways | #948 |
| humanized mice | #949 |
| riii | #950 |
| vivo | #950 |
| l3t4 | #954 |
| environmental determinants | #955 |
| nos1 | #957 |
| carrying | #958 |
| differentiation tlymphocyte antigens | #959 |
| mhc peptide | #962 |
| levels ros | #962 |
| chronic disease | #963 |
| cellular immunization | #965 |
| monoclonal antigens | #967 |
| cytotoxic tlymphocytes | #967 |
| animals cytokines | #967 |
| cells lymphocytes | #967 |
| cell transfer | #969 |
| lower frequency | #969 |
| chromosome 15 | #971 |
| draining lymph nodes | #972 |
| secreting cells | #973 |
| susceptibility locus | #978 |
| cartilage articular | #979 |
| synovial membrane | #981 |
| lymphocytes | #982 |
| w5 | #982 |
| genes chromosome | #982 |
| binding peptides | #983 |
| pain behavior | #984 |
| tbb | #987 |
| tallele | #988 |
| microspectrophotometry | #990 |
| macrophages cells | #991 |
| knockout models | #991 |
| allergic contact dermatitis | #992 |
| immunodominance | #992 |
| cells reactive | #993 |
| patients rp | #994 |
| transgenic expression | #994 |
| 510 | #994 |
| hej | #995 |
| cartilage bone | #995 |
| formyl peptide | #997 |
| knee joints | #997 |
| spontaneously | #997 |
| laminin fibronectin | #998 |
| antigen expression | #999 |
| immunoglobulin fragments | #1000 |
| lymphocyte subpopulations | #1002 |
| multiple loci | #1003 |
| aggravate | #1004 |
| expands | #1004 |
| processing presentation | #1004 |
| protective role | #1007 |
| igg subclasses | #1011 |
| nrc | #1012 |
| cyclic peptides | #1012 |
| 95 stroke | #1013 |
| interleukin21 | #1013 |
| direct comparison | #1015 |
| igg | #1015 |
| model multiple | #1015 |
| nerve roots | #1016 |
| cells mast | #1016 |
| cellular composition | #1016 |
| aged arthritis | #1017 |
| melatonin levels | #1019 |
| patients early | #1019 |
| cd4 antigens | #1020 |
| immunoglobulin variable | #1022 |
| cysteine protease | #1025 |
| diseases animals | #1026 |
| genetic humans | #1027 |
| innate killer cells | #1028 |
| il4 | #1029 |
| baseline 24 months | #1031 |
| dr1 | #1031 |
| mice treated | #1032 |
| oxidase | #1034 |
| major regulator | #1036 |
| species production | #1039 |
| tramp | #1040 |
| arthritis psoriatic | #1041 |
| expression mrna | #1042 |
| complementary genes | #1043 |
| das28 | #1045 |
| myelin proteins | #1050 |
| parental strain | #1050 |
| patients rheumatoid | #1051 |
| chromosome 5 | #1052 |
| inflammatory macrophages | #1055 |
| gamma delta | #1055 |
| antigens differentiation | #1056 |
| immune defense | #1056 |
| mannans | #1057 |
| rat cells | #1060 |
| morula | #1062 |
| lymphocytes cells | #1062 |
| sterile inflammation | #1062 |
| transgenic | #1063 |
| tarsus | #1066 |
| oxazoles | #1069 |
| decidua | #1069 |
| disease humans polymorphism | #1069 |
| role immune | #1069 |
| synovial fluids | #1071 |
| transgenic cells | #1075 |
| fcγ | #1076 |
| radiological | #1077 |
| peptidylarginine deiminase | #1078 |
| epistasis | #1079 |
| key steps | #1080 |
| adjuvant cfa | #1080 |
| lymphoid cells | #1082 |
| reestablishment | #1082 |
| irf1 | #1086 |
| dependent regulation | #1087 |
| al2 | #1088 |
| uppsala | #1089 |
| haplotypes | #1089 |
| enlarged | #1091 |
| inflamed | #1092 |
| osteoclast formation | #1093 |
| 7 weeks | #1096 |
| oligodendrocyte | #1098 |
| inkt cells | #1102 |
| igs | #1103 |
| effector mechanisms | #1104 |
| cells increased | #1105 |
| arginine deiminase | #1114 |
| subdominant | #1115 |
| molecular mimicry | #1115 |
| fibril | #1115 |
| clinical disease | #1116 |
| sclerosis myelin | #1116 |
| genetic factors | #1117 |
| disulfide | #1117 |
| animal immunity | #1117 |
| deamidation | #1117 |
| cd5 | #1117 |
| antitoxin | #1117 |
| antigenic peptides | #1118 |
| pil | #1121 |
| lymphocytes regulatory | #1123 |
| recognizing | #1126 |
| primary immunodeficiency | #1127 |
| predisposing | #1128 |
| foreign antigens | #1128 |
| isomerase | #1128 |
| humans lymphocyte | #1128 |
| cells ifn | #1128 |
| dissected | #1130 |
| skeletal muscle fibers | #1132 |
| treatment day | #1132 |
| superantigen | #1134 |
| cryosections | #1135 |
| immune response | #1135 |
| glucosyl | #1136 |
| overlapped | #1136 |
| vivo administration | #1136 |
| c57 | #1137 |
| underline | #1138 |
| peptide sequence | #1138 |
| editorial | #1139 |
| anticardiolipin antibodies | #1139 |
| cd4foxp3 | #1142 |
| mice rats | #1146 |
| syntenic | #1147 |
| treatment animals | #1149 |
| helpers | #1149 |
| agonist | #1150 |
| cd4 cells | #1151 |
| subcloned | #1155 |
| disease onset | #1157 |
| antibody affinity | #1160 |
| inactivating | #1161 |
| lxr | #1161 |
| respiratory burst | #1163 |
| prolactin rats | #1164 |
| stainings | #1168 |
| demonstrating | #1168 |
| increased severity | #1170 |
| activated cells | #1171 |
| transduction toll | #1174 |
| gp91phox | #1175 |
| nadph oxidoreductases | #1176 |
| inflamed tissues | #1178 |
| models disease | #1178 |
| 10b | #1179 |
| preponderance | #1180 |
| recombinant interferon | #1180 |
| genetic background | #1181 |
| chemiluminescent | #1182 |
| destructive | #1182 |
| arginine residues | #1184 |
| objective investigate | #1186 |
| disease haplotypes humans | #1186 |
| synovial fibroblasts | #1188 |
| lymphocytes cell | #1188 |
| human type | #1190 |
| ileitis | #1191 |
| splenic cells | #1192 |
| rat human | #1192 |
| antiphospholipid | #1193 |
| infiltrates | #1195 |
| primary sjögrens syndrome | #1195 |
| cells rheumatoid | #1199 |
| basic mechanisms | #1200 |
| susceptibility | #1200 |
| antibody | #1200 |
| antibodies mabs | #1200 |
| somatically | #1201 |
| lung mice mice | #1204 |
| protein arginine | #1208 |
| identified loci | #1210 |
| h2k | #1211 |
| onset progression | #1212 |
| predisposition disease | #1212 |
| c5a | #1213 |
| singlecell | #1214 |
| rationales | #1214 |
| hdacs | #1217 |
| critical issues | #1218 |
| chronic inflammation | #1218 |
| igg subclass | #1220 |
| ilc2 | #1221 |
| adaptive immune response | #1223 |
| compared wt | #1223 |
| mononuclear | #1223 |
| subcellular fractionation | #1224 |
| adaptive immune responses | #1225 |
| tlymphocyte antigens | #1226 |
| chromosome 4 | #1227 |
| antimicrobial peptides amps | #1229 |
| linkage analysis | #1229 |
| analyse | #1230 |
| experimental models | #1231 |
| therapeutically | #1232 |
| aps | #1233 |
| subsets lymphocytes | #1233 |
| host defense | #1238 |
| immunological mechanisms | #1240 |
| human cd4 | #1241 |
| cell lymphocytes | #1244 |
| indel | #1247 |
| mouse | #1250 |
| immune inflammatory | #1251 |
| lining | #1252 |
| animal | #1253 |
| ltb | #1253 |
| dead cells | #1254 |
| animal doseresponse relationship | #1259 |
| differentiation lymphocyte | #1263 |
| mesenteric lymph nodes | #1263 |
| antigen presenting cells | #1264 |
| synovium | #1265 |
| pathogenic mechanisms | #1266 |
| adenine dinucleotide | #1269 |
| suppress | #1269 |
| rheumatoid arthritis patients | #1270 |
| molecular pathogenesis | #1270 |
| suppressive function | #1270 |
| synovial fluid | #1271 |
| rat mouse | #1273 |
| claudin4 | #1274 |
| eae model | #1274 |
| chromosomal regions | #1275 |
| rats mice | #1275 |
| inducer | #1279 |
| becn1 | #1282 |
| rattus norvegicus | #1282 |
| staphylococcal | #1283 |
| hla molecules | #1283 |
| c4a | #1283 |
| rodent models | #1284 |
| spreading | #1286 |
| joint destruction | #1287 |
| attacked | #1288 |
| disease response | #1290 |
| pathological processes | #1294 |
| immunochip | #1295 |
| suppressor cells | #1296 |
| serm | #1297 |
| peripheral cells | #1297 |
| day pregnancy | #1297 |
| production anti | #1299 |
| nadph oxidase activity | #1299 |
| publication animals antigens | #1300 |
| data protein | #1300 |
| restimulation | #1305 |
| hdac3 | #1307 |
| model experimental | #1307 |
| peptide library | #1309 |
| ali | #1310 |
| social isolation | #1310 |
| fab2 | #1312 |
| generated | #1313 |
| phagocytic cells | #1313 |
| introgressed | #1314 |
| lymphoproliferation | #1315 |
| permissive | #1315 |
| detailed characterization | #1316 |
| increased susceptibility | #1316 |
| immune | #1316 |
| protects | #1319 |
| estradiol treatment | #1320 |
| immunoglobulin isotypes | #1321 |
| hydrolyzes | #1321 |
| phagocytes | #1322 |
| healthy human subjects | #1322 |
| intrathymic | #1322 |
| collagen types | #1323 |
| submandibular | #1323 |
| aureus infections | #1325 |
| valuable tool | #1327 |
| acute phase proteins | #1327 |
| therapeutic antibodies | #1328 |
| dietary nitrate | #1329 |
| human igg | #1330 |
| receptor 2 | #1330 |
| immunological memory | #1332 |
| pockets | #1333 |
| identically | #1335 |
| thymectomy | #1335 |
| new therapies | #1336 |
| rats rats | #1336 |
| acute phase response | #1338 |
| cells mice | #1341 |
| induction phase | #1341 |
| adjuvants | #1344 |
| increasing evidence | #1348 |
| knockout mutation | #1349 |
| promiscuity | #1350 |
| galactosylceramides | #1356 |
| allergic contact | #1359 |
| position | #1361 |
| elimination | #1361 |
| alp | #1361 |
| regulatory genes | #1362 |
| believed | #1364 |
| disease activity score | #1364 |
| n44 | #1366 |
| hypersensitivity | #1367 |
| 590 | #1368 |
| bacterial arthritis | #1372 |
| ameliorates | #1374 |
| betad | #1375 |
| membrane glycoproteins | #1375 |
| shared | #1375 |
| trait | #1375 |
| rat spinal cord | #1379 |
| il1r | #1381 |
| immunogen | #1383 |
| abrogates | #1383 |
| surface cells | #1384 |
| exacerbation | #1388 |
| rats humans | #1388 |
| variable region | #1389 |
| suffer | #1389 |
| regulatory treg | #1390 |
| cd2 | #1390 |
| clinical signs | #1390 |
| human patients | #1392 |
| squalene | #1392 |
| feto | #1393 |
| phage display | #1393 |
| cd4cd8 | #1394 |
| effects rats | #1396 |
| inbred mice | #1397 |
| disease outcomes | #1397 |
| positional | #1399 |
| submandibular glands | #1400 |
| early patients | #1403 |
| joint disease | #1403 |
| mononuclear phagocytes | #1406 |
| linkage genetic | #1409 |
| disease phenotypes | #1412 |
| animals disease | #1413 |
| antigens humans | #1415 |
| enzymelinked immunosorbent | #1416 |
| humans immune | #1417 |
| activation neutrophils | #1417 |
| cytokine profile | #1424 |
| class switching | #1425 |
| bacterial infections | #1431 |
| genetic heterogeneity | #1436 |
| gene usage | #1438 |
| stages disease | #1439 |
| cells type | #1440 |
| peptide | #1441 |
| guillainbarré syndrome | #1451 |
| arthritis systemic | #1453 |
| inbred strains mice | #1454 |
| cell activation | #1458 |
| alpha1 | #1458 |
| monoclonal | #1460 |
| proinflammatory responses | #1461 |
| knockout rats | #1461 |
| expression genetic | #1462 |
| lupus | #1464 |
| salt concentrations | #1465 |
| pfp | #1467 |
| ccr6 | #1467 |
| opens | #1467 |
| cell origin | #1468 |
| inflammatory properties | #1469 |
| cells pregnancy | #1472 |
| activation status | #1473 |
| cartilage cell | #1474 |
| immune deficiency | #1474 |
| muscle muscle | #1476 |
| cells activated | #1478 |
| allelic variants | #1479 |
| allotype | #1480 |
| specific gene | #1482 |
| responses animals | #1482 |
| markers genetic | #1483 |
| blisters | #1483 |
| genetic regulation | #1486 |
| initiate | #1486 |
| cells lung | #1486 |
| inflammatory diseases | #1486 |
| stroke 95 | #1487 |
| host defence | #1489 |
| hormone release | #1489 |
| donated | #1490 |
| inbred rats | #1491 |
| human cartilage | #1491 |
| mice day | #1491 |
| humoral immune | #1497 |
| myelin | #1499 |
| emphysematous | #1499 |
| treatment inflammatory | #1504 |
| regulatory effects | #1504 |
| monocytes neutrophils | #1504 |
| vivo vitro | #1505 |
| specific monoclonal | #1505 |
| mimicking | #1507 |
| joint arthritis | #1507 |
| eluate | #1507 |
| fls | #1508 |
| mapped | #1509 |
| inflammatory cell | #1510 |
| hindlimbs | #1511 |
| chromosome 6 | #1512 |
| stimulates | #1515 |
| egfp | #1516 |
| induced ali | #1520 |
| human leukocyte antigen | #1524 |
| earlier studies | #1525 |
| lia | #1525 |
| genes dominant | #1528 |
| knockout mitochondria | #1530 |
| sex steroids | #1531 |
| streptococcus pyogenes | #1533 |
| glutamic acid | #1535 |
| malaise | #1536 |
| lysines | #1537 |
| downregulate | #1540 |
| net release | #1545 |
| protein rna | #1546 |
| unexpectedly | #1547 |
| production macrophages | #1547 |
| increased numbers | #1548 |
| acetylglucosaminidase | #1549 |
| chronic phase | #1554 |
| higher level | #1555 |
| mediated diseases | #1559 |
| intraperitoneally | #1560 |
| 4 humans | #1563 |
| neuroimmunomodulation | #1563 |
| copy variations | #1563 |
| activate | #1564 |
| intradermal | #1565 |
| vsg | #1566 |
| matrix components | #1567 |
| guerin | #1567 |
| immunoglobulin humans | #1568 |
| mammalian embryo | #1568 |
| formyl | #1569 |
| sufficient | #1573 |
| pineal | #1574 |
| cytotoxic lymphocyte | #1574 |
| independent | #1577 |
| cochran | #1577 |
| cathelicidin | #1578 |
| glycolipid | #1580 |
| collagens | #1585 |
| fab | #1592 |
| mac1 | #1593 |
| factor beta | #1597 |
| directed | #1597 |
| conserved | #1597 |
| defines | #1598 |
| cell mediated | #1600 |
| adoptive transfer | #1600 |
| f1 | #1600 |
| twins | #1600 |
| reactive nitrogen species | #1603 |
| autoantibodies biomarkers | #1604 |
| cell receptor | #1605 |
| cells th17 | #1607 |
| estriol | #1607 |
| helical | #1611 |
| stromal cells | #1615 |
| chondrocyte | #1616 |
| immunity animals | #1617 |
| chronic inflammatory diseases | #1617 |
| isosteric | #1619 |
| autoimmune diabetes | #1621 |
| humans immunoglobulin | #1622 |
| anaphylatoxin | #1622 |
| c57bl 6 | #1622 |
| differently | #1625 |
| unreactive | #1626 |
| antigen | #1626 |
| rat spinal | #1629 |
| iggs | #1630 |
| complement component | #1632 |
| c3b | #1635 |
| immunohistology | #1635 |
| collagen fibers | #1639 |
| lund | #1639 |
| type interferon | #1641 |
| mice increased | #1642 |
| p6 | #1644 |
| abrogated | #1644 |
| c4b | #1645 |
| aspartic acid | #1647 |
| intracellular ros | #1651 |
| sjl | #1652 |
| opsonization | #1653 |
| complement activation | #1657 |
| linked | #1658 |
| defence | #1658 |
| commonly | #1660 |
| complement receptors | #1660 |
| staphylococcal enterotoxin | #1661 |
| immune complexes | #1661 |
| transporter type | #1661 |
| enterotoxins | #1662 |
| mice knockout | #1664 |
| tcell receptors | #1665 |
| salt intake | #1668 |
| tumor vasculature | #1669 |
| coincided | #1670 |
| primary sjögren | #1671 |
| isopropylacrylamide | #1672 |
| immunologic epitopes | #1673 |
| pathogenic cells | #1673 |
| gamma production | #1678 |
| single nucleotide | #1683 |
| complement c5a | #1686 |
| cd206 | #1686 |
| cocktail | #1689 |
| auto | #1689 |
| igm antibodies | #1691 |
| method analysis | #1693 |
| agouti | #1694 |
| ido1 | #1694 |
| classical pathway | #1696 |
| transgenic mice | #1696 |
| severity | #1701 |
| animals autoantigens | #1704 |
| triple | #1704 |
| precede | #1704 |
| 5 months | #1704 |
| suppressors | #1706 |
| encoded | #1707 |
| disulfiram | #1711 |
| treg cells | #1711 |
| erosions | #1712 |
| beta chains | #1712 |
| mice neutrophils | #1714 |
| sjögrens syndrome | #1719 |
| ankylosis | #1719 |
| evoke | #1720 |
| pulmonary aspergillosis | #1721 |
| tolerance | #1721 |
| skewing | #1725 |
| oophorectomy | #1727 |
| showing | #1728 |
| myelin proteolipid | #1729 |
| mutant mice | #1729 |
| drug targets | #1732 |
| analysis protein | #1734 |
| immune responses | #1734 |
| 369 | #1734 |
| staphylococcal infections | #1736 |
| sicca | #1737 |
| phagocytic | #1737 |
| fmoc | #1739 |
| intranasally | #1740 |
| arthritis patients | #1742 |
| affinity binding | #1743 |
| prophylactic treatment | #1744 |
| 626 | #1744 |
| cd11 | #1745 |
| osteoclasts | #1746 |
| strain mice | #1748 |
| zap70 | #1748 |
| alternative pathway | #1748 |
| new loci | #1749 |
| responded | #1750 |
| neoplastic disease models | #1753 |
| peroxide | #1758 |
| infiltrating | #1762 |
| endoglycosidase | #1764 |
| dr2 | #1766 |
| inhibitory receptors | #1766 |
| triggering | #1770 |
| multiple genes | #1770 |
| higher frequency | #1770 |
| glycosylation | #1774 |
| peptide antigens | #1775 |
| operate | #1776 |
| blocking | #1781 |
| adoptively | #1782 |
| cnbr | #1783 |
| articular cell | #1784 |
| ll37 | #1784 |
| local administration | #1788 |
| immunohistological | #1789 |
| compartmentalized | #1791 |
| carbohydrates | #1792 |
| pathogenesis | #1793 |
| dogma | #1794 |
| render | #1794 |
| competed | #1797 |
| immune recognition | #1800 |
| polymorphism genetic | #1801 |
| disease pathogenesis | #1801 |
| rat models | #1802 |
| rechallenge | #1803 |
| cd19 antigens | #1803 |
| peyer | #1804 |
| obese diabetic | #1805 |
| aureus infection | #1808 |
| immunogenic | #1810 |
| predisposed | #1810 |
| complement pathway | #1811 |
| elucidation | #1811 |
| activated lymphocytes | #1811 |
| psoriatic | #1813 |
| recovery phase | #1814 |
| pregnancy rats | #1817 |
| nonfunctional | #1817 |
| il2r | #1818 |
| ossification | #1818 |
| promoting | #1818 |
| blymphocyte | #1819 |
| intravenously | #1819 |
| crossed | #1823 |
| katpase | #1824 |
| hydroxylated | #1825 |
| myelin sheath | #1825 |
| neurodegenerative diseases | #1827 |
| deplete | #1830 |
| female sex | #1833 |
| genetic susceptibility | #1836 |
| new treatments | #1839 |
| pathogenesis disease | #1841 |
| trif | #1843 |
| resolution inflammation | #1844 |
| subsequently | #1846 |
| clinical score | #1846 |
| inflammation macrophages | #1847 |
| estrogen | #1848 |
| cultured disease | #1849 |
| pyogenes | #1852 |
| specific immunity | #1854 |
| genetic variance | #1854 |
| cd8 lymphocytes | #1856 |
| macrophages neutrophils | #1856 |
| humoral | #1857 |
| rac2 | #1858 |
| barre | #1858 |
| cocktails | #1860 |
| haenszel | #1862 |
| secreting | #1863 |
| structural basis | #1864 |
| aggravation | #1864 |
| lacrimal apparatus | #1865 |
| rats groups | #1871 |
| silastic | #1871 |
| immunoadsorption | #1873 |
| inkt | #1874 |
| carries | #1875 |
| major | #1876 |
| subsequent development | #1879 |
| cartilages | #1879 |
| candidate | #1883 |
| antigen humans | #1890 |
| inflammation lung | #1892 |
| polyclonal | #1893 |
| bacterial clearance | #1894 |
| ovalbumin | #1897 |
| cyanogen | #1900 |
| striking | #1902 |
| tcr repertoire | #1903 |
| lymphatics | #1903 |
| indicating | #1905 |
| complexity | #1905 |
| proteins rats | #1907 |
| model rats | #1908 |
| mediated | #1910 |
| gammadelta | #1910 |
| enzyme linked | #1911 |
| cells neutrophils | #1912 |
| cell maturation | #1912 |
| interferon gamma | #1914 |
| erythematosus sle | #1916 |
| chromosome | #1916 |
| totally | #1918 |
| 6 hours | #1920 |
| cartilage tissue | #1923 |
| anti | #1924 |
| 721 | #1924 |
| gαq | #1926 |
| pronounced | #1927 |
| ears | #1929 |
| isoantigens | #1931 |
| bcell receptors | #1933 |
| expression cytokines | #1934 |
| animals lymphocytes | #1937 |
| trypanosoma brucei | #1937 |
| sialyltransferases | #1939 |
| mice receptors | #1940 |
| antigen tcell receptors | #1944 |
| type plasminogen | #1945 |
| predisposition | #1949 |
| subclasses | #1950 |
| prevented | #1950 |
| constituting | #1955 |
| cardiac allografts | #1956 |
| perforin | #1957 |
| snakes | #1957 |
| agp | #1959 |
| mmc | #1962 |
| levels serum | #1967 |
| pinocytosis | #1967 |
| edition | #1967 |
| iga igg | #1967 |
| fcγ receptor | #1969 |
| possibilities | #1969 |
| strong | #1971 |
| intravenous injection | #1972 |
| react | #1975 |
| mip | #1977 |
| stimulations | #1978 |
| synovial tissues | #1979 |
| carp | #1979 |
| inbred cba | #1980 |
| ova | #1980 |
| cd154 | #1982 |
| pregnant rats | #1983 |
| cell clone | #1985 |
| disease pathology | #1985 |
| milder | #1988 |
| spans | #1997 |
| mast cell | #1999 |
| cd18 | #2000 |
| transgenic rats | #2001 |
| microglia activation | #2002 |
| presenting cell | #2006 |
| heteroplasmy | #2007 |
| reverted | #2008 |
| contact dermatitis | #2008 |
| rats effects | #2008 |
| prototypic | #2011 |
| abca1 | #2016 |
| response infection | #2016 |
| barré syndrome | #2018 |
| knockout | #2020 |
| tissue inflammation | #2021 |
| immunoglobulin | #2023 |
| genes | #2025 |
| cell | #2027 |
| cytokine secretion | #2028 |
| mabs | #2028 |
| demyelination | #2030 |
| chord | #2031 |
| tetramers | #2032 |
| c5ar | #2033 |
| conformational epitopes | #2035 |
| mesenteric lymph | #2035 |
| beta gene | #2035 |
| 4 tlr4 | #2041 |
| factor mif | #2041 |
| mab | #2042 |
| diethyldithiocarbamate | #2043 |
| immunomodulatory properties | #2044 |
| sex chromosome | #2045 |
| cell immunity | #2047 |
| oestrogens | #2050 |
| hypergammaglobulinemia | #2050 |
| cell function | #2053 |
| castration | #2053 |
| species signal | #2053 |
| coinciding | #2055 |
| emphysema | #2056 |
| glycosylation humans | #2057 |
| innate inflammation | #2058 |
| increased frequency | #2058 |
| dramatically | #2059 |
| activation complement | #2061 |
| vitro vivo | #2061 |
| accompanied | #2067 |
| genetic differences | #2068 |
| dominant | #2070 |
| contributors | #2071 |
| proteomics analysis | #2072 |
| hyaluronoglucosaminidase | #2072 |
| mdsc | #2076 |
| mature cells | #2077 |
| polyradiculoneuropathy | #2077 |
| respiratory tract | #2079 |
| lysine residues | #2080 |
| antiphospholipid syndrome | #2081 |
| cell depletion | #2082 |
| mice pregnancy | #2083 |
| methotrexate mtx | #2094 |
| complement | #2094 |
| conditional deletion | #2095 |
| lysine | #2096 |
| addressed | #2097 |
| bioreactor | #2100 |
| αβ | #2100 |
| suggested | #2102 |
| led | #2103 |
| evokes | #2103 |
| antigens hla | #2104 |
| patients rheumatoid arthritis | #2105 |
| human chondrocytes | #2110 |
| nose | #2117 |
| lentiviral vectors | #2120 |
| glycan | #2122 |
| pulmonary inflammation | #2122 |
| immune functions | #2126 |
| pad4 | #2127 |
| oxidants | #2129 |
| total igg | #2130 |
| secondary receptors | #2133 |
| inducing | #2136 |
| occurring | #2139 |
| histopathological | #2140 |
| target tissues | #2141 |
| selective estrogen | #2141 |
| dissection | #2142 |
| plasminogen | #2143 |
| transduction lymphocytes | #2145 |
| subphenotypes | #2146 |
| extracellular calcium | #2146 |
| bound | #2147 |
| h2d | #2147 |
| circulating monocytes | #2149 |
| 129 strain mice | #2151 |
| immunohistochemical analysis | #2151 |
| reality | #2153 |
| clinical aspects | #2157 |
| periphery | #2161 |
| major histocompatibility complex | #2162 |
| late stages | #2165 |
| moabs | #2165 |
| rheumatoid biomarkers | #2165 |
| prone | #2169 |
| entire | #2174 |
| syringes | #2176 |
| mimics | #2177 |
| animal model | #2179 |
| immune regulation | #2180 |
| human leukocytes | #2181 |
| psoriatic arthritis | #2184 |
| dynorphins | #2184 |
| dnp | #2185 |
| native | #2188 |
| injury ali | #2200 |
| dss | #2203 |
| lps stimulation | #2204 |
| structural requirements | #2211 |
| molecular pathways | #2213 |
| confirming | #2214 |
| 12th | #2215 |
| therapeutic effects | #2216 |
| interleukin2 | #2216 |
| animal mice mice | #2217 |
| activation cells | #2217 |
| naïve | #2219 |
| regulates | #2220 |
| galactose | #2220 |
| suggesting | #2221 |
| wt mice | #2224 |
| immunoreactivity | #2225 |
| mammalian | #2232 |
| shrna | #2232 |
| governs | #2233 |
| neutralized | #2233 |
| presentation | #2234 |
| accelerates | #2236 |
| ctla4 | #2239 |
| autoimmune conditions | #2239 |
| reduced susceptibility | #2239 |
| lacked | #2240 |
| graft rejection | #2244 |
| cholera toxin | #2248 |
| inflammatory phenotype | #2248 |
| cell priming | #2252 |
| exacerbated | #2253 |
| monoclonal antibodies | #2254 |
| cell receptors | #2256 |
| tcell proliferation | #2261 |
| sjögren | #2263 |
| regulation immune | #2265 |
| involved pathogenesis | #2267 |
| hla | #2269 |
| progeny | #2274 |
| mph | #2274 |
| immunospot | #2278 |
| antigenic | #2279 |
| murine | #2279 |
| neutrophil apoptosis | #2280 |
| mice treatment | #2280 |
| lymph nodes | #2281 |
| dependent | #2284 |
| inflammatory | #2288 |
| immunizations | #2289 |
| homologous | #2292 |
| plasmatic | #2293 |
| modified proteins | #2296 |
| determining | #2296 |
| histological evaluation | #2296 |
| cba mice | #2297 |
| regulatory mechanisms | #2299 |
| knockout mice | #2300 |
| apocynin | #2302 |
| segregating | #2308 |
| infiltrating macrophages | #2309 |
| presentation antigens | #2310 |
| wounding | #2312 |
| genetic basis | #2315 |
| drastically | #2315 |
| il10 | #2317 |
| healthy donors | #2318 |
| barré | #2320 |
| hydroxylation | #2320 |
| inflammatory mechanisms | #2321 |
| throughput nucleotide | #2325 |
| sera | #2325 |
| p00002 | #2326 |
| antigens histocompatibility | #2328 |
| wild | #2329 |
| cells induced | #2331 |
| demyelinating disease | #2336 |
| n24 | #2338 |
| lewis | #2345 |
| gk | #2347 |
| reciprocal | #2353 |
| receptor α | #2353 |
| specific igg | #2358 |
| ethylenes | #2358 |
| illness stress | #2361 |
| monosaccharide | #2363 |
| hyaline | #2364 |
| biological agents | #2365 |
| lectins type | #2366 |
| acrylamides | #2366 |
| sex hormone | #2366 |
| degradative | #2367 |
| phosphoproteins | #2369 |
| wf | #2374 |
| eliminated | #2374 |
| peptides derived | #2375 |
| lymphotoxin | #2375 |
| immunogens | #2375 |
| treatment rheumatoid arthritis | #2376 |
| genetic selection | #2376 |
| amps | #2382 |
| cxcl1 | #2382 |
| antinociceptive | #2383 |
| nonalcoholic steatohepatitis | #2384 |
| contaminating | #2386 |
| mouse model | #2386 |
| sidechain | #2391 |
| phenotypes | #2391 |
| receptor transforming | #2392 |
| syngeneic | #2394 |
| knock | #2394 |
| septic arthritis | #2396 |
| systemic lupus erythematosus | #2397 |
| hla genes | #2398 |
| p38 mapk | #2400 |
| inflammatory reaction | #2400 |
| serum autoantibodies | #2408 |
| increased incidence | #2409 |
| mice models | #2411 |
| equina | #2413 |
| intraperitoneal injections | #2418 |
| genetic studies | #2420 |
| genetic receptors | #2420 |
| structure analysis | #2423 |
| realtime pcr | #2424 |
| mice expression | #2426 |
| tlr2 tlr4 | #2429 |
| lentivirus | #2430 |
| suggestive evidence | #2430 |
| acute phase | #2430 |
| unmodified | #2431 |
| cko | #2432 |
| cytokines chemokines | #2432 |
| collagen fibrils | #2432 |
| lymphocytes cd4 | #2432 |
| cells antigens | #2434 |
| agents arthritis | #2440 |
| early phases | #2440 |
| inflammatory activity | #2442 |
| mice multiple | #2446 |
| genetic predisposition | #2449 |
| b6 | #2450 |
| receptors complement | #2450 |
| 551 | #2451 |
| lipoxin | #2458 |
| inflammatory demyelinating | #2459 |
| animal disease models | #2463 |
| exemplified | #2466 |
| idiotype | #2468 |
| antibody responses | #2469 |
| strains | #2471 |
| administration intranasal | #2473 |
| animals cd4 | #2473 |
| additively | #2477 |
| axotomy | #2477 |
| translational modifications | #2477 |
| quantitative | #2480 |
| class | #2480 |
| regulatory | #2487 |
| animal experiments | #2492 |
| specific | #2493 |
| organ specific | #2497 |
| transforming growth factor | #2498 |
| negative feedback | #2501 |
| albeit | #2502 |
| alleviated | #2502 |
| cystatin | #2504 |
| mhc class genes | #2505 |
| multiparous | #2511 |
| transgenic microscopy | #2512 |
| bystander | #2515 |
| il17a | #2516 |
| ppd | #2518 |
| dichotomous | #2519 |
| chemokines cytokines | #2519 |
| contribute | #2522 |
| naturally | #2523 |
| treatment rheumatoid | #2524 |
| hyperostosis | #2525 |
| amiloride | #2526 |
| nod mice | #2527 |
| pathogenicity | #2534 |
| microsatellite markers | #2534 |
| infiltration | #2541 |
| resemblance | #2542 |
| undertaken | #2545 |
| postmenopausal osteoporosis | #2546 |
| proteolipid | #2552 |
| dapsone | #2560 |
| similarities | #2561 |
| igm iga | #2562 |
| plp | #2563 |
| kynurenine | #2563 |
| deprotection | #2564 |
| nox | #2566 |
| succeeded | #2567 |
| fine | #2573 |
| transferring | #2573 |
| passive | #2574 |
| rp patients | #2575 |
| dying cells | #2575 |
| tumor models | #2576 |
| quantitative traits | #2577 |
| incomplete | #2577 |
| complementarity | #2580 |
| peptides | #2585 |
| chick | #2589 |
| calgranulin | #2590 |
| antibody levels | #2591 |
| peritoneal macrophages | #2591 |
| misinterpretation | #2593 |
| interferon type | #2595 |
| sex hormones | #2597 |
| fibrinolysin | #2598 |
| antiinflammatory properties | #2603 |
| onset | #2603 |
| unlinked | #2605 |
| zymosan | #2610 |
| induction | #2611 |
| postulated | #2614 |
| exert | #2615 |
| antimicrobial peptides | #2618 |
| surprising | #2621 |
| interferon beta | #2623 |
| proteolipid protein | #2632 |
| ifn α | #2634 |
| single chain | #2639 |
| sialoglycoproteins | #2643 |
| plasmin | #2647 |
| unable | #2649 |
| asparagine | #2651 |
| tlr9 | #2653 |
| antigens | #2656 |
| disease genotype | #2658 |
| hla antigens | #2659 |
| submandibular gland | #2663 |
| functional impact | #2663 |
| antinuclear | #2663 |
| eluted | #2666 |
| osteonectin | #2667 |
| invading | #2670 |
| n22 | #2670 |
| brucei | #2670 |
| microliters | #2671 |
| biological pathways | #2673 |
| bordetella | #2680 |
| ease | #2683 |
| new therapeutic strategies | #2683 |
| leukocyte antigen | #2688 |
| th1 | #2690 |
| acd | #2696 |
| day treatment | #2697 |
| allelic | #2697 |
| genetic variations | #2698 |
| igg3 | #2698 |
| animal encephalomyelitis | #2702 |
| neutrophils macrophages | #2703 |
| gamma mice | #2711 |
| peptides protein | #2714 |
| γδ | #2716 |
| treatment mice | #2717 |
| rat model | #2718 |
| human complement | #2725 |
| patients anti | #2727 |
| polymorphic | #2729 |
| biased | #2730 |
| lymphocyte subsets | #2730 |
| ifngamma | #2730 |
| post partum | #2731 |
| fumigatus | #2735 |
| lamina propria | #2735 |
| serum anti | #2738 |
| vav | #2743 |
| fragment | #2743 |
| mice exposed | #2750 |
| leucocyte | #2754 |
| resemble | #2762 |
| bromocriptine | #2768 |
| transgenic mouse | #2772 |
| depleting | #2773 |
| tyrosine phosphatase | #2774 |
| human leukocyte | #2774 |
| qtls | #2777 |
| strong evidence | #2777 |
| cytolysis | #2777 |
| enigmatic | #2780 |
| detectable | #2780 |
| iga igm | #2780 |
| genetically | #2782 |
| explanation | #2785 |
| finemapping | #2785 |
| alcoholic steatohepatitis | #2786 |
| treated rats | #2786 |
| intraperitoneal | #2787 |
| tolerogenic | #2789 |
| bone cartilage | #2790 |
| sjogren syndrome | #2791 |
| inbred mrl | #2798 |
| current review | #2798 |
| animal encephalomyelitis autoimmune | #2799 |
| hk | #2801 |
| callithrix | #2804 |
| spleen | #2812 |
| 261 | #2813 |
| neuropathology | #2817 |
| genistein | #2819 |
| alpha | #2821 |
| lack | #2822 |
| activated macrophages | #2825 |
| hyaluronidase | #2830 |
| conventionally | #2831 |
| narrowed | #2832 |
| prl | #2835 |
| olive oil | #2838 |
| demyelinating diseases | #2841 |
| resistant | #2842 |
| hallmark | #2843 |
| glucose uptake | #2846 |
| beta receptor | #2847 |
| beta tgf | #2848 |
| bind | #2848 |
| demyelinating | #2852 |
| th1 response | #2852 |
| polymorphonuclear leukocytes | #2856 |
| phases | #2858 |
| treg cell | #2859 |
| dependent cell | #2859 |
| antibodies antinuclear | #2864 |
| polymorphonuclear | #2864 |
| interleukin receptors | #2864 |
| characterising | #2865 |
| splenocytes | #2865 |
| interleukin33 | #2869 |
| rats inbred strains | #2869 |
| cyanogen bromide | #2874 |
| disease characterized | #2875 |
| guillain | #2875 |
| cells cd8 | #2881 |
| periodontitis | #2882 |
| parvalbumin | #2884 |
| reveals | #2885 |
| clone cells | #2885 |
| exacerbate | #2888 |
| igg iga | #2891 |
| migration inhibitory | #2892 |
| tgfbeta | #2895 |
| costimulatory molecules | #2895 |
| dce | #2896 |
| innate immune responses | #2896 |
| antigens class humans | #2898 |
| dq | #2905 |
| antigen hla | #2907 |
| atp synthase | #2909 |
| linked immunosorbent | #2911 |
| enhancement | #2911 |
| studying | #2918 |
| shortly | #2920 |
| diseases disease | #2920 |
| allogenic | #2921 |
| ergometry | #2921 |
| steadily | #2925 |
| vaccine development | #2925 |
| type lectin | #2926 |
| obvious | #2927 |
| ifn γ | #2931 |
| autoimmune disorder | #2935 |
| dextran | #2939 |
| female flow | #2943 |
| injections | #2944 |
| expression macrophages | #2944 |
| ifn gamma | #2945 |
| proteins peptides | #2946 |
| cd68 | #2947 |
| patients antibodies | #2949 |
| interleukin4 | #2950 |
| cells immune | #2955 |
| eventually | #2956 |
| toll receptor | #2961 |
| cell infiltration | #2962 |
| expressions | #2963 |
| calcium ions | #2964 |
| qtl | #2965 |
| histocytochemistry | #2967 |
| suppressed | #2967 |
| hnrnp | #2980 |
| genetics | #2982 |
| ifn response | #2985 |
| cepacia | #2988 |
| antirheumatic agents | #2993 |
| elusive | #2994 |
| hdac | #2995 |
| thymus gland | #2997 |
| swedish | #2998 |
| respective | #3000 |
| lineage commitment | #3003 |
| indoleamine | #3009 |
| time points | #3009 |
| cells female | #3010 |
| therapeutic strategies | #3014 |
| innate | #3014 |
| illustrating | #3017 |
| anthrax | #3019 |
| interferon ifn | #3020 |
| wild type mice | #3026 |
| defensins | #3027 |
| vdr | #3031 |
| lung inflammation | #3033 |
| accelerating | #3033 |
| macrophage migration | #3036 |
| t‐cell | #3039 |
| endo | #3039 |
| synthetic peptides | #3040 |
| appearance | #3045 |
| quinoxalines | #3047 |
| cd8 | #3048 |
| immunomodulator | #3050 |
| model mice | #3051 |
| longterm treatment | #3052 |
| twin studies | #3053 |
| complex traits | #3055 |
| ppt | #3058 |
| interleukin23 | #3061 |
| profound | #3067 |
| sjögren syndrome | #3069 |
| prevailing | #3073 |
| salivary | #3076 |
| mediated immune | #3077 |
| role cell | #3078 |
| beta | #3080 |
| destruction | #3082 |
| model human | #3083 |
| irrespective | #3083 |
| gene expression profiling | #3086 |
| impairing | #3087 |
| nodes | #3091 |
| glutamic | #3092 |
| inhibitory factors | #3092 |
| parvalbumins | #3093 |
| receptor 4 | #3098 |
| inbred balb mice | #3098 |
| genetic deletion | #3100 |
| detailed description | #3101 |
| postpartum period | #3107 |
| germinal | #3108 |
| antirheumatic | #3109 |
| staphylococcus | #3114 |
| type wt | #3120 |
| neuronal cell | #3123 |
| effects treatment | #3124 |
| suspect | #3127 |
| igm igg | #3130 |
| specificity | #3131 |
| glycans | #3136 |
| monoclonal antibody | #3137 |
| receptors tlrs | #3142 |
| psoriasis | #3142 |
| logarithm | #3146 |
| cd4 cd8 | #3147 |
| preformed | #3151 |
| immune systems | #3152 |
| possibility | #3153 |
| cell activity | #3154 |
| propria | #3155 |
| molecule | #3155 |
| cba | #3164 |
| posttranslational modification | #3167 |
| sjogren | #3171 |
| massively | #3172 |
| accumulated | #3180 |
| cell specific | #3185 |
| precedes | #3185 |
| blockage | #3187 |
| dynorphin | #3191 |
| tissue specific | #3191 |
| pertussis toxin | #3192 |
| adult mice | #3193 |
| cells rats | #3193 |
| keratinocytes | #3194 |
| unravel | #3199 |
| reactivity | #3202 |
| helper | #3204 |
| modified | #3205 |
| ovx | #3208 |
| serum levels | #3210 |
| erbeta | #3211 |
| antiinflammatory | #3211 |
| phagosomes | #3212 |
| nitroarginine | #3212 |
| abs | #3216 |
| cells animals | #3224 |
| publication arthritis | #3224 |
| gpi | #3226 |
| chromosome 1 | #3237 |
| class iii | #3239 |
| clarified | #3242 |
| permitting | #3246 |
| collagenous | #3247 |
| macrophage | #3247 |
| lod score | #3252 |
| bacterial antibodies | #3254 |
| backbone | #3257 |
| nonalcoholic steatohepatitis nash | #3260 |
| female gonadal | #3263 |
| treated animals | #3264 |
| acrylic | #3265 |
| chronic inflammatory | #3267 |
| meps | #3270 |
| immunosorbent assay | #3272 |
| implicate | #3274 |
| proteoglycans | #3278 |
| inflammation interferon | #3278 |
| sch | #3280 |
| arthralgia | #3283 |
| nephritis | #3283 |
| gonadal steroid | #3284 |
| normal rats | #3287 |
| abundantly | #3289 |
| igg1 | #3298 |
| models genetic | #3298 |
| immunoglobulin heavy | #3303 |
| erythematosus | #3305 |
| adaptations | #3309 |
| proteins mice | #3309 |
| characterise | #3314 |
| elicits | #3314 |
| blastocyst | #3315 |
| nociception | #3316 |
| absence | #3318 |
| diseases autoimmune | #3321 |
| publication animals | #3325 |
| beta receptors | #3325 |
| mice protein | #3327 |
| anticardiolipin | #3328 |
| confirmed | #3329 |
| gc cells | #3331 |
| serologically | #3332 |
| suppression | #3338 |
| regional lymph nodes | #3341 |
| macromolecular | #3343 |
| clinical phenotypes | #3345 |
| cd62l | #3353 |
| influenced | #3355 |
| trypanosoma | #3358 |
| akr | #3371 |
| vitamin d3 | #3373 |
| editor | #3377 |
| antinuclear antibodies | #3382 |
| sle | #3384 |
| genetic polymorphisms | #3385 |
| ovariectomy | #3386 |
| macroporous | #3395 |
| mechanistic studies | #3395 |
| levels inflammatory | #3395 |
| explains | #3396 |
| mount | #3397 |
| tubercle | #3402 |
| somatic mutations | #3406 |
| receptors transforming | #3410 |
| haptens | #3413 |
| early phase | #3413 |
| positions | #3418 |
| erythematosus systemic | #3419 |
| nk cells | #3419 |
| reacts | #3421 |
| neutrophil activation | #3421 |
| penetrant | #3425 |
| reply | #3432 |
| receptor type | #3434 |
| proving | #3434 |
| dendritic cells | #3436 |
| serum igg | #3437 |
| alleles | #3440 |
| permitted | #3441 |
| cauda | #3443 |
| 4 months | #3444 |
| injection | #3445 |
| superoxide production | #3446 |
| protein tyrosine | #3447 |
| obscure | #3448 |
| humans immunization | #3448 |
| increased sensitivity | #3449 |
| antimicrobial peptide | #3451 |
| diffusely | #3459 |
| characterised | #3469 |
| patients sle | #3470 |
| h5n1 | #3470 |
| flow cytometry | #3476 |
| modifying | #3477 |
| inflammatory mediators | #3491 |
| multimers | #3491 |
| proteoglycan | #3496 |
| successes | #3497 |
| il21 | #3500 |
| ly | #3501 |
| elucidate | #3503 |
| developed | #3505 |
| classical | #3505 |
| protein processing | #3506 |
| salivary gland | #3507 |
| publication animals animals | #3509 |
| neutrophilic | #3510 |
| pathobiology | #3511 |
| pathological features | #3517 |
| specific cd4 | #3519 |
| globulins | #3526 |
| deoxyguanosine | #3528 |
| 267 | #3528 |
| germline | #3529 |
| phenotypically | #3529 |
| predispose | #3532 |
| micrometer | #3534 |
| lacrimal | #3534 |
| transglutaminases | #3535 |
| radiolabelled | #3539 |
| cyclosporins | #3540 |
| regulatory cells tregs | #3540 |
| mbq | #3541 |
| dominantly | #3548 |
| histological examination | #3554 |
| investigate | #3559 |
| infections staphylococcus | #3561 |
| mast cells | #3563 |
| cultured disease models | #3568 |
| socs1 | #3570 |
| humans interferon | #3571 |
| histological | #3574 |
| homogenate | #3576 |
| gamma | #3580 |
| interesting | #3580 |
| negative patients | #3583 |
| artificially | #3584 |
| role development | #3585 |
| cytolytic | #3589 |
| hindlimb | #3590 |
| il33 | #3593 |
| compared wild | #3597 |
| triggered | #3597 |
| usage | #3601 |
| immunohistochemical staining | #3608 |
| upregulation | #3612 |
| previous findings | #3617 |
| intranasal | #3619 |
| tcr | #3622 |
| cleave | #3624 |
| potential roles | #3624 |
| genetic association | #3629 |
| rp | #3633 |
| attenuate | #3633 |
| mapping chromosomes | #3634 |
| genetic | #3637 |
| valuable | #3637 |
| adhere | #3638 |
| today | #3645 |
| cultured culture media | #3651 |
| allele | #3655 |
| gene deletion | #3657 |
| enhances | #3657 |
| cd4 positive | #3659 |
| exerts | #3663 |
| tolllike receptor | #3665 |
| clinical severity | #3665 |
| luminol | #3667 |
| 95 association | #3671 |
| cd44 | #3678 |
| il23 | #3690 |
| tgf beta | #3691 |
| female genes | #3694 |
| fibronectins | #3697 |
| toll receptors | #3700 |
| igg igm | #3702 |
| heavy chain | #3705 |
| synovitis | #3708 |
| publication animals humans | #3708 |
| cyclohexanecarboxylic | #3709 |
| aggregated | #3717 |
| inbred nod mice | #3730 |
| systemic male | #3735 |
| sequence deletion | #3740 |
| dh | #3742 |
| 378 | #3746 |
| cells produce | #3750 |
| therapeutic benefit | #3752 |
| macrophage cell | #3753 |
| mediate | #3754 |
| contributing | #3754 |
| complement c4 | #3758 |
| immunochemistry | #3759 |
| type 4 | #3763 |
| biomedicine | #3763 |
| lymphocytes tumor | #3766 |
| epitope mapping | #3767 |
| identification | #3771 |
| partum | #3772 |
| mtdna | #3773 |
| d3 | #3775 |
| jakob | #3786 |
| th17 | #3786 |
| reduced expression | #3787 |
| diphtheria | #3803 |
| immunohistochemical | #3805 |
| hind | #3808 |
| skewed | #3820 |
| superoxide | #3822 |
| integrins | #3822 |
| ribonucleoprotein | #3823 |
| new opportunities | #3831 |
| models immunological | #3834 |
| encompassing | #3838 |
| mmp9 expression | #3839 |
| puerperal | #3839 |
| noncoding rna | #3840 |
| unclear | #3847 |
| amelioration | #3854 |
| il17 | #3858 |
| postulate | #3858 |
| identical | #3859 |
| housed | #3861 |
| genetic dna | #3867 |
| cells treg | #3873 |
| genetic promoter regions | #3880 |
| prominent | #3887 |
| kinase2 | #3887 |
| glycoside | #3887 |
| reacting | #3888 |
| dinucleotide | #3894 |
| decreased levels | #3896 |
| synoviocytes | #3900 |
| microsatellite repeats | #3903 |
| superoxides | #3904 |
| dominate | #3907 |
| recognition | #3912 |
| endogenous | #3918 |
| established | #3919 |
| animal studies | #3926 |
| rats messenger | #3931 |
| hladr | #3934 |
| immunophenotyping | #3941 |
| manifestations | #3942 |
| nerves | #3944 |
| toes | #3946 |
| affect | #3947 |
| neutrophils | #3947 |
| polymorphism | #3949 |
| gingivalis | #3957 |
| nets | #3958 |
| mechanisms involved | #3961 |
| involvement | #3973 |
| associate | #3975 |
| disrupted | #3975 |
| 297 | #3982 |
| adult arthritis | #3988 |
| heavy chains | #3992 |
| stimulate | #3992 |
| ifn β | #3999 |
| question | #3999 |
| broader | #4001 |
| patients osteoarthritis | #4009 |
| elevated levels | #4012 |
| sinuses | #4016 |
| chondrocytes | #4018 |
| superoxide dismutase | #4018 |
| individual patients | #4028 |
| ags | #4029 |
| inflammatory processes | #4033 |
| influences | #4034 |
| higher expression | #4034 |
| efficiently | #4050 |
| glycoproteins | #4054 |
| hla alleles | #4059 |
| expression cell | #4063 |
| conferred | #4065 |
| c1q | #4069 |
| produce | #4072 |
| fragments | #4072 |
| hinge | #4074 |
| eliciting | #4075 |
| stat4 | #4076 |
| requirement | #4076 |
| plethora | #4077 |
| glycoprotein | #4077 |
| contrast | #4085 |
| llc | #4089 |
| upregulated | #4090 |
| systemic lupus | #4092 |
| expression type | #4098 |
| fine mapping | #4102 |
| atpases | #4103 |
| leukocyte | #4105 |
| glands | #4107 |
| conferring | #4108 |
| neutrophil | #4113 |
| creutzfeldt | #4115 |
| current concepts | #4116 |
| gelatin | #4120 |
| absent | #4121 |
| therapy genetic | #4122 |
| sclerosis animals | #4124 |
| drives | #4126 |
| regulatory cells | #4126 |
| protect | #4131 |
| mycobacterial | #4133 |
| promoter polymorphism | #4137 |
| stat1 | #4144 |
| functionally | #4147 |
| articular cartilage | #4161 |
| lupus erythematosus | #4162 |
| hla dq | #4165 |
| motor neurons | #4166 |
| polygenic | #4169 |
| placenta pregnancy | #4173 |
| tumour necrosis factor | #4177 |
| stimulatory | #4178 |
| early pregnancy | #4180 |
| immunology | #4183 |
| effector | #4184 |
| systemic disease | #4187 |
| superoxide anion | #4191 |
| infiltrating lymphocytes | #4192 |
| spe | #4193 |
| monocyte | #4201 |
| breeders | #4203 |
| enterotoxin | #4206 |
| ici | #4207 |
| porphyromonas gingivalis | #4207 |
| beads | #4213 |
| antigens cd8 | #4214 |
| animal drug | #4222 |
| depletion | #4223 |
| cytometric analysis | #4224 |
| parathyroid | #4225 |
| long noncoding | #4227 |
| mutant | #4232 |
| inbred balb | #4239 |
| treated mice | #4242 |
| macrophage infiltration | #4244 |
| kidneys | #4244 |
| granulocytic | #4249 |
| chondrosarcoma | #4250 |
| continuously | #4250 |
| witnessed | #4252 |
| conjunction | #4256 |
| immunological | #4257 |
| immunity innate | #4258 |
| bout | #4260 |
| igh | #4262 |
| lymphoid | #4264 |
| cell repertoire | #4268 |
| denominator | #4270 |
| day1 | #4270 |
| complex | #4272 |
| suggestive | #4276 |
| experimental mice | #4285 |
| dermatitis | #4285 |
| clues | #4286 |
| gene targeting | #4290 |
| cd4 | #4291 |
| balb | #4292 |
| disease genetic | #4294 |
| repertoire | #4302 |
| provocation | #4303 |
| molecular modeling | #4303 |
| sciatic | #4307 |
| shares | #4307 |
| tuberculin | #4308 |
| positive cells | #4309 |
| functional role | #4310 |
| receptors interleukin2 | #4317 |
| cell populations | #4317 |
| suppressive effects | #4320 |
| hydroxy2deoxyguanosine | #4331 |
| pparγ | #4350 |
| new insight | #4353 |
| trypanosomiasis | #4358 |
| glutamine | #4364 |
| fungal infection | #4364 |
| peritonitis | #4365 |
| wildtype | #4370 |
| immunoassays | #4373 |
| swelling | #4375 |
| penetrance | #4381 |
| caused | #4381 |
| cell clones | #4396 |
| disease chronic | #4402 |
| mucous | #4402 |
| prevents | #4414 |
| restored | #4417 |
| joint | #4420 |
| modulating | #4426 |
| closer | #4434 |
| disturbed | #4434 |
| receptor beta | #4434 |
| buprenorphine | #4435 |
| model systems | #4443 |
| early | #4453 |
| acute chronic | #4454 |
| aspartic | #4458 |
| parathyroid glands | #4470 |
| confers | #4473 |
| inflammatory pain | #4477 |
| disease duration | #4480 |
| thymocytes | #4481 |
| calmette | #4488 |
| strains rats | #4489 |
| synthase type | #4490 |
| treg | #4493 |
| thickened | #4503 |
| neutralizing antibodies | #4503 |
| human cell | #4505 |
| genetic loci | #4510 |
| extensively | #4516 |
| colitis | #4526 |
| derived cells | #4532 |
| therapeutic implications | #4534 |
| immunotoxins | #4535 |
| beta cells | #4539 |
| cells th2 | #4541 |
| challenged | #4542 |
| lymphocytes cd8 | #4545 |
| 101 | #4546 |
| cytotoxic lymphocytes | #4547 |
| articular chondrocytes | #4553 |
| interleukin5 | #4558 |
| messenger rats rats | #4564 |
| beta cell | #4566 |
| homing | #4576 |
| extracellular ca2 | #4576 |
| hydrolases | #4577 |
| fasl | #4578 |
| cell separation | #4580 |
| proliferative | #4581 |
| neurosecretory | #4585 |
| immunologic | #4592 |
| production inflammatory | #4593 |
| suggests | #4596 |
| inbred shr rats | #4607 |
| modulatory | #4608 |
| interact | #4613 |
| igg antibody | #4613 |
| ros levels | #4613 |
| confer | #4616 |
| depleted | #4639 |
| conditioned medium | #4642 |
| environmental factors | #4643 |
| positive selection | #4658 |
| fashion | #4658 |
| porphyromonas | #4666 |
| visualized | #4667 |
| endorphins | #4669 |
| implicated | #4670 |
| determinant | #4675 |
| causing | #4678 |
| chains | #4681 |
| langerhans | #4681 |
| monocytes macrophages | #4683 |
| animals antigens | #4693 |
| 259 | #4696 |
| female rats | #4699 |
| protecting | #4707 |
| lymph | #4707 |
| inherited | #4709 |
| defined | #4710 |
| destabilization | #4716 |
| facs | #4718 |
| human studies | #4720 |
| orthomyxoviridae infections | #4725 |
| humans inflammation | #4729 |
| cell population | #4734 |
| positive patients | #4736 |
| α1 | #4739 |
| clone | #4741 |
| mediating | #4744 |
| factor 88 | #4750 |
| panel | #4753 |
| gout | #4757 |
| new drugs | #4764 |
| histopathology | #4767 |
| orchiectomy | #4773 |
| cellular localization | #4775 |
| e4 | #4776 |
| alveolar macrophages | #4776 |
| purified | #4778 |
| differing | #4793 |
| eralpha | #4798 |
| male membrane | #4800 |
| rodents | #4801 |
| osteoclastogenesis | #4809 |
| displaying | #4809 |
| hydrolyzed | #4815 |
| tumor antigens | #4816 |
| effector cells | #4819 |
| cytokines | #4821 |
| paw | #4821 |
| cd4 cd8 cells | #4821 |
| cholera | #4822 |
| distinct | #4831 |
| coincides | #4833 |
| litters | #4843 |
| stress rats | #4846 |
| tissue injury | #4847 |
| rats receptors | #4850 |
| matrix ecm | #4852 |
| interferon γ | #4852 |
| stemness | #4860 |
| articular | #4861 |
| venules | #4863 |
| infiltrate | #4868 |
| th17 cells | #4872 |
| tlr2 | #4880 |
| hpa axis | #4882 |
| ifn | #4885 |
| exocrine | #4888 |
| multifactorial | #4889 |
| 116 | #4891 |
| lod | #4892 |
| specific binding | #4893 |
| ige | #4896 |
| humoral immunity | #4897 |
| induced lung | #4899 |
| preimplantation | #4905 |
| essential roles | #4915 |
| discuss | #4916 |
| immunosorbent | #4917 |
| correlating | #4923 |
| interleukins | #4927 |
| deacetylases | #4928 |
| closely | #4932 |
| timepoints | #4940 |
| humans multiple | #4945 |
| deficiency | #4946 |
| disease process | #4962 |
| naturally occurring | #4962 |
| monitored | #4964 |
| elicit | #4966 |
| forelimb | #4967 |
| contradictory | #4975 |
| point mutation | #4976 |
| cell antigen | #4990 |
| understand | #4995 |
| male rats | #4998 |
| kupffer cells | #5001 |
| thymic | #5003 |
| innate immune | #5004 |
| eosinophilia | #5004 |
| modulates | #5011 |
| isotype | #5012 |
| wt | #5012 |
| upa | #5014 |
| opened | #5018 |
| sh3 | #5019 |
| granuloma | #5021 |
| gland | #5024 |
| expand | #5026 |
| enhancing | #5026 |
| vimentin | #5026 |
| poliomyelitis | #5041 |
| explaining | #5042 |
| il5 | #5044 |
| diamines | #5048 |
| heterozygous | #5049 |
| coculture techniques | #5051 |
| cd8 cells | #5055 |
| caveolin | #5065 |
| th1 cells | #5067 |
| linkage | #5067 |
| phospholipid | #5071 |
| arthritis juvenile | #5072 |
| sitedirected mutagenesis | #5076 |
| molecular basis | #5084 |
| cells blood | #5085 |
| bcg | #5086 |
| alum | #5087 |
| autologous | #5087 |
| olive | #5088 |
| new treatment | #5089 |
| multiple sclerosis | #5098 |
| master regulator | #5100 |
| osteopontin | #5109 |
| aged anti | #5110 |
| occurs | #5112 |
| elispot | #5112 |
| sulfasalazine | #5115 |
| isoantibodies | #5120 |
| dq antigens | #5134 |
| contributes | #5139 |
| lesser | #5145 |
| traditionally | #5148 |
| cytosolic | #5152 |
| epidermis | #5158 |
| connection | #5165 |
| cytokines female | #5170 |
| titrated | #5171 |
| preceded | #5175 |
| antigen receptor | #5178 |
| lymphocytes cytotoxic | #5179 |
| binding | #5185 |
| sex characteristics | #5186 |
| transfer | #5187 |
| polymorphism single | #5188 |
| phenotypic | #5191 |
| complement proteins | #5192 |
| molecular level | #5196 |
| ovariectomized | #5210 |
| popliteal | #5224 |
| ers | #5235 |
| beta2 | #5238 |
| serves | #5238 |
| chimeric | #5241 |
| immunosuppressive | #5246 |
| epidermal | #5250 |
| cognate | #5258 |
| mucus | #5258 |
| cd86 | #5261 |
| tested | #5262 |
| deleterious effects | #5266 |
| progenitors | #5270 |
| costimulation | #5275 |
| detects | #5277 |
| osteoclast | #5277 |
| erosion | #5278 |
| therapeutic intervention | #5280 |
| prolactin | #5280 |
| maternally | #5289 |
| gels | #5292 |
| leu | #5294 |
| plasmapheresis | #5298 |
| clinical findings | #5299 |
| drug humans | #5301 |
| key component | #5301 |
| neutralization | #5301 |
| amino | #5310 |
| staphylococcus aureus | #5312 |
| suggestion | #5312 |
| anhydrases | #5315 |
| c57bl 6j | #5320 |
| manner | #5320 |
| spontaneous | #5321 |
| lipopolysaccharides macrophages | #5345 |
| genetic mapping | #5348 |
| ketoglutarate | #5350 |
| opposing | #5352 |
| proinflammatory | #5365 |
| clathrin | #5369 |
| multiplexed | #5371 |
| glomerulonephritis | #5377 |
| modifies | #5379 |
| cultured human | #5386 |
| expansion | #5387 |
| il1α | #5391 |
| tolllike receptors | #5397 |
| oxidation reduction | #5398 |
| new strategies | #5401 |
| mice molecular | #5402 |
| positive lymphocytes | #5402 |
| tnf α | #5411 |
| antiinflammatory agents | #5417 |
| epigenetic mechanisms | #5417 |
| adversely | #5418 |
| activation | #5420 |
| fulvestrant | #5420 |
| dendritic | #5428 |
| antigens surface | #5429 |
| compartments | #5429 |
| signaling molecules | #5432 |
| mif | #5457 |
| cell culture | #5458 |
| wide spectrum | #5473 |
| sideeffects | #5478 |
| multitude | #5482 |
| located | #5499 |
| immunoglobulins | #5500 |
| histological analysis | #5507 |
| reproduced | #5507 |
| lactating | #5515 |
| cytotoxic | #5519 |
| cytokines humans | #5525 |
| balb mice | #5542 |
| therapeutic | #5547 |
| thymus | #5551 |
| immunosuppressive agents | #5559 |
| sexual dimorphism | #5560 |
| pv | #5560 |
| nociceptive | #5565 |
| redox | #5572 |
| cell expansion | #5578 |
| acute lung | #5583 |
| t1d | #5585 |
| percentage | #5588 |
| allergic reactions | #5592 |
| typed | #5596 |
| lipopolysaccharide lps | #5598 |
| potently | #5600 |
| acute lung injury | #5603 |
| oxidase activity | #5613 |
| control animals | #5614 |
| structural homology | #5616 |
| sequence amino | #5621 |
| synthases | #5633 |
| biotinylation | #5642 |
| bead | #5645 |
| pemphigus | #5649 |
| urgent | #5650 |
| type ifn | #5655 |
| proliferative responses | #5658 |
| explants | #5660 |
| abolished | #5660 |
| regarded | #5663 |
| 198 | #5671 |
| directing | #5676 |
| lung mice | #5677 |
| heterotrimeric | #5684 |
| antioxidant defense | #5685 |
| numbers | #5685 |
| aetiology | #5687 |
| triggers | #5689 |
| keratins | #5695 |
| progression disease | #5697 |
| cytokine expression | #5697 |
| skeletal muscle | #5698 |
| experimental animals | #5700 |
| immune mediated | #5710 |
| avenues | #5715 |
| effective treatments | #5735 |
| altogether | #5737 |
| variable | #5759 |
| integrases | #5760 |
| hfd | #5762 |
| ecm | #5776 |
| mechanisms | #5794 |
| mast | #5802 |
| frozen | #5808 |
| b16 | #5808 |
| linking | #5808 |
| inflammatory disorders | #5809 |
| diabetes t1d | #5814 |
| allergic | #5820 |
| splenic | #5829 |
| bal | #5830 |
| hampered | #5832 |
| toxoid | #5835 |
| earliest | #5837 |
| key regulators | #5844 |
| gabapentin | #5847 |
| type receptors | #5850 |
| large proportion | #5851 |
| proteinases | #5862 |
| cfa | #5868 |
| stronger | #5871 |
| disease genotype humans | #5872 |
| deleted | #5875 |
| hyaluronan receptors | #5875 |
| vitro experiments | #5880 |
| microtomography | #5882 |
| single cells | #5896 |
| evidence role | #5898 |
| modulation | #5900 |
| ace2 | #5917 |
| standardization | #5918 |
| abp | #5919 |
| synthetic | #5920 |
| bronchoalveolar lavage fluid | #5925 |
| low doses | #5925 |
| ics | #5932 |
| subclass | #5941 |
| identifying | #5941 |
| depend | #5947 |
| genomic regions | #5947 |
| explain | #5951 |
| interfere | #5953 |
| biobank | #5960 |
| cytokine production | #5962 |
| expression humans | #5965 |
| nerve regeneration | #5966 |
| factor 1 | #5968 |
| avidin | #5970 |
| foxp3 | #5975 |
| costimulatory | #5977 |
| clarify | #5980 |
| symptom onset | #5983 |
| denaturation | #5986 |
| inability | #5988 |
| knee joint | #5990 |
| eosinophils | #5991 |
| cell subset | #6000 |
| immunity | #6010 |
| glyburide | #6010 |
| 88 | #6014 |
| tetanus | #6019 |
| stress induced | #6022 |
| consisting | #6023 |
| fluorescent dyes | #6044 |
| cnvs | #6045 |
| stimulated | #6056 |
| nih | #6065 |
| igm | #6073 |
| tumor infiltrating | #6074 |
| cleared | #6074 |
| laminin | #6075 |
| genetic therapy | #6077 |
| relapsing remitting | #6083 |
| sle patients | #6089 |
| responsible | #6091 |
| undertook | #6097 |
| messengers | #6100 |
| cages | #6103 |
| stat6 | #6105 |
| ligated | #6107 |
| bone diseases | #6115 |
| uncoupling | #6115 |
| telomeric | #6122 |
| infection mice | #6127 |
| unique | #6140 |
| replacing | #6149 |
| plasma cells | #6150 |
| lowers | #6156 |
| inguinal | #6166 |
| susceptibility gene | #6171 |
| responses | #6171 |
| prophylactic | #6183 |
| genomewide association studies | #6193 |
| instances | #6210 |
| cell functions | #6210 |
| models human | #6217 |
| interferon | #6220 |
| translation | #6222 |
| humans lupus | #6235 |
| characterized | #6236 |
| progesterone | #6253 |
| introduction | #6260 |
| cell type | #6265 |
| exclusively | #6269 |
| protective | #6270 |
| microarray | #6272 |
| serum concentration | #6278 |
| sexes | #6280 |
| immune cell | #6285 |
| myelomonocytic | #6286 |
| histone | #6287 |
| biological evaluation | #6290 |
| difficult | #6298 |
| dermis | #6313 |
| sheath | #6316 |
| monolithic | #6318 |
| minor | #6320 |
| allowed | #6320 |
| tracheal | #6322 |
| estrus | #6336 |
| immunomodulatory | #6337 |
| lymphocyte count | #6339 |
| localize | #6347 |
| tumor immune | #6348 |
| cell biology | #6355 |
| remitting | #6355 |
| borrelia burgdorferi | #6355 |
| microsatellite | #6356 |
| virgin | #6356 |
| signs | #6360 |
| tears | #6363 |
| tryptic | #6370 |
| pertussis | #6372 |
| unresolved | #6378 |
| ros generation | #6379 |
| cells cell | #6381 |
| metalloproteinase | #6392 |
| human subjects | #6394 |
| nicotinamide | #6408 |
| registers | #6410 |
| prodromal | #6450 |
| gonadal | #6451 |
| neuropathological | #6454 |
| models molecular | #6455 |
| peritoneum | #6460 |
| express | #6470 |
| biologic | #6473 |
| transgenes | #6474 |
| c4 | #6475 |
| immunity mucosal | #6476 |
| inoculation | #6477 |
| genetic variants | #6477 |
| severe | #6501 |
| gene function | #6502 |
| demonstrates | #6508 |
| organ specificity | #6511 |
| cell numbers | #6513 |
| stages | #6515 |
| nitrite | #6523 |
| synergy | #6523 |
| chronic | #6523 |
| share | #6539 |
| played | #6540 |
| proteins animals | #6559 |
| apc | #6559 |
| antibody titers | #6572 |
| cytotoxicity immunologic | #6575 |
| pace | #6583 |
| rheumatic | #6588 |
| proteases | #6588 |
| expression genes | #6603 |
| toll | #6603 |
| stain | #6604 |
| major source | #6614 |
| translocating | #6615 |
| parturition | #6635 |
| hpa | #6636 |
| whitney | #6639 |
| solid phase | #6644 |
| affinity | #6645 |
| regulation | #6650 |
| parenchyma | #6650 |
| presently | #6651 |
| sclerosis | #6655 |
| memory cell | #6657 |
| cystine | #6658 |
| cells cd4 | #6665 |
| subfamily | #6672 |
| animals antioxidants | #6683 |
| melatonin | #6683 |
| current understanding | #6687 |
| burgdorferi | #6696 |
| macrophages alveolar | #6701 |
| long noncoding rnas | #6715 |
| histone deacetylases | #6742 |
| pups | #6747 |
| normal levels | #6747 |
| estrogens | #6749 |
| demonstration | #6755 |
| relevant | #6761 |
| comparative genomics | #6768 |
| elastase | #6774 |
| cd8 positive | #6776 |
| helpful | #6782 |
| interleukin18 | #6782 |
| cytometric | #6804 |
| demonstrate | #6812 |
| study role | #6813 |
| glucose transport | #6814 |
| crystal structure | #6819 |
| induced acute | #6825 |
| intra articular | #6825 |
| cd19 | #6829 |
| cterminal | #6829 |
| eosinophil | #6829 |
| conflicting | #6830 |
| lname | #6833 |
| antilymphocyte | #6836 |
| molecules | #6840 |
| case control | #6852 |
| aspergillosis | #6852 |
| lymphoid tissues | #6854 |
| participates | #6855 |
| periodontal disease | #6855 |
| vascular endothelium | #6862 |
| sciatic nerve | #6863 |
| alter | #6865 |
| bioreactors | #6867 |
| activating | #6871 |
| facial nerve | #6873 |
| cell communication | #6882 |
| tool | #6883 |
| cytokine release | #6887 |
| lethality | #6889 |
| inflammatory responses | #6893 |
| lung injury | #6900 |
| ankle joint | #6907 |
| harboring | #6908 |
| gastritis | #6915 |
| tumour necrosis | #6921 |
| recessive | #6922 |
| acetaldehyde | #6925 |
| induced pulmonary | #6931 |
| alternative | #6934 |
| microarray analysis | #6937 |
| cyclic | #6951 |
| inflammatory response | #6953 |
| sulfones | #6960 |
| player | #6974 |
| likewise | #6976 |
| exacerbations | #6984 |
| cdr | #6993 |
| equally | #7001 |
| rac1 | #7013 |
| biological function | #7014 |
| mapping | #7016 |
| degrade | #7020 |
| translational | #7020 |
| mimic | #7025 |
| assay elisa | #7033 |
| fewer | #7033 |
| suppressing | #7047 |
| th1 th2 | #7048 |
| histology | #7056 |
| nucleotide | #7060 |
| genome wide | #7063 |
| target cells | #7063 |
| heterogeneous | #7071 |
| subjected | #7072 |
| aureus | #7072 |
| immune cells | #7075 |
| serine proteases | #7082 |
| proportion | #7083 |
| reduced | #7086 |
| glomeruli | #7088 |
| finally | #7092 |
| atherosclerotic lesions | #7094 |
| orthomyxoviridae | #7108 |
| lyme disease | #7115 |
| thp1 cells | #7121 |
| apoptotic cells | #7124 |
| dividing | #7134 |
| mounted | #7137 |
| autophagy | #7144 |
| extracellular | #7153 |
| immunity cellular | #7161 |
| genetic markers | #7162 |
| messenger rats | #7166 |
| cascades | #7175 |
| synteny | #7188 |
| moiety | #7194 |
| promoted | #7198 |
| higher incidence | #7202 |
| lymphoid tissue | #7205 |
| bovine serum albumin | #7219 |
| dependency | #7223 |
| amino acid | #7225 |
| relevance | #7233 |
| mtx | #7237 |
| recognised | #7238 |
| polysaccharides | #7242 |
| sirt1 | #7251 |
| participate | #7253 |
| prevalent | #7262 |
| immuno | #7265 |
| role pathogenesis | #7272 |
| breeding | #7286 |
| inheritance | #7292 |
| rolling | #7300 |
| prime | #7313 |
| dissecting | #7326 |
| avidity | #7332 |
| expressed genes | #7334 |
| adhesins | #7335 |
| inflammasome | #7342 |
| potential targets | #7343 |
| secreted | #7347 |
| disease specific | #7350 |
| uncontrolled | #7353 |
| metalloendopeptidases | #7355 |
| microglobulin | #7363 |
| adulthood | #7369 |
| transduction animals | #7370 |
| oxide nitric | #7377 |
| array | #7387 |
| analyses | #7391 |
| nervous | #7406 |
| transglutaminase | #7410 |
| interleukin6 | #7411 |
| chemokines | #7411 |
| proven | #7418 |
| supernatants | #7428 |
| genotyping | #7446 |
| immunocytochemistry | #7453 |
| fusion protein | #7456 |
| cells peripheral | #7461 |
| β2 | #7467 |
| airways | #7489 |
| adjuvant | #7493 |
| inhibitory factor | #7500 |
| cytotoxic cells | #7518 |
| disease incidence | #7535 |
| anchor | #7536 |
| eliminate | #7540 |
| early disease | #7541 |
| il1 beta | #7545 |
| lesser extent | #7547 |
| interleukin1beta | #7549 |
| necrotic | #7550 |
| activity relationship | #7553 |
| responder | #7562 |
| elevations | #7589 |
| interacting | #7594 |
| micrograms | #7596 |
| appeared | #7610 |
| hydrocarbon | #7610 |
| arginine | #7621 |
| evident | #7628 |
| cytometry | #7630 |
| unexplained | #7632 |
| allogeneic | #7640 |
| peripheral nervous | #7645 |
| sustain | #7654 |
| receptors immunologic | #7659 |
| component | #7661 |
| graft survival | #7661 |
| murine model | #7665 |
| considerable | #7704 |
| histone deacetylase | #7707 |
| placental | #7712 |
| differentially expressed | #7721 |
| chromosomes | #7722 |
| activators | #7728 |
| motifs | #7730 |
| critical roles | #7731 |
| diagnostics | #7735 |
| bacterial toxins | #7735 |
| initiation | #7745 |
| 325 | #7749 |
| rodent | #7751 |
| chain | #7753 |
| granulocyte | #7754 |
| leukocytes mononuclear | #7766 |
| candidate genes | #7769 |
| activates | #7772 |
| mer | #7772 |
| 37°c | #7773 |
| manuscript | #7780 |
| resolving | #7797 |
| carbonic | #7798 |
| cells tregs | #7800 |
| cell surface receptors | #7807 |
| diet fat | #7810 |
| tgf beta1 | #7831 |
| lipopolysaccharides | #7836 |
| patients levels | #7843 |
| strain | #7844 |
| cells pbmcs | #7853 |
| sirtuin | #7854 |
| retinoid | #7862 |
| interleukin1 | #7866 |
| ifnγ | #7872 |
| gene therapy | #7878 |
| amenable | #7895 |
| analyze | #7897 |
| illness | #7901 |
| lymphopenia | #7909 |
| 2nd | #7917 |
| th2 | #7918 |
| fact | #7925 |
| mann | #7929 |
| myocarditis | #7932 |
| discoveries | #7955 |
| cellular immune | #7957 |
| immunodiffusion | #7959 |
| transform infrared | #7960 |
| positive | #7982 |
| nitrites | #7983 |
| candidate gene | #7987 |
| scoring | #7989 |
| direct effects | #7991 |
| tregs | #7991 |
| unknown | #7993 |
| immune function | #7994 |
| oxidative | #7996 |
| fertilized | #8002 |
| identifies | #8007 |
| haplotypes humans | #8011 |
| polymorphisms | #8012 |
| psa | #8015 |
| essential | #8017 |
| hydroxy | #8030 |
| capacity | #8031 |
| raised | #8040 |
| lncrna | #8047 |
| macroscopic | #8049 |
| myeloid differentiation | #8054 |
| respiratory distress | #8063 |
| address | #8064 |
| drive | #8066 |
| evaluation preclinical | #8067 |
| ascertained | #8077 |
| factor signal | #8077 |
| spanning | #8085 |
| hypophyseal | #8087 |
| tetramer | #8088 |
| appearing | #8088 |
| clinical evaluation | #8089 |
| suboptimal | #8101 |
| physiological | #8105 |
| prolongation | #8108 |
| homozygosity | #8108 |
| considerably | #8109 |
| intronic | #8113 |
| prerequisite | #8120 |
| reasons | #8130 |
| bovine | #8133 |
| nash | #8133 |
| latest | #8134 |
| macrophages peritoneal | #8141 |
| definition | #8141 |
| dying | #8148 |
| trachea | #8156 |
| peripheral nerve | #8160 |
| relapses | #8166 |
| conditioned | #8167 |
| elevated | #8167 |
| harbor | #8170 |
| characterize | #8170 |
| bacterial infection | #8176 |
| expression | #8180 |
| member | #8181 |
| induced inflammation | #8186 |
| rescue | #8192 |
| sacrificed | #8197 |
| cassette | #8198 |
| analysing | #8209 |
| underlying | #8214 |
| preferential | #8216 |
| genetic associations | #8225 |
| sulphate | #8225 |
| defective | #8238 |
| ors | #8241 |
| marginal zone | #8244 |
| foster | #8245 |
| wide | #8261 |
| cultured cytokines | #8268 |
| ppar | #8274 |
| fibrinogen | #8275 |
| bone resorption | #8290 |
| clinical manifestations | #8294 |
| disease genome | #8295 |
| differ | #8295 |
| subcutaneous injection | #8300 |
| streptococcal | #8302 |
| oxygen | #8304 |
| combined treatment | #8309 |
| monoester | #8310 |
| remodeling | #8311 |
| 11 | #8316 |
| peptide1 | #8316 |
| aspergillus fumigatus | #8316 |
| genetically modified | #8320 |
| tlr | #8339 |
| cov2 infection | #8349 |
| boronic | #8363 |
| vh | #8363 |
| frequency | #8364 |
| parietal | #8367 |
| firstly | #8379 |
| fibrils | #8388 |
| migrate | #8391 |
| expressed | #8400 |
| poly | #8401 |
| residue | #8401 |
| p001 | #8404 |
| cd11b | #8408 |
| unaffected | #8411 |
| hydrophilicity | #8420 |
| notion | #8424 |
| advancement | #8424 |
| macrophage activation | #8429 |
| highlights | #8433 |
| defense | #8436 |
| viable | #8460 |
| 14 | #8468 |
| lamina | #8472 |
| manifestation | #8482 |
| protein conformation | #8485 |
| damaging | #8500 |
| promotes | #8502 |
| booster | #8512 |
| inflammatory process | #8516 |
| involves | #8520 |
| cells express | #8525 |
| mildly | #8527 |
| phenotype | #8539 |
| drug development | #8539 |
| burkholderia | #8540 |
| forkhead transcription | #8544 |
| human neutrophils | #8545 |
| estradiol | #8546 |
| copy | #8554 |
| tubule | #8558 |
| adaptive | #8568 |
| inflammatory cytokines | #8576 |
| responsive | #8580 |
| cellular functions | #8582 |
| marginal | #8600 |
| productive | #8609 |
| region | #8618 |
| stress reactive | #8622 |
| chickens | #8638 |
| xanthine | #8641 |
| positivity | #8659 |
| uncovered | #8689 |
| inducers | #8705 |
| outline | #8708 |
| experimental mice mice | #8716 |
| constitutive expression | #8717 |
| vigorous | #8717 |
| ccaat | #8720 |
| staphylococci | #8725 |
| regulatory cell | #8734 |
| cytokine | #8750 |
| recovered | #8751 |
| resorption | #8757 |
| rejection | #8759 |
| larynx | #8761 |
| subset | #8775 |
| chemokine receptor | #8777 |
| impaired | #8781 |
| highlight | #8782 |
| promoter | #8789 |
| cells human | #8790 |
| homozygous | #8792 |
| 4 weeks | #8792 |
| generate | #8799 |
| fungal infections | #8807 |
| occasionally | #8808 |
| human serum | #8808 |
| parotid | #8809 |
| chemically | #8809 |
| generates | #8811 |
| female male | #8812 |
| cytokine levels | #8825 |
| correlated | #8830 |
| kupffer | #8836 |
| cell phenotype | #8866 |
| pathway | #8867 |
| precisely | #8877 |
| bovis | #8882 |
| pathways | #8883 |
| unidentified | #8885 |
| frequencies | #8890 |
| deletion | #8893 |
| key regulator | #8903 |
| endopeptidases | #8922 |
| flow cytometric | #8932 |
| strengthen | #8941 |
| hypothalamo | #8941 |
| and or | #8942 |
| staining | #8944 |
| chemiluminescence | #8945 |
| modulate | #8948 |
| pge2 | #8966 |
| pitfalls | #8967 |
| subpopulation | #8967 |
| attack | #8975 |
| neonatal | #8981 |
| gene | #8983 |
| endosomal | #8987 |
| 129 | #8990 |
| vasculature | #9008 |
| rna long | #9017 |
| adrenocorticotropic | #9019 |
| chemoattractant | #9019 |
| discriminate | #9043 |
| thp1 | #9068 |
| leading | #9074 |
| positioned | #9075 |
| specific role | #9081 |
| glut4 | #9084 |
| hl60 | #9115 |
| cd4 cell | #9129 |
| differentially | #9131 |
| human | #9131 |
| cell surface | #9135 |
| pad | #9136 |
| ongoing | #9160 |
| reconstitution | #9166 |
| negative | #9175 |
| causative | #9182 |
| preincubation | #9186 |
| secrete | #9196 |
| tnf | #9198 |
| lethal | #9205 |
| serologic | #9213 |
| respiratory syndrome | #9222 |
| innate immunity | #9233 |
| started | #9233 |
| sequence | #9238 |
| cells isolated | #9241 |
| glomerulus | #9242 |
| immortalized | #9244 |
| severely | #9250 |
| orphan | #9255 |
| offer | #9255 |
| millions | #9268 |
| ubiquitous | #9272 |
| matrix | #9273 |
| killer | #9278 |
| crystal structures | #9313 |
| clear | #9315 |
| smoking status | #9329 |
| sdspage | #9335 |
| copolymers | #9346 |
| carbohydrate | #9368 |
| neutralizing | #9381 |
| immunoblot | #9395 |
| sweden | #9420 |
| functionality | #9425 |
| cysteine | #9458 |
| ifnα | #9459 |
| lacks | #9460 |
| treatment strategies | #9463 |
| immunomodulation | #9473 |
| luminescent | #9474 |
| molecular | #9484 |
| endotoxins | #9487 |
| tlr4 | #9501 |
| immobilized | #9505 |
| cyclosporin | #9519 |
| hormonal | #9519 |
| immunofluorescence | #9519 |
| sensitized | #9523 |
| detrimental | #9524 |
| heritable | #9530 |
| preexisting | #9543 |
| neuroinflammation | #9558 |
| factor beta1 | #9560 |
| interferon regulatory | #9572 |
| regulated | #9576 |
| culture techniques | #9577 |
| analogous | #9593 |
| entering | #9608 |
| affinities | #9614 |
| steroid hormones | #9615 |
| pretreated | #9624 |
| vaccinated | #9638 |
| gestation | #9639 |
| mammalian cells | #9643 |
| attached | #9647 |
| genetic models | #9655 |
| basement membrane | #9657 |
| key | #9658 |
| vehicle | #9670 |
| cell adhesion | #9678 |
| dramatic | #9694 |
| slight | #9694 |
| accessible | #9708 |
| snp | #9709 |
| azathioprine | #9721 |
| ear | #9723 |
| environment interaction | #9730 |
| livers | #9753 |
| humanized | #9753 |
| maintenance | #9756 |
| metabolic syndrome mets | #9758 |
| functional analysis | #9772 |
| blocked | #9776 |
| cleavage | #9781 |
| microscopic | #9784 |
| adhesion cell | #9784 |
| nasal | #9786 |
| plasminogen activator | #9788 |
| structure activity | #9789 |
| lowered | #9804 |
| infectious | #9804 |
| sterile | #9810 |
| driven | #9836 |
| fibronectin | #9846 |
| delineation | #9856 |
| rheumatology | #9870 |
| phage | #9872 |
| memory cells | #9874 |
| nonhuman primates | #9876 |
| pathogens | #9902 |
| serological | #9907 |
| coculture | #9927 |
| interleukin8 | #9936 |
| healthy control | #9938 |
| reactions | #9953 |
| monkeys | #9973 |
| anticipated | #9993 |
| nucleic acids | #10007 |
| flare | #10014 |
| inflammatory cytokine | #10023 |
| genotype | #10053 |
| serum | #10061 |
| leukocytes | #10067 |
| administered | #10070 |
| differentiation factor | #10076 |
| inflammation male | #10091 |
| generating | #10093 |
| surface receptors | #10102 |
| fibrin | #10105 |
| cells patients | #10110 |
| virulence factors | #10110 |
| activated | #10122 |
| ccl4 | #10125 |
| il1beta | #10131 |
| edge | #10132 |
| new strategy | #10136 |
| host cells | #10139 |
| mitogens | #10140 |
| cell signaling | #10143 |
| kappa | #10143 |
| th2 cells | #10147 |
| retroviridae | #10157 |
| postmenopausal | #10172 |
| traps | #10177 |
| hydrogen peroxide | #10184 |
| placenta | #10185 |
| named | #10188 |
| tlrs | #10207 |
| delta | #10218 |
| summarize | #10236 |
| day | #10244 |
| molecular biology | #10259 |
| rats spraguedawley receptors | #10277 |
| arg | #10279 |
| reproducible | #10283 |
| animals anti | #10304 |
| germ | #10305 |
| gene environment | #10307 |
| tendency | #10317 |
| scid | #10324 |
| lectins | #10329 |
| dismutase | #10332 |
| avian influenza | #10343 |
| reductive | #10347 |
| complete | #10365 |
| mediators | #10378 |
| nterminal | #10392 |
| partially | #10400 |
| lasting | #10406 |
| promote | #10424 |
| determine | #10429 |
| cterminus | #10432 |
| refined | #10437 |
| kill | #10441 |
| cattle | #10446 |
| assays | #10447 |
| indirectly | #10460 |
| mediates | #10474 |
| thioredoxin | #10475 |
| occur | #10477 |
| motif | #10479 |
| redundant | #10502 |
| receptor binding | #10504 |
| developing | #10513 |
| behavior animal | #10515 |
| promoter regions | #10545 |
| phosphate | #10548 |
| produced | #10552 |
| exception | #10554 |
| dysregulated | #10557 |
| critical | #10564 |
| influence | #10568 |
| understood | #10572 |
| converting enzyme | #10584 |
| progressive | #10597 |
| rise | #10608 |
| female | #10609 |
| shortened | #10612 |
| small molecule | #10616 |
| nf kappa | #10617 |
| extracellular matrix | #10620 |
| paralysis | #10632 |
| primers | #10636 |
| collectively | #10637 |
| underlie | #10642 |
| testosterone | #10659 |
| macrophage colony | #10664 |
| selective inhibitor | #10667 |
| aged osteoarthritis | #10675 |
| summary | #10684 |
| repeats | #10685 |
| pbs | #10702 |
| respond | #10705 |
| cerebrospinal fluid | #10708 |
| 17 | #10713 |
| disruption | #10729 |
| issue | #10762 |
| conformation | #10767 |
| il18 | #10770 |
| generation | #10781 |
| cleaved | #10800 |
| 103 | #10811 |
| conditional | #10821 |
| capture | #10822 |
| operated | #10824 |
| seropositive | #10826 |
| cellular mechanisms | #10838 |
| saline | #10857 |
| belonging | #10857 |
| restraint | #10864 |
| phosphatase | #10866 |
| immunoblotting | #10872 |
| factor1 | #10880 |
| base | #10885 |
| connective tissue | #10896 |
| multifunctional | #10904 |
| phagocytosis | #10904 |
| avoid | #10909 |
| ineffective | #10909 |
| luciferase | #10915 |
| bronchoalveolar | #10916 |
| promise | #10920 |
| pivotal | #10926 |
| secondary | #10926 |
| mulatta | #10929 |
| mannose | #10934 |
| persisted | #10939 |
| concluded | #10955 |
| methotrexate | #10967 |
| myeloid cells | #10978 |
| airway inflammation | #10982 |
| degrading | #10983 |
| immunoassay | #10984 |
| subcutaneously | #10984 |
| characterization | #10986 |
| governing | #10998 |
| septic | #11000 |
| ethanol | #11000 |
| tnfα | #11003 |
| mpo | #11010 |
| cell subsets | #11012 |
| originally | #11016 |
| 263 | #11027 |
| immunohistochemistry | #11028 |
| scid mice | #11030 |
| occurrence | #11030 |
| messenger | #11037 |
| hyper | #11040 |
| optical imaging | #11045 |
| skin | #11056 |
| establish | #11066 |
| calcitriol | #11067 |
| tumor progression | #11088 |
| paternal | #11094 |
| add | #11096 |
| freezing | #11102 |
| systemic | #11112 |
| infection animals | #11117 |
| focusing | #11144 |
| genetic polymorphism | #11161 |
| male | #11167 |
| innate immune response | #11167 |
| osteoarthritis | #11176 |
| influx | #11177 |
| receptors | #11177 |
| subsequent | #11177 |
| affinity chromatography | #11186 |
| genes involved | #11187 |
| ankylosing spondylitis | #11197 |
| article | #11201 |
| directly | #11208 |
| bsa | #11210 |
| limited | #11223 |
| sorting | #11229 |
| elicited | #11230 |
| interleukin10 | #11232 |
| disulfides | #11233 |
| contributed | #11248 |
| peptidase | #11251 |
| human blood | #11281 |
| ability | #11284 |
| extensive | #11297 |
| humans influenza | #11314 |
| genotyped | #11318 |
| compared controls | #11322 |
| depends | #11323 |
| oxidant | #11344 |
| caution | #11347 |
| addressing | #11351 |
| tissue damage | #11352 |
| correlate | #11354 |
| extra | #11356 |
| histopathologic | #11376 |
| neuroglia | #11384 |
| modifications | #11385 |
| experimental evidence | #11409 |
| increased expression | #11410 |
| pharmacology | #11413 |
| oxidative phosphorylation | #11428 |
| eosinophilic | #11432 |
| interleukin12 | #11437 |
| quantified | #11438 |
| receptor | #11445 |
| hla class | #11447 |
| cell death | #11460 |
| enhance | #11461 |
| reduces | #11466 |
| governed | #11476 |
| initiating | #11479 |
| contrasting | #11480 |
| melanoma cells | #11488 |
| compared healthy | #11489 |
| cd8 cell | #11498 |
| ankle | #11508 |
| serine | #11525 |
| cytosol | #11542 |
| recipient | #11546 |
| ca2 | #11559 |
| therapeutic interventions | #11561 |
| mets | #11566 |
| jurkat | #11569 |
| backgrounds | #11570 |
| inflammatory effects | #11595 |
| culture medium | #11599 |
| differential expression | #11606 |
| alteration | #11627 |
| frequently | #11627 |
| chicken | #11649 |
| swiss | #11652 |
| enhanced | #11661 |
| exerted | #11663 |
| immunologic memory | #11672 |
| transforming growth | #11678 |
| relief | #11691 |
| synergism | #11703 |
| psychotic | #11730 |
| controls | #11730 |
| toxin | #11735 |
| aiming | #11737 |
| innovative | #11751 |
| amyotrophic | #11769 |
| cell lineage | #11773 |
| constitutes | #11774 |
| inoculated | #11781 |
| commentary | #11785 |
| multiple | #11805 |
| selective | #11814 |
| display | #11817 |
| moderately | #11819 |
| altered | #11829 |
| insufficient | #11830 |
| sequence homology | #11840 |
| 9 | #11857 |
| graft | #11866 |
| analogues | #11871 |
| forkhead | #11888 |
| stained | #11890 |
| enzyme | #11942 |
| augmentation | #11943 |
| classic | #11944 |
| supplied | #11946 |
| gastrointestinal tract | #11958 |
| reveal | #11966 |
| animals bone | #11966 |
| maternal fetal | #11968 |
| adherent | #11980 |
| stress response | #11991 |
| contribution | #11998 |
| tgf | #12005 |
| biomarker | #12016 |
| antiserum | #12017 |
| cricetulus | #12021 |
| deacetylase | #12050 |
| encoding | #12051 |
| plasma cell | #12059 |
| aethiops | #12067 |
| propose | #12072 |
| fat diet | #12104 |
| immunologic factors | #12106 |
| protection | #12107 |
| downstream | #12107 |
| il2 | #12111 |
| tyrosine | #12113 |
| lung | #12116 |
| effectively | #12118 |
| replaced | #12144 |
| induced cell | #12147 |
| bromide | #12152 |
| humans | #12155 |
| quiescent | #12181 |
| switched | #12181 |
| genetic vectors | #12203 |
| oligodeoxyribonucleotides | #12204 |
| myd88 | #12222 |
| histologic | #12222 |
| lectin | #12223 |
| therapeutics | #12230 |
| mesenteric | #12231 |
| toxic | #12231 |
| represents | #12233 |
| receptors estrogen | #12236 |
| corticosterone | #12242 |
| noncoding | #12244 |
| diabetic mice | #12257 |
| fibroblasts humans | #12268 |
| recombinant | #12270 |
| splice | #12271 |
| involving | #12273 |
| fluorescent antibody | #12276 |
| mineral | #12297 |
| tnf alpha | #12300 |
| streptococcus | #12310 |
| harmful | #12319 |
| depending | #12361 |
| acid | #12363 |
| leukocyte count | #12369 |
| syndromes | #12371 |
| tradeoff | #12389 |
| interplay | #12412 |
| origin | #12416 |
| clonal | #12420 |
| microfilament | #12423 |
| reversed | #12439 |
| publication adaptor proteins | #12462 |
| weaker | #12464 |
| protein expression | #12503 |
| pain | #12532 |
| hydrochloride | #12535 |
| drug design | #12567 |
| functional | #12573 |
| rats treated | #12596 |
| suppressor | #12596 |
| binding site | #12597 |
| monomeric | #12605 |
| medullary | #12637 |
| cells natural | #12637 |
| explained | #12643 |
| macaca | #12645 |
| notably | #12664 |
| chronic diseases | #12665 |
| fetuses | #12665 |
| adenine | #12679 |
| cdnas | #12679 |
| p38 mitogen | #12681 |
| 6 weeks | #12681 |
| investigation | #12697 |
| instance | #12709 |
| alveolar | #12729 |
| persistent | #12729 |
| receptor alpha | #12743 |
| modulators | #12770 |
| interactions | #12785 |
| aimed | #12791 |
| nature | #12795 |
| influencing | #12800 |
| diminished | #12804 |
| tibia | #12813 |
| initiated | #12813 |
| sole | #12814 |
| metalloproteinases | #12819 |
| thought | #12823 |
| twin | #12854 |
| isolated | #12871 |
| solely | #12882 |
| disadvantages | #12886 |
| sulfhydryl | #12921 |
| sustained | #12922 |
| assay | #12926 |
| breakdown | #12984 |
| cell division | #13004 |
| embryonic development | #13020 |
| damage | #13056 |
| removing | #13067 |
| tryptophan | #13079 |
| tightly | #13087 |
| crystallography | #13101 |
| hyaluronic | #13102 |
| enabling | #13133 |
| time pcr | #13141 |
| publications | #13143 |
| receptors cell | #13145 |
| stereoisomerism | #13158 |
| distress syndrome | #13175 |
| ancestral | #13179 |
| retained | #13203 |
| valine | #13205 |
| division | #13213 |
| suffering | #13215 |
| single nucleotide polymorphisms | #13234 |
| opportunity | #13243 |
| opportunities | #13258 |
| 1 protein | #13270 |
| chemotaxis | #13279 |
| modulator | #13283 |
| lavage fluid | #13293 |
| transgene | #13297 |
| ascending | #13302 |
| regulators | #13320 |
| elucidated | #13323 |
| purity | #13330 |
| bronchoalveolar lavage | #13334 |
| nk | #13353 |
| fisher | #13357 |
| inhibitory effects | #13362 |
| lymphoproliferative | #13372 |
| amyotrophic lateral | #13377 |
| facilitating | #13380 |
| overexpressed | #13383 |
| scattered | #13389 |
| borrelia | #13393 |
| intact | #13410 |
| independently | #13433 |
| thiol | #13434 |
| fibroblast | #13447 |
| oocytes | #13463 |
| embryos | #13465 |
| marrow derived | #13484 |
| spraguedawley receptors | #13488 |
| overcome | #13489 |
| endopeptidase | #13500 |
| aspect | #13523 |
| lateral sclerosis | #13577 |
| tail | #13589 |
| selectively | #13591 |
| lipopolysaccharide | #13598 |
| elisa | #13612 |
| heritability | #13616 |
| vertebrates | #13627 |
| renal disease | #13634 |
| cure | #13674 |
| peripheral | #13689 |
| reproductive | #13755 |
| clones | #13757 |
| requires | #13783 |
| profiling gene | #13808 |
| lavage | #13811 |
| exon | #13822 |
| arising | #13831 |
| secretory | #13835 |
| techniques | #13873 |
| 6 | #13879 |
| killer cells | #13891 |
| exposed | #13917 |
| cloned | #13927 |
| iga | #13936 |
| hepatocytes | #13938 |
| tolerant | #13992 |
| lncrnas | #14002 |
| anti inflammatory | #14010 |
| killed | #14033 |
| selectin | #14034 |
| sensitization | #14035 |
| environmental | #14057 |
| insertion | #14063 |
| recombinant proteins | #14070 |
| neighboring | #14098 |
| reflects | #14102 |
| great | #14120 |
| preclinical | #14123 |
| highlighting | #14145 |
| preventing | #14148 |
| healthy individuals | #14159 |
| administration | #14164 |
| vaccination | #14176 |
| potent | #14183 |
| retroviral | #14208 |
| multigene | #14246 |
| advances | #14275 |
| amino acids | #14298 |
| ester | #14310 |
| oxidative stress | #14315 |
| cord | #14319 |
| incidence | #14322 |
| impairs | #14323 |
| domain | #14325 |
| psychosis | #14326 |
| bovine serum | #14329 |
| p38 | #14329 |
| isolation | #14334 |
| differentiation | #14342 |
| multiprotein | #14366 |
| mineral density | #14406 |
| #14414 | |
| differentiation cells | #14414 |
| resolve | #14420 |
| colony stimulating | #14421 |
| consistently | #14448 |
| paracrine | #14452 |
| kinases animals | #14452 |
| adenoviridae | #14472 |
| chlorocebus | #14481 |
| marrow transplantation | #14485 |
| targeted | #14490 |
| pathology | #14492 |
| il1 | #14500 |
| integrative | #14510 |
| cells vitro | #14537 |
| monocytes | #14540 |
| bone density | #14589 |
| infectious diseases | #14593 |
| biomedical | #14605 |
| nitrate | #14616 |
| nf kappab | #14627 |
| recombinant human | #14632 |
| divergent | #14638 |
| pathological | #14640 |
| enzyme activation | #14658 |
| lupus nephritis | #14661 |
| smoking | #14673 |
| transforming | #14675 |
| gfp | #14681 |
| inborn | #14696 |
| hand | #14698 |
| green fluorescent | #14703 |
| scarce | #14718 |
| risk developing | #14724 |
| substances | #14724 |
| nitrates | #14728 |
| oxide synthase | #14731 |
| p005 | #14732 |
| particulate | #14751 |
| oxidoreductases | #14753 |
| protein binding | #14757 |
| blood vessels | #14759 |
| human cells | #14768 |
| interferon alpha | #14780 |
| il1β | #14800 |
| degenerative | #14815 |
| proteinase | #14817 |
| originating | #14824 |
| vitro | #14829 |
| overlapping | #14835 |
| biocompatible | #14851 |
| prostaglandins | #14881 |
| controlled | #14895 |
| interaction | #14916 |
| chronically | #14923 |
| genomic dna | #14929 |
| potential therapeutic | #14939 |
| colleagues | #14950 |
| plays | #15011 |
| cross | #15041 |
| implications | #15063 |
| escape | #15078 |
| granule | #15079 |
| receptor gene | #15089 |
| phosphoric | #15090 |
| converting | #15126 |
| acute respiratory | #15173 |
| spinal cord | #15185 |
| seroepidemiologic | #15205 |
| bmd | #15213 |
| proliferation cells | #15219 |
| covalently | #15234 |
| preferentially | #15252 |
| adhesion | #15299 |
| fetus | #15300 |
| processed | #15329 |
| allografts | #15337 |
| synthase | #15339 |
| bone mineral density | #15340 |
| accelerate | #15346 |
| neurodegenerative | #15377 |
| pretreatment | #15379 |
| blood mononuclear | #15414 |
| interleukin6 il6 | #15440 |
| comparative | #15474 |
| selected | #15486 |
| antigens bacterial | #15511 |
| cells dcs | #15513 |
| locally | #15521 |
| transcriptase polymerase | #15530 |
| influenza human | #15537 |
| basis | #15540 |
| hormone | #15542 |
| central nervous | #15566 |
| estrogen receptor | #15572 |
| transduction | #15579 |
| vaccines | #15623 |
| responsiveness | #15647 |
| rna interference | #15649 |
| binds | #15651 |
| accelerator | #15673 |
| limitation | #15675 |
| pyruvate | #15682 |
| sequenced | #15696 |
| conformational | #15701 |
| cd28 | #15708 |
| connective | #15748 |
| gastric | #15775 |
| single | #15789 |
| fluorescent | #15793 |
| bone loss | #15832 |
| induced expression | #15835 |
| protein structure | #15849 |
| spinal | #15861 |
| vasculitis | #15884 |
| treating | #15887 |
| kappab | #15894 |
| gcsf | #15908 |
| competitive | #15910 |
| positron emission | #15913 |
| downregulation | #15914 |
| systemic inflammation | #15944 |
| methylated | #15945 |
| neurodegeneration | #15945 |
| involve | #15980 |
| ap1 | #15985 |
| plasmon resonance | #15986 |
| reflected | #15993 |
| chromatographic | #16019 |
| cnv | #16065 |
| oligonucleotide array | #16092 |
| 106 | #16097 |
| responding | #16105 |
| pluripotent | #16135 |
| bone mineral | #16141 |
| undetectable | #16148 |
| skeletal | #16151 |
| neurons | #16154 |
| tissue distribution | #16155 |
| disequilibrium | #16156 |
| beta1 | #16172 |
| exhibited | #16189 |
| response treatment | #16236 |
| grafted | #16238 |
| array sequence | #16239 |
| glandular | #16252 |
| functional studies | #16273 |
| responders | #16278 |
| new class | #16282 |
| subunit | #16293 |
| required | #16309 |
| animals base | #16310 |
| subclinical | #16311 |
| linkage disequilibrium | #16342 |
| receptor signaling | #16351 |
| difference | #16367 |
| remarkably | #16382 |
| molecular structure | #16391 |
| form | #16409 |
| signalling | #16414 |
| molecular mechanism | #16419 |
| publication antibodies | #16433 |
| cd40 | #16468 |
| shr | #16471 |
| capable | #16496 |
| grouped | #16512 |
| subcutaneous | #16522 |
| fibroblasts | #16525 |
| revealing | #16544 |
| targeting | #16552 |
| node | #16585 |
| respiratory | #16585 |
| organs | #16586 |
| tumor cells | #16600 |
| antibodies bacterial | #16603 |
| subunits | #16626 |
| profiling | #16651 |
| necrosis | #16655 |
| negatively | #16709 |
| establishing | #16709 |
| uric | #16743 |
| irradiated | #16757 |
| nick | #16765 |
| intramolecular | #16795 |
| deeper | #16801 |
| instrumental | #16812 |
| detected | #16851 |
| immunoreactive | #16859 |
| clinically | #16859 |
| serve | #16878 |
| inhibitory | #16881 |
| documented | #16904 |
| greatly | #16907 |
| colony | #16928 |
| turn | #16941 |
| immunosuppression | #16942 |
| mmps | #16957 |
| inhibition | #16959 |
| receptor 1 | #16964 |
| additionally | #16970 |
| humans hydrogen | #16982 |
| structurally | #16985 |
| prior | #16994 |
| additional | #17005 |
| binding protein | #17006 |
| recombinant fusion | #17013 |
| sulfate | #17069 |
| b7 | #17077 |
| count | #17083 |
| il12 | #17096 |
| sex factors | #17111 |
| consist | #17113 |
| minimal | #17116 |
| alpha subunit | #17119 |
| lysosomal | #17126 |
| unexpected | #17137 |
| tissue | #17148 |
| pluripotent stem | #17151 |
| receptors tumor | #17172 |
| csf | #17185 |
| activator | #17202 |
| lymph node | #17208 |
| underlying mechanisms | #17217 |
| stimulation | #17249 |
| starting | #17298 |
| peritoneal | #17299 |
| cell proliferation | #17318 |
| fluid | #17330 |
| propensity | #17345 |
| generations | #17377 |
| humans immunity | #17410 |
| constitute | #17425 |
| demonstrated | #17444 |
| membrane | #17466 |
| muscle skeletal | #17479 |
| types | #17505 |
| allowing | #17505 |
| transcriptase | #17515 |
| fibrous | #17515 |
| type iii | #17546 |
| localization | #17547 |
| constitutive | #17559 |
| cytometry humans | #17570 |
| discovery | #17583 |
| treatments | #17596 |
| peripheral blood | #17615 |
| variation | #17616 |
| packed | #17678 |
| differed | #17683 |
| expanded | #17687 |
| proved | #17691 |
| plasmon | #17698 |
| longitudinally | #17713 |
| pbmcs | #17728 |
| stimulating factor | #17743 |
| somatic | #17805 |
| inflammatory bowel disease | #17815 |
| dcs | #17827 |
| relating | #17861 |
| alpha tnf | #17880 |
| neuroendocrine | #17920 |
| oligonucleotide | #17954 |
| homology | #17962 |
| surface plasmon | #17971 |
| pregnancy | #17985 |
| chromosomal | #17994 |
| post | #17998 |
| inhibit | #18002 |
| labelled | #18004 |
| damaged | #18064 |
| osmolar | #18107 |
| 2 4 | #18130 |
| creating | #18142 |
| cytoplasm | #18155 |
| released | #18157 |
| trigger | #18161 |
| corticosteroids | #18164 |
| species | #18168 |
| endocrine | #18192 |
| vertebrate | #18206 |
| labeled | #18208 |
| subcellular | #18231 |
| rna messenger | #18235 |
| protein serine | #18279 |
| limiting | #18281 |
| reverse transcriptase | #18325 |
| evidenced | #18329 |
| truncated | #18336 |
| avian | #18345 |
| net | #18345 |
| males | #18375 |
| critically | #18389 |
| assumed | #18433 |
| modulated | #18444 |
| rats wistar | #18448 |
| pathogen | #18464 |
| immunogenicity | #18486 |
| acids | #18490 |
| reaching | #18494 |
| nonparametric | #18512 |
| constitutively | #18518 |
| processing | #18609 |
| hyaluronan | #18609 |
| sulfonamides | #18643 |
| investigating | #18651 |
| 15 | #18656 |
| 22 | #18658 |
| verify | #18669 |
| signal transduction | #18682 |
| agents steroidal | #18685 |
| remaining | #18721 |
| aim | #18788 |
| cerebrospinal | #18788 |
| created | #18803 |
| balanced | #18823 |
| cultured | #18823 |
| carry | #18829 |
| pathophysiological | #18830 |
| production | #18927 |
| nerve | #18943 |
| nested | #18957 |
| nfκb | #18987 |
| failed | #18988 |
| sequence analysis | #19002 |
| specific antigen | #19050 |
| observations | #19062 |
| provided | #19067 |
| bone marrow | #19084 |
| lungs | #19111 |
| stimulating | #19136 |
| protein | #19164 |
| bearing | #19167 |
| publication administration | #19185 |
| gained | #19200 |
| mitochondrial | #19260 |
| symptoms | #19288 |
| lost | #19298 |
| majority | #19304 |
| intra | #19311 |
| interacts | #19344 |
| hormones | #19441 |
| fatal | #19464 |
| interferons | #19489 |
| analyzing | #19515 |
| exogenous | #19526 |
| cytoskeletal | #19553 |
| adrenal | #19553 |
| rapidly | #19574 |
| inducible | #19616 |
| etiology | #19652 |
| environment | #19668 |
| implanted | #19680 |
| lps | #19681 |
| mice scid | #19683 |
| vesicular | #19701 |
| lineage | #19719 |
| markers | #19789 |
| histologically | #19817 |
| offers | #19826 |
| cutaneous | #19834 |
| precise | #19836 |
| pharmacological | #19854 |
| fetal | #19862 |
| shifted | #19875 |
| newly | #19892 |
| supporting | #19915 |
| vitro techniques | #19945 |
| yielded | #19948 |
| 8 | #19978 |
| 28 | #19979 |
| cns | #19979 |
| response relationship | #20014 |
| transient | #20038 |
| modify | #20055 |
| designated | #20056 |
| reverse | #20057 |
| casecontrol study | #20088 |
| mutagenesis | #20118 |
| illustrated | #20126 |
| downregulated | #20133 |
| ultimately | #20202 |
| κb | #20256 |
| 1 diabetes | #20263 |
| hypothalamic | #20285 |
| primary | #20303 |
| entered | #20310 |
| nitric | #20316 |
| gene expression | #20364 |
| markedly | #20453 |
| genotype humans | #20460 |
| mature | #20491 |
| microglia | #20561 |
| circulating | #20574 |
| overexpressing | #20593 |
| human pair | #20604 |
| polyacrylamide | #20612 |
| marrow | #20651 |
| defining | #20660 |
| pregnant | #20665 |
| equal | #20678 |
| resting | #20729 |
| injured | #20739 |
| mild | #20819 |
| local | #20825 |
| discovered | #20835 |
| cricetinae | #20839 |
| reduction | #20847 |
| illustrate | #20874 |
| lactic | #20908 |
| hypothesized | #20913 |
| tended | #20919 |
| successful | #20952 |
| 10 | #20952 |
| cell derived | #20955 |
| aberrant | #20961 |
| animals biomarkers | #21033 |
| 2 | #21085 |
| attractive | #21228 |
| acute | #21279 |
| produces | #21297 |
| transfected | #21316 |
| marked | #21340 |
| decreased | #21383 |
| maternal | #21389 |
| emerged | #21445 |
| survived | #21524 |
| confirms | #21558 |
| membrane proteins | #21585 |
| forming | #21593 |
| preserved | #21732 |
| contained | #21802 |
| previous | #21805 |
| 16 | #21813 |
| doses | #21835 |
| immunodeficiency | #21852 |
| electrophoresis | #21867 |
| mellitus type | #21871 |
| natural killer | #21877 |
| cell count | #21898 |
| prolonged | #21903 |
| heavy | #21965 |
| increasing | #21979 |
| polymeric | #22042 |
| gradually | #22067 |
| glial | #22202 |
| selecting | #22242 |
| extremely | #22248 |
| 4 | #22274 |
| opportunistic | #22307 |
| accepted | #22356 |
| emission tomography | #22395 |
| enable | #22402 |
| humans models | #22445 |
| initially | #22458 |
| microscopy confocal | #22466 |
| physiologic | #22470 |
| appears | #22488 |
| releasing | #22497 |
| suitable | #22522 |
| humans immunosuppressive | #22529 |
| confirm | #22553 |
| chemokine | #22558 |
| metabolic | #22585 |
| actins | #22597 |
| loss | #22611 |
| nf | #22756 |
| reactive protein | #22834 |
| utilizing | #22899 |
| transformed | #22917 |
| progression female | #22918 |
| detailed | #23005 |
| natural | #23089 |
| cell types | #23132 |
| sex | #23234 |
| null | #23277 |
| untranslated | #23305 |
| signaling | #23324 |
| syndrome | #23335 |
| bone | #23397 |
| necrosis factor | #23407 |
| rich | #23430 |
| cells tumor | #23467 |
| nucleic | #23501 |
| continued | #23663 |
| cellular | #23667 |
| expression gene | #23728 |
| attenuated | #23757 |
| mitogen | #23814 |
| serine threonine | #23835 |
| examine | #23864 |
| fusion proteins | #23968 |
| organ | #23990 |
| remained | #23998 |
| prevent | #24026 |
| confined | #24245 |
| oxidized | #24325 |
| called | #24330 |
| discussed | #24334 |
| genomic | #24394 |
| covering | #24485 |
| embryonic | #24490 |
| interleukin | #24583 |
| varying | #24640 |
| weeks | #24698 |
| mechanistic | #24796 |
| putative | #24897 |
| sarcoidosis | #24963 |
| detect | #24963 |
| remains | #25082 |
| controversial | #25175 |
| implies | #25192 |
| stromal | #25269 |
| type 1 diabetes | #25410 |
| enriched | #25470 |
| relation | #25543 |
| attributed | #25618 |
| 7 | #25632 |
| proteins | #25644 |
| tumor necrosis | #25683 |
| dysregulation | #25711 |
| cytoplasmic | #25732 |
| inflammatory agents | #25735 |
| energetic | #25813 |
| healthy | #25887 |
| representing | #25917 |
| challenging | #25976 |
| threonine | #25988 |
| mechanisms underlying | #26094 |
| signal | #26163 |
| tnfalpha | #26432 |
| frequent | #26487 |
| individuals | #26568 |
| antibodies viral | #26579 |
| growth factor | #26602 |
| validated | #26686 |
| lower | #26708 |
| treat | #26713 |
| 3 | #26751 |
| tolerated | #26780 |
| pathophysiology | #26782 |
| explored | #26850 |
| tumor necrosis factor | #26925 |
| comparable | #26955 |
| normal | #27016 |
| define | #27055 |
| exist | #27121 |
| presented | #27123 |
| consists | #27152 |
| intracellular | #27233 |
| invariant | #27331 |
| animals cells | #27339 |
| adaptor proteins | #27447 |
| chromosomes human | #27524 |
| associations | #27560 |
| kda | #27648 |
| tract | #27680 |
| possess | #27765 |
| exclude | #27824 |
| cell tumor | #27826 |
| attributable | #28018 |
| proteins humans | #28150 |
| heterozygote | #28266 |
| treated | #28436 |
| observe | #28472 |
| remain | #28560 |
| regulation humans | #28667 |
| threonine kinases | #28809 |
| hypothesis | #28819 |
| require | #28838 |
| examined | #29041 |
| infection | #29082 |
| 5 | #29247 |
| animals apoptosis | #29491 |
| intracellular signaling | #29517 |
| easily | #29557 |
| effective | #29656 |
| 005 | #29706 |
| fully | #29936 |
| exhibit | #29947 |
| gtp binding | #29997 |
| intravenous | #30185 |
| cell movement | #30520 |
| oxide | #30546 |
| reached | #30655 |
| active | #30908 |
| versus | #30963 |
| 1 | #31228 |
| cell differentiation | #31374 |
| vary | #31548 |
| blotting western | #31843 |
| free | #32409 |
| expression regulation | #32516 |
| needed | #32543 |
| objectives | #32805 |
| generally | #33368 |
| inhibited | #33394 |
| clinical | #33439 |
| sought | #34008 |
| reduce | #34128 |
| biological | #34247 |
| reflect | #34701 |
| separately | #34818 |
| agents | #34868 |
| assess | #34935 |
| polymerase | #35201 |
| nuclear | #35715 |
| polymerase chain | #36180 |
| formed | #36819 |
| chain reaction | #36949 |
| 001 | #36954 |
| measured | #42007 |
Relatório de execução | |
Prominent publications by Rikard Holmdahl
KOL-Index: 15284
The purpose of the study was to map the dominant T cell epitope of the CB11 sequence of CII in RTlu haplotype rats and to determine if, when used as a synthetic peptide, it would induce tolerance to protect against CIA. A dominant epitope corresponding to residues 184-198 included in the sequence of the CB11 fragment of bovine CII was identified in proliferation assay using peptides in an epitope scanning system using synthetic peptides of 15 amino acids, overlapping by 12 amino acids. ...
| Conhecido por Mucosal Tolerance | Synthetic Peptide | Cell Epitope | Cia Cii | Collagen‐induced Arthritis |
KOL-Index: 14658
An antibody response to defined epitopes located on the triple helical portion of type II collagen (CII) is associated with the development of collagen-induced arthritis (CIA) and rheumatoid arthritis (RA). Monoclonal antibodies to epitopes associated with arthritis, but not antibodies specific for epitopes not associated with arthritis, induce arthritis in mice, the so-called collagen antibody induced arthritis (CAIA) model. We have selected monoclonal IgG antibodies specific for four ...
| Conhecido por Collagen Antibody | Induced Arthritis | Monoclonal Antibodies | Mice Inbred | Specific Epitopes |
KOL-Index: 13984
The Aq major histocompatibility complex (MHC) class II molecule is associated with susceptibility to murine collagen-induced arthritis (CIA), whereas the closely related H-2Ap molecule is not. To understand the molecular basis for this difference, we have analyzed the ability of H-2Aq and H-2Ap molecules (referred to as Aq and Ap) to bind and present collagen type II (CII)-derived glycosylated and non-glycosylated peptides. T cell clones specific for the immunodominant CII 256-270 ...
| Conhecido por Collagen‐induced Arthritis | Transgenic Models | Aq Molecule | Structural Basis | C3h Mice |
KOL-Index: 13727
BACKGROUND: Autoantibodies to cyclic citrullinated peptides (anti-CCP) are present in most patients with rheumatoid arthritis (RA), and associate with HLA-DRB1 shared epitope (SE) alleles.
OBJECTIVE: To investigate reactivities of anti-CCP to various citrullinated proteins/peptides, which represent potential autoantigens in RA, and to examine the relationship between such antibodies, and their association with genetic variants within HLA-DRB1 SE alleles.
METHODS: Serum samples from 291 ...
| Conhecido por Citrullinated Antigens | Rheumatoid Arthritis | Drb1 Alleles | Ccp Patients | Antibody Reactivities |
Localization of a critical restriction site on the I-A beta chain that determines susceptibility to collagen-induced arthritis in mice
[ PUBLICATION ]
Type II collagen-induced arthritis (CIA) in mice is an autoimmune experimental model for rheumatoid arthritis. Susceptibility to CIA is associated with certain major histocompatibility complex class II haplotypes. The two very closely related haplotypes H-2q and H-2p differ in susceptibility to CIA. Only mice of H-2q (DBA/1, B10G strains) but not mice of H-2p-expressing strains (like strain B10P) develop CIA and an autoimmune response to type II collagen (CII) after immunization with ...
| Conhecido por Mice Cia | Beta Chain | Rheumatoid Arthritis | H2q Haplotype | Type Collagen Cii |
KOL-Index: 13513
INTRODUCTION: It has previously been shown that an increased number of antibodies against citrullinated peptides/proteins (ACPA) predate the onset of rheumatoid arthritis (RA). Over time antibody positivity expands, involving more specific responses when approaching the onset of symptoms. We investigated the impact of human leukocyte antigen-shared epitope (HLA-SE) alleles and smoking on the development of ACPA, as well as in combination with ACPA during the state of quiescent ...
| Conhecido por Citrullinated Peptides | Onset Symptoms | Development Rheumatoid Arthritis | Combination Acpa | Hlase Smoking |
Antibodies to several citrullinated antigens are enriched in the joints of rheumatoid arthritis patients
[ PUBLICATION ]
OBJECTIVE: High titers of specific anti-citrullinated protein antibodies (ACPAs) are frequently present in the serum of rheumatoid arthritis (RA) patients, but their presence in synovial fluid is less well characterized. The purpose of this study was to compare the levels of antibody to 4 well-defined citrullinated candidate RA autoantigens in serum and synovial fluid and to determine whether antibodies to one citrullinated antigen are dominant over another. Furthermore, we studied their ...
| Conhecido por Citrullinated Antigens | Synovial Fluid | Rheumatoid Arthritis Patients | Type Collagen | Antibodies Acpas |
Toll-like receptor 3 upregulation in macrophages participates in the initiation and maintenance of pristane-induced arthritis in rats
[ PUBLICATION ]
INTRODUCTION: Toll-like receptors (TLRs) are involved in both innate and adaptive immune responses and are likely to play a complex role in the pathogenesis of human rheumatoid arthritis (RA) and experimental arthritis. The objective of this study was to identify the key TLR in pristane-induced arthritis (PIA), a rat model for RA, and to clarify its roles in the initiation and maintenance of arthritis.
METHODS: Arthritis in DA rats was induced by pristane and the severity was evaluated ...
| Conhecido por Induced Arthritis | Tlr3 Expression | Rats Pristane | Receptor 3 | Inbred Strains Severity |
KOL-Index: 12776
Multiple sclerosis (MS) is a complex chronic neurologic disease with a suspected autoimmune pathogenesis1,2. Although there is evidence that the development of MS is determined by both environmental influences and genes, these factors are largely undefined3,4, except for major histocompatibility (MHC) genes. Linkage analyses and association studies have shown that susceptibility to MS is associated with genes in the human histocompatibility leukocyte antigens (HLA) class II region, but ...
| Conhecido por Multiple Sclerosis | Transgenic Mice | Hla Dr2 | Humanized Model | Spontaneous Disease |
KOL-Index: 12721
Polymorphism of the major histocompatibility complex (MHC) influences susceptibility to experimental autoimmune encephalomyelitis (EAE) induced by myelin basic protein (MBP) in rats. Current concepts relate such influences to the capacity of class II molecules to present relevant peptides to autoreactive T cells. We have here analyzed the MHC influence on the immune response and the development of EAE after immunization with the immunodominant peptide MBP-63-88. Analysis of MHC-congenic ...
| Conhecido por Myelin Basic Protein | Experimental Autoimmune | Major Histocompatibility | Rats Eae | Immune Response |
Multiplex Analyses of Antibodies Against Citrullinated Peptides in Individuals Prior to Development of Rheumatoid Arthritis
[ PUBLICATION ]
OBJECTIVE: The presence of antibodies against cyclic citrullinated peptides has been demonstrated to precede the onset of symptoms of rheumatoid arthritis (RA) by several years. The aim of this study was to analyze antibodies against 10 citrullinated autoantigen-derived peptides for reactivity before the onset of RA symptoms.
METHODS: A case-control study was conducted within the Medical Biobank of Northern Sweden. The study was performed in 409 individuals, 386 of whom donated 717 blood ...
| Conhecido por Citrullinated Peptides | Rheumatoid Arthritis | Onset Symptoms | Antibodies Cep1 | Type Collagen |
KOL-Index: 12510
Antibodies against type II collagen (anti-CII) are arthritogenic and have a crucial role in the initiation of collagen-induced arthritis. Here, we have determined the dependence of T and B cells in collagen-antibody-induced arthritis (CAIA) during different phases of arthritis. Mice deficient for B and/or T cells were susceptible to the CAIA, showing that the antibodies induce arthritis even in the absence of an adaptive immune system. To determine whether CII-reactive T cells could have ...
| Conhecido por Collagen Type | Arthritis Mice | Antigen Tcell | Antibodies Cii | Adaptive Immune |
KOL-Index: 12427
The nonobese diabetic (NOD) mouse spontaneously develops autoimmune-mediated diseases such as diabetes and Sjögren's syndrome. To investigate whether NOD genes also promote autoimmune-mediated arthritis we established a NOD strain with an MHC class II fragment containing the A(q) class II gene predisposing for collagen induced arthritis (NOD.Q). However, this mouse was resistant to arthritis in contrast to other A(q) expressing strains such as B10.Q and DBA/1. To determine the major ...
| Conhecido por Genetic Control | Complement Factor | Induced Arthritis | Locus Chromosome | Mice Inbred |
Pessoas importantes para Rheumatoid Arthritis
Principais kols do mundo
Selecione uma frase de pesquisa rheumatoid arthritis , rheumatoid arthritis patients , rheumatoid arthritis treatment , rheumatoid arthritis risk , rheumatoid arthritis study
Rikard Holmdahl:Impacto especializado
Conceitos para os quaisRikard Holmdahltem influência direta:Rheumatoid arthritis, Induced arthritis, Experimental arthritis, Collagen type, Type collagen, Animal models, Reactive oxygen species, Autoimmune diseases.
Rikard Holmdahl:Kol Impact
Conceitos relacionados ao trabalho de outros autores para os quaisfor which Rikard Holmdahl tem influência:Rheumatoid arthritis, Multiple sclerosis, Autoimmune diseases, Oxidative stress, Animal models, Reactive oxygen species, Nadph oxidase.
Tools
Este é o seu perfil? Reivindique seu perfil Copiar URL Incorporar link para o seu perfil |